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Abstract of a thesis submitted in partial fulfilment of the 
requirements for the Degree of Doctor of Philosophy 
Abstract 
Investigation of Robustness and Dynamic Behaviour of G1/S 
Checkpoint/DNA-damage Signal Transduction Pathway based on 
Mathematical Modelling and a Novel Neural Network Approach         
 
by 
Hong Ling 
 
The control of cell cycle checkpoints in cell cycle regulation is an extremely important 
function in living organisms. Mutation of the checkpoint regulators can cause gene or 
chromosome instability, which eventually results in different types of human cancers or cell 
apoptosis (death). A critical task in biological and medical research is to gain a thorough 
understanding of the mechanisms and dynamics of checkpoints in cell cycle regulation. In this 
thesis, a combined approach of mathematical modelling, computational simulations, 
analytical techniques and an artificial neural network (ANN) has been used to obtain deeper 
insights into the robustness and dynamic behaviour of the G1/S transition, as well as the 
DNA-damage signal transduction pathway and the p53-Mdm2 oscillation systems.  
 
The first part of this thesis focuses on mathematically representing the cellular processes 
involved in detecting DNA-damage in cells, and their repair mechanisms, during cell division. 
This study uses a novel mathematical model of the G1/S transition that involves the DNA-
damage signal transduction pathway, as published in 2008 by Iwamoto et al. [2008]. We 
develop a new analytical approach which includes: a choice of biomarkers (peak time of E2F 
and CycE), local and global sensitivity analysis, Type II error and mathematical definitions of 
biological robustness, to investigate the dynamic behaviour and robustness of biomarkers in 
the G1/S checkpoint in response to various levels of parameter perturbations and different 
DNA-damage intensities. More specifically, we concentrate on investigating the probability 
of accurately distinguishing healthy cells from defective cells in the G1/S transition. The 
results revealed from the model simulation, in terms of percentages of damaged cells passing 
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as healthy cells, were in good agreement with very recent experimental findings and 
observations. 
 
The mathematical simulation outcomes from the first part, with corroboration from the 
phenomenon that the damaged cells are caught not in the pre-tumor stage but in the pre-
malignant tissue where a non-invasive tumour is formed through activation of cellular 
senescence (another form of cell death), gives us the inspiration to develop new research 
questions. In the second part of this thesis, we are interested in whether the proposed G1/S 
model can highlight cellular senescence and so formulated scenarios, based on currently 
established biology, for lowering the threshold for senescence to enable cells to catch  
damaged cells before they reach the pre-malignant stage and evaluate the model’s efficacy 
and outcome in this respect. Our analysis showed that cellular senescence can be highlighted 
through investigating the probability of DNA-damaged cells passing the G1/S checkpoint 
while lowering the critical trigger – CDK2 (Cyclin dependent kinase 2). We then analysed the 
relationship between CDK2 and its corresponding CKIs (CDK inhibitory proteins) in order to 
find other effective ways to bring forward cellular senescence. Finally, we validated the 
robustness of CDK2 for lowering the bar for cellular senescence. 
 
The final part of the thesis introduces a novel ANN approach for modelling regulatory 
pathways. The developed ANN model is a new recurrent neural network which exactly 
represented the interactions among molecules in a pathway and its internal parameters are the 
corresponding kinetic parameters. Importantly, the proposed method solves the perennial 
problem of parameter estimation in differential equation based models by simply evolving the 
parameter values iteratively based on data. We applied the ANN model to simulate the p53-
Mdm2 oscillation system with negative feedback and investigate the robustness of this system. 
Results from the ANN and corresponding ordinary differential equation based models 
published in 2006 by Geva-Zatorsky [2006] were then compared.  By means of simulations, 
we showed that the proposed network can successfully represent the behaviour of the p53-
Mdm2 oscillation system and solve the parameter estimation problem with 100% accuracy.   
Furthermore, we also investigated the robustness of the p53-Mdm2 system using the trained 
network, in the presence of various levels of parameter perturbation, to gain a greater 
understanding of the inner workings of the p53-Mdm2 system and the results revealed 
robustness and stability of the system and sensitivity to parameters.   
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In summary, the success of this research demonstrated the value of mathematical models and 
artificial neural networks for interpreting experimental observations, gaining novel insights 
into the dynamic behaviour of the G1/S checkpoint integrating the DNA-damage signal 
transduction pathway and the p53-Mdm2 oscillation system.  In particular, the demonstration 
of the value of neural networks for estimating unknown kinetic parameters from data is a 
significant contribution of the thesis along with the analysis of the developed neural networks 
to investigate the robustness of the studied system. Furthermore, the thesis extended the 
mathematical model to elucidate a possible way, through understanding cellular senescence, 
for developing an effective cancer treatment. 
  
Keywords:  Artifical neural network, biomarkers, cell cycle, cell cycle checkpoints, cell cycle 
regulation, cell division, chemical kinetic equations, cellular senescence, DNA-damage signal 
transduction pathway,  G1/S checkpoint pathway, nonlinear ordinary differential equations, 
p53-Mdm2 oscillation system, parameter sensitivity analysis, recurrent neural networks, 
biological robustness,  Type II error 
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Chapter 1: Introduction 
1.1 Systems Biology 
Systems biology is an interdisciplinary field concerned with a system-level understanding of 
biological processes [Aderem, 2005; Ge et al., 2003, Heath and Kavraki, 2009; Ideker et al., 
2001; Kitano, 2002; Oltvai and Barabasi, 2002]. The field is found upon taking an integrative 
approach that combines mathematical modelling and extensive computational analysis with 
experimental techniques to understand the functioning of complex biological systems as a 
whole instead of the individual components. For instance, systems biology offers an 
opportunity to quantitatively understand the characteristics of molecular (genetic, metabolic 
and signalling) pathways by investigating the inter-relationships (organization/structure) and 
inter-actions (dynamics/behaviour) of genes, enzymes, proteins and metabolites [Kitano, 2002; 
Wolkenhauer, 2001].  
 
The idea of applying systems theory to biological sciences started as early as the 1940s with 
the introduction of cybernetics, which focuses on the analysis of control and communication 
in animals and machines [Trewavas, 2006; Wiener, 1948]. Since then, system-level 
understanding of biological systems has become a recurrent theme in biological science. For 
example, Ludwig von Bertalanffy [1950] proposed general and organismal systems theory in 
an attempt to establish a general theory of systems, and Mihajlo Mesarovic [1968] developed 
further ideas for combining systems theory and biological science. However, most work 
before the 20
th
 century only described and analyzed biological systems at the physiological 
level mainly due to limitations of knowledge and theories in molecular biology. Remarkable 
progress in molecular biology
1
, particularly in genome sequencing and high-throughput 
measurement techniques, makes it possible to collect comprehensive data sets on system 
performance and gain more useful information on the underlying molecules. A unique feature 
of modern systems biology is that it is distinguished from the previous attempts in that it 
connects system-level theory to molecular-level knowledge. There are three main issues 
within systems biology: (1) to generate quantitative high-throughput measurements for 
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 Molecular biology is the study of biology at a molecular level. This field focuses on investigations of 
macromolecules and the macromolecular mechanisms involved in life processes, such as structural and 
functional genomics, the structure and function of proteins and nucleic acids. 
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collecting comprehensive data sets on system performance and extracting the information, (2) 
to understand the structures of the systems and the interactions among molecules, and (3) to 
develop mathematical models based on the experimental data collected and an understanding 
of system structures.  
 
Robustness is one of the fundamental and ubiquitously observed characteristics of biological 
systems. Investigating the mechanisms and principles underlying the robustness of biological 
systems plays an essential part in gaining a deeper understanding of biological complexity at 
the system level. In general, robustness is defined as a property that allows a system to 
maintain its functionality or characteristic behaviour in the face of internal perturbations (such 
as mutations), external perturbations (such as environmental variations) as well as other 
uncertainties (such as stochastic fluctuations in the abundance of the chemical species 
involved and their corresponding biochemical reactions) [Kitano et al., 2004, 2004a, b; Kitano, 
2007; Kitano and Oda, 2006; Stelling et al., 2004]. More precisely, robustness allows a 
system to change its structure, components and states in response to perturbations or 
conditions of uncertainty, while the specific functionalities of the system remain unchanged. 
Therefore, robustness is a broader concept than stability and homeostasis
2
, and robustness in 
subsystems is essential for homeostasis of the whole system [Stelling et al., 2004]. The 
measurement of robustness of biological systems based on mathematical models focuses on 
the investigation of a system’s characteristics that maintain one or more of its functions (the 
model’s output) under the effects of perturbations in the kinetic parameters involved as well 
as the effects of molecular noise on the cellular behaviours involved. Therefore, this 
underlines that the analysis of robustness in complex biological systems mainly involves the 
definition of a system, its function and the related perturbations. 
 
1.2 Mathematical Modelling in Cell Cycle Regulation 
The cell cycle is the process that achieves cell growth, DNA replication, chromosome 
segregation and cell division in mammalian cells. The purpose of cell cycle regulation is to 
make two daughter cells that have exactly the same characteristics as their parents [Stein and 
Pardee, 2004]. Cell cycle regulation mediates the proliferation, differentiation, apoptosis (cell 
death) and other important intra-cellular processes through a complex set of distinct molecular 
                                                 
2
  Homeostasis is one of the most remarkable properties of a system that regulates its internal environment and 
maintains the system in a stable, constant condition. 
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networks associated with cell cycle checkpoints that are regarded as surveillance and quality 
control mechanisms in the cell cycle [Tessema et al., 2004]. The main responsibilities of the 
checkpoints are to ensure faithful genome DNA replication as well as to protect, conserve and 
maintain the fidelity of the genome for cell growth through the control of a series of 
biochemical reactions among multiple proteins, genes and their mRNAs [Kohn, 1998]. 
Therefore, the control of checkpoints in cell cycle regulation is an extremely important 
function in living organisms. For example, cancer can be regarded as a product of a 
malfunction in cell cycle regulation, such that the defective and abnormal cells malignantly 
proliferate promoting the accumulation of mutations in the human body. Mutations usually 
happen in proto-oncogenes and tumour suppressor-genes that are very important in 
controlling the checkpoints in cell cycle regulation; and there is a strong relationship between 
cell cycle regulation and human cancer [Dickson and Schwartz, 2009; Enders et al., 2010; 
Foster, 2008; Giordano and Galderisi, 2010; Hartwell and Kastan, 1994; Lapenna and 
Giordano, 2009; Malumbres and Barbacid, 2009; Molinari, 2000; Poehlman and Roessner, 
2010; Vermeulen et al., 2003].  
 
Because cancer is strongly associated with loss of control over the cell cycle regulation 
system, investigation of the mechanisms and functions of cell cycle regulation has become the 
critical focus of biological and medical research during the past decades [Hanahanand and 
Weinberg, 2000]. More importantly, a detailed understanding of the mechanisms and 
functions underlying checkpoint pathways, tumour growth, DNA damage repair, intercellular 
signalling and other processes involved in the cell cycle regulation plays a significant role in 
the diagnosis, treatment and prognosis of human cancer. However, the following three aspects 
make the cell cycle regulatory system complicated: (1) there are a large number of enzymes 
and proteins involved in cell cycles regulation; (2) there are a large number of interactions 
between enzymes and proteins; and (3) there are many different ways to promote the 
interaction between enzymes and proteins, performing the stimulatory, inhibitory or other 
modulating functions. The enormous complexity of cell cycle regulation makes it difficult to 
study and analyze the characteristics of roles and functions of genes, enzymes and proteins 
using only in vitro experiments. Thus, the systems biology approach, including both 
experimental and computational components working in conjunction, would help us to 
understand the complex biological regulatory systems. 
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The mathematical principles for cell cycle regulation models are applied to one of two 
biochemical domains: gene regulatory networks and protein-protein interaction networks. 
With regard to gene regulatory networks, the models mainly focus on the interactions between 
genes and proteins on a genetic level. The dominant phenomenon in gene regulatory networks 
is molecular binding, polymerization and degradation. In terms of the protein-protein 
networks, the models concentrate on the interaction between proteins and enzymatic reactions 
represented in the protein-protein interaction or regulatory network. In fact, cell cycle 
regulation mainly depends on the interactions of proteins and enzymes and their modification 
through their phosphorylation and dephosphorylation by kinases and phosphates, respectively. 
Therefore, most mathematical models for cell cycle regulation are based on protein-protein 
networks. For the successful application of mathematical modelling to cell cycle regulation, 
the following questions will be answered: what is the system in question and what is the 
system’s environment? How can we model the system, its structure and inputs and which 
mathematical techniques should be used for the model?  What do we expect to observe and 
what insights do we expect from the application of the model? Which type of methods should 
we use for the analysis and validation of the model? How can we most effectively obtain 
experimental evidence to support new hypotheses?  
 
The mathematical models of cell cycle regulation heavily use nonlinear ordinary differential 
equations (ODEs) which describe the reaction rates of interactions between molecular species 
in the system according to chemical kinetic theory [Fuss et al., 2005; Heath, 2009;  Tyson et 
al., 1996;  Tyson et al. 2002]. In general, ODEs are mathematical equations which represent 
changes in concentration of all molecular species in cell cycle regulation over time. The ODE 
models of cell cycle regulation were first developed for frog eggs by Borisuk [1998], and then 
expanded to budding yeast [Chen et al., 2000],  and finally generalized to eukaryotes in 2006 
[Csikasz-Nagy, 2006]. The advantages of ODEs are: (i) ODEs have deep mathematical roots 
that are used to analyze and understand a system and its properties, particularly system 
robustness, and (ii) ODEs can be solved by using many software packages, such as Matlab
®
 
and Mathematica
®
. However, the difficulties associated with ODEs are: (i) the lack of 
experimentally determined parameters reduces the accuracy of the ODE models, and (ii) 
ODEs ignore the randomness and noise found in biological systems, which may play an 
important role in understanding and investigating their function [Blake et al., 2003; Raser and 
O’Shea, 2004]. 
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1.3 Motivation for the Study  
This thesis starts with a biological-level understanding of the cell cycle and cell cycle 
regulation. Most previous molecular cell biology researchers have focused on cell growth and 
proliferation, their regulatory mechanisms and their response to certain intracellular or 
extracellular conditions, which provided important information for the diagnosis, treatment 
and prognosis of cancer. Due to the complexity of cell cycle regulation, as discussed in 
section 1.2, mathematical modelling and computational simulations are developed to gain a 
detailed understanding of the mechanisms underlying cell cycle and related processes. 
However, there is still a need for fundamental knowledge from both molecular cell biology 
and systems biology research about cell cycle regulation. We aim to outline the essential 
information available through asking three questions: 
(a) How does the complex network of regulatory enzymes and cellular components 
control cell cycle regulation, particularly cell cycle checkpoints? 
(b) How are mathematical models developed to investigate the dynamic behaviour and 
biological robustness of cell cycle checkpoints? 
(c) What existing models of cell cycle checkpoints have been used to study their 
mechanisms and functions? 
We address these questions by reviewing the existing literature using the keywords “cell cycle 
regulation, cell cycle checkpoints, mathematical models, systems biology”; details relevant to 
this are shown in Chapter 2. 
 
According to a review of the literature about cell cycle checkpoints, we find that the G1/S 
checkpoint takes more responsibility for the disruption of the stability of cell cycle than other 
checkpoints [Iwamoto et al., 2008; Malumbres and Carnero, 2003]. Therefore, we choose to 
investigate the G1/S cell-cycle checkpoint pathway incorporating the DNA-damage signal 
transduction pathway in cell division. 
 
The primary objective of this thesis is to mathematically represent cellular processes 
involved in detecting DNA-damage in cells during cell division, in particular, in the G1/S 
transition, to understand how cells respond to DNA-damage situations in order to shed 
light on the dynamic behaviour and biological robustness of the G1/S checkpoint. 
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This primary objective is accomplished by using a novel mathematical model of the G1/S 
checkpoint pathway integrating the DNA-damage signal transduction pathway which was 
published in 2008 by Iwamoto et al. [2008]. The original authors mainly focused on the 
influence of the change in value of the chemical species in the proposed model at a steady-
state in response to changes in the value of individual kinetic parameters (more related 
information is presented in Chapter 3). We start our investigation by identifying the following 
three challenging questions: 
(1) What are the major indicators for the proper function of the G1/S checkpoint pathway 
involving DNA-damage signal that are in a biologically meaningful manner?  
(2) How does the model investigate the robustness and the behaviours of the G1/S 
checkpoint under parameter perturbations with or without DNA-damage? 
To address the above two questions, we identify the peak times (PTs) of two key proteins 
(E2F and CycE) as in silico biomarkers, based on the currently established biological theory. 
Then, we introduce an analytical approach including parameter sensitivity analysis (local and 
global), Type II error and mathematical definitions of biological robustness to investigate the 
dynamic behaviour and the robustness of these two critical proteins in the G1/S checkpoint in 
the presence of various levels of parameter perturbations under different levels and different 
DNA-damage intensities. More specially, we are interested in analyzing the probability (  ) 
of a DNA-damaged cell passing as a healthy cell in the G1/S transition. Work related to this is 
discussed in Chapter 4. 
(3) Do the model simulation results qualitatively support the experimental findings and 
the biological theory? 
We validate our simulation results, in terms of percentages of damaged cells that pass the 
G1/S checkpoint that agree very well with the good agreement with very recent experimental 
findings showing that a large number of damaged cells undergo proliferation without being 
caught at DNA-damage checkpoints [Collado and Serrano, 2010; Serrano, 2010]. Chapter 5 
covers the simulation results obtained from the analytical approach developed. The work 
related to this principal objective has been published in Biosystems with the article entitled 
“Robustness of G1/S checkpoint pathways in cell cycle regulation based on probability of 
DNA-damaged cells passing as healthy cells” [Ling et al., 2010]. 
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The second objective of this thesis is inspired by the mathematical simulation outcomes from 
the primary objective with the corroboration of the phenomenon that cellular senescence
3
 
(premature cell death), as played out, lies in the strategy used by cells to initially allow a 
considerable proportion of cells carrying oncogenes
4
 to pass through the cell cycle, at any 
given time, as there are probably millions of cells that are oncogenically primed and catching 
all these initially would be an exhausting task for a cell [Collado and Serrano, 2010; Serrano, 
2010]. 
  
The second objective of this thesis involves exploring and probing the model of the G1/S 
checkpoint pathway involving DNA-damage signal to further investigate how cancer 
prone cells can be identified.  In particular, it is tested if the model can highlight how the 
senescence bar can be effectively lowered to catch cancer prone cells earlier than in the 
usual senescence.      
 
This objective is achieved from a good understanding of cellular senescence to identify the 
critical factor (Cyclin-dependent kinase 2-CDK2 inhibition) in the G1/S checkpoint pathway 
that lowers the bar for triggering senescence in cancerous cells based on experimental 
findings, which helps us to formulate scenarios for the proposed model to highlight cellular 
senescence. We aim to provide valuable findings that biologists and clinicians may find useful 
to validate experimentally the actual efficacy of these targets for treating cancer. Given these 
observations, challenging questions are identified: 
(4) How does the mathematical model highlight cellular senescence in response to a 
lowering of the critical point - CDK2 inhibition?  
(5) Are there any other effective ways to bring forward cellular senescence through model 
analysis? 
To address the above two questions，we calculate the values of   for a DNA-damaged cell 
passing a G1/S checkpoint using the same analytical approach and parameter set as our earlier 
study by reducing CDK2 levels for two DNA-damage situations. The model will highlight 
cellular senescence depending on whether β decreases with decreasing levels of CDK2 or not. 
We then interrogate the model to investigate the relationship between CDK2 and CDK 
                                                 
3
 Cellular senescence is considered to be an irreversible state of cell cycle arrest whereby a normal cell loses the 
ability to divide and promote cell proliferation. 
4
 Oncogenes are genes that have the potential contribution to cause cancer. In general, oncogenes are mutations 
of normal cellular genes. 
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inhibitory proteins (CKIs) under different DNA-damage situations in search of alternative 
approaches to lowering the cellular senescence bar through these relationships by exploring 
the most effective means of bringing cellular senescence forward.  
(6) How robust is cellular senescence triggered by lowering the bar through reduced 
CDK2?  
We investigate the robustness of CDK2 on lowering the bar for cellular senescence through 
two different approaches: (i) analysing the values of β for different thresholds of PTs for the 
previously chosen two biomarkers under the given parameter perturbation regimes and under 
different DNA-damage situations in response to different reduced CDK2 levels, and (ii) 
analysing the robustness of CDK2 in triggering cellular senescence based on our 
mathematical definition of biological robustness. The details of both approaches for 
investigating the robustness are shown in the context of achieving the primary purpose of this 
thesis. The work related to this specific objective is presented in Chapter 6. 
 
As mentioned in section 1.2, one weakness of the ODE models is parameter estimation, which 
plays a significant role in the accuracy of the models in representing real biological systems. 
This leads to the development of another purpose of this thesis. 
 
The third objective of this thesis involves how an artificial neural network (ANN) 
technique is implemented to deal with the “parameter estimation” problem in the ODE 
models for biological systems and investigate the dynamic behaviour and robustness of 
the system based on the analytical results from the proposed ANN model.  
 
This objective can be accomplished by using mathematical models of the p53-Mdm2 
oscillation system, as proposed by Geva-Zatorsky et al. [2006], for developing the ANN 
models. The original ODE models have successfully captured the observed oscillations and 
variability in the p53-Mdm2 system in response to DNA damage caused by gamma 
irradiation. We start our study by answering the following three questions:   
(7) How do we develop ANN models to represent the exact behaviour and interactions in 
the p53-Mdm2 oscillation system?  
ANNs can be viewed as mathematical models to simulate natural and biological systems on 
the basis of mimicking the information processing methods in the human brain. Development 
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of an ANN model for the p53 system gives most attention to the following three factors: the 
number of neurons needed, the structure of the network and the learning algorithm. 
(8) How do we validate the proposed ANN models with high levels of accuracy? 
We use two different methods to validate the proposed ANN models: (i) compare the model 
parameters with previously reported parameter values, and (ii) compare the temporal 
behaviour of p53 and Mdm2 with that generated from ODE-based models. 
(9) What is used as a measure to investigate the robustness of the p53-Mdm2 oscillation 
system in the presence of various levels of perturbations in the model parameters? 
According to studies on investigating the robustness of circadian rhythms, the ratio of the 
half-life of the correlation divided by the mean period can be used as a measure of robustness 
of the oscillation system [Baras, 1997; Baras, et al., 1990; Gonze et al., 2002]. Thus, we used 
this approach to analyze the robustness of the p53-Mdm2 oscillation system in response to 
various model parameter perturbations. The details of this work are presented in Chapter 7. 
 
1.4 Overview of the Chapters 
This thesis comprises eight chapters. 
In the current chapter, an introduction is provided to systems biology, cell cycle regulation 
and mathematical modelling of cell cycle regulations, and the motivation for the thesis.  
Chapter two provides biological and mathematical background knowledge, ANN techniques 
as well as mathematical definition of robustness that are useful for later chapters. It also 
includes a detailed historic summary of the development of the mathematical modelling for 
the G1/S transition.  
In Chapter three, a detailed background of the molecular components and interactions in the 
G1/S checkpoint pathway that integrates the DNA-damage signal transduction pathway is 
given, followed by a complete description of the proposed mathematical model for G1/S 
transition including the DNA-damage signal pathway, based on Iwamoto et al.’s [2008] 
model as well as the biochemical meaning of kinetic parameters, the initial conditions and the 
parameter values for the G1/S model.  
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In Chapter four, we define a new analytical approach to investigate robustness and dynamic 
behaviour of chemical species in G1/S transition in response to DNA-damage situations. This 
analytical approach (which includes local sensitivity analysis, global sensitivity analysis, 
Type II error and the mathematical definition of robustness) mainly focuses on the 
investigation of the dynamic response of a limited number of key proteins (biomarkers) in the 
G1/S checkpoint pathway in the presence of various levels of perturbations in the kinetic 
parameters under different DNA-damage conditions.  
Chapter five presents the results and an analysis of the numerical simulations of the behaviour 
of the chosen biomarkers of the G1/S checkpoint pathway under various levels of parameter 
perturbations in response to different DNA-damage situations and draws relevant conclusions 
based on the revealed results from the in silico experiments.  
In Chapter six, we use the proposed mathematical model of the G1/S checkpoint to highlight 
cellular senescence under DNA-damage situations and explore the potential possibility of 
lowering the bar for triggering cellular senescence in cells, for catching damage prone cells 
earlier than normal senescence, based on the model’s analytical results. More importantly, we 
investigate the robustness of CDK2 in triggering cellular senescence. 
In Chapter seven, the ANN technique is used to solve the parameter estimation problem in the 
ODE models of the p53-Mdm2 oscillation system. The trained ANNs are used to study and 
analyze the dynamic characteristics and robustness of the p53-Mdm2 oscillation system.  
Finally, in Chapter eight, a retrospective look at the overall implications of this work, as well 
as the contribution of the thesis and direction for future research, is provided. 
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Chapter 2: Background and Literature Review 
This chapter provides the necessary background information for the research. It covers the 
fundamental biological concepts and theories of cell cycles, cell division and cell cycle 
checkpoints, the primary mathematical concepts of modelling the cell cycle checkpoint 
pathway (for example, chemical kinetic theory and the Hill function), as well as a 
comprehensive review of the developed mathematical models of cell cycle regulation, 
particularly for modelling the mammalian G1/S cell cycle phase transition. 
 
2.1 Overview 
There is a very strong relationship between cell cycle checkpoints and human diseases, such 
as various cancers [Dickson and Schwartz, 2009; Enders et al., 2010; Foster, 2008; Giordano 
and Galderisi, 2010; Hartwell and Kastan, 1994; Lapenna and Giordano, 2009; Malumbres 
and Barbacid, 2009; Molinari, 2000; Poehlman and Roessner, 2010; Vermeulen et al., 2003]. 
The main function of checkpoints is the protection, conservation and maintenance of cell 
growth and development. However, mutation of these checkpoint regulators causes gene or 
chromosome instability as well as further losses of proliferation, which eventually cause 
diverse types of cancer or apoptosis. Furthermore, mutations of tumour suppressor genes 
controlling the cell cycle checkpoints cause oncogenic propagation resulting in the 
development of tumour cells [Morgan, 2007; Murray and Hunt, 1993; Petersen et al., 2010; 
Stein and Pardee, 2004]. As a result, it is necessary to have a thorough understanding of the 
whole cell cycle regulation system, which makes a significant contribution to the diagnosis, 
treatment and prognosis of human cancer. Moreover, there are some difficulties in studying 
and analyzing cell cycle regulation using real experiments, for example, in the analysis of 
complex interactions between various proteins and enzymes. Due to the limitations of 
experimental research on cell cycle regulation, more and more mathematical models have 
become powerful tools to analyze and understand the complex behaviour of cell cycle 
regulation [Fuss et al., 2005; Klipp and Liebermeister, 2006]. 
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2.2 Biological Concepts 
2.2.1 Cell Cycle and Cell Division 
Before designing and developing a mathematical model, it is essential to answer this question: 
what is the logical formulation of a mathematical model for cell cycle regulation? 
Consequently, the current focus is to learn and understand some fundamental concepts and 
theories about cell cycle, cell division and cell cycle checkpoints. There are some excellent 
books on some of these topics: Murray and Hunt [1993] give an excellent introduction to cell 
cycle and its control; Stein and Pardee [2004] provide a wealth of information on cell cycle, 
growth control as well as their significant role in human cancer development, Pierce [2005] 
describes a wide panoramic view of genes, DNA and chromosomes, and Morgan [2007] 
provides a clear, concise and easily accessible guidebook with an in-depth description of all 
the essential aspects of cell cycle and cell division.   
 
2.2.1.1 Cell Cycle 
The cell cycle, which is also called cell-division cycle, means that a series of events; for 
instance, cell growth, DNA replication, chromosomes segregation and cell division, occur in 
human cells in order to replicate or duplicate themselves [Murray and Hunt, 1993; Stein and 
Pardee, 2004]. There are two fundamental parts in a cell cycle: interphase and mitosis. 
Interphase is the major part of the cell cycle. The functional characteristic of the interphase is 
to complete DNA replication and accumulate enough nutrients for mitosis, while the function 
of the mitotic phase is to divide a cell into two distinct daughter cells in order to finish the 
process of nuclear division (karyokinese) as well as cytoplasmic division (cytokinesis). Figure 
2-1 shows an overview of the cell cycle. 
 
The interphase consists of three steps: G1 phase, S phase and G2 phase, which indicates that 
the whole cell cycle has four distinct phases. After the mitotic phase, the daughter cells enter 
the interphase of a new cell cycle. This marks the mitotic phase as the signal for the end of the 
previous cell cycle and the beginning of the current cell cycle. The first phase of interphase is 
G1, which mainly synthesizes of various enzymes for DNA replication in the S phase. Then 
the cell enters the S phase (called DNA synthesis phase) the most important part of the cell 
cycle. The reason is that DNA synthesis happens in this phase. When DNA synthesis is 
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Figure 2-1  An overview of cell cycle. The cell cycle, or cell-division cycle, is the well-
ordered sequence of events that occur in human cells for their division and replication. 
The events of the cell cycle include G1 phase (cell growth and preparation of DNA 
synthesis), S phase (precise replication of DNA), G2 phase (further cell growth and 
prepraration for cell division) and M phase (cell division- mitosis). There are multiple 
cell cycle checkpoints, which are localized in each phase of the cell cycle. The main 
responsibility of these checkpoints is to ensure the fidelity of cell division.  
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complete, each chromosome is replicated, which means that it has two sister chromatids. 
Furthermore, these two sister chromatids remain attached to each other through kinetochores. 
After the S phase, the cell enters the G2 phase, which prepares it for cell division. The 
remarkable change in the G2 phase is the organization of microtubules through the synthesis 
of many significant proteins. The aim of this is to prepare for mitosis. Finally, the cell enters 
the mitotic phase marking the end of the current cell cycle [Morgan, 2007; Murray and Hunt, 
1993; Stein and Pardee, 2004]. 
 
2.2.1.2 Cell Division 
Cell division is considered as the division of a parent cell into two daughter cells. In general, 
there are two different types of cell division: mitosis and meiosis [Freeman, 2002]. Mitosis is 
a process which separates the duplicated chromosomes of the parent cells into two identical 
daughter cells. This means that the two daughter cells have the same number of chromosomes 
as the parent cell and they can divide again. In meiosis, the daughter cells have only half the 
number of chromosomes so they cannot divide until fertilization. The focus of the following 
discussion is on the process of mitosis. There are four stages involved in the process of 
mitosis: prophase, metaphase, anaphase and telophase [Cooper, 2000; Pierce, 2005; 
Zimmerman and Ebrary, 2004]. A schematic depiction of the stages of mitosis is displayed in 
Figure 2-2. 
 
The sign of mitosis entry is a period called prophase. During prophase, the chromatid 
becomes condensed in order to form chromosomes. Each chromosome has a pair of sister 
chromatids joined at the centromere. This means that the number of chromosomes is equal to 
the number of centromeres. The nuclear envelope then breaks down and the nucleolus 
disappears. The centrioles start to move to opposite poles of the cell and the mitotic spindles 
(which are also called microtubules) are formed by the protein fibres between them. The 
second stage of mitosis is called the metaphase. It contains two sub-stages: prometaphase and 
metaphase. In the early stage-prometaphase the spindle fibres attach to the chromosomes at 
the centromeres creating kinetochores. Meanwhile, some mitotic spindle microtubules form 
an attachment to the kinetochores to make a connection between the centromeres and the 
centrioles, and then the chromosomes begin to move, marking the progression to metaphase. 
During this phase, the chromosomes attached to microtubules align in the middle plane of the 
cell. The next stage of mitosis is anaphase stage for the separation of the sister chromatids. 
The centromeres are divided in order to create sister chromosomes instead of a pair of 
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Figure 2-2  Schematic depiction of the stages of mitosis. 
Source:http://www.maph49.galeon.com/mitosis/stages1.gif
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attached sister chromatids. Furthermore, the created sister chromosomes are pulled apart by 
the spindle apparatus and move to opposite poles of the cell. The fourth stage, telophase, is 
entered when the chromosomes arrive at the opposite poles of the cell and the daughter nuclei 
form. After that, the nucleoli reappear inside the daughter nuclei, the new nuclear envelops 
forms around the daughter nuclei and the chromosomes decondense in the daughter cells and 
become invisible. In addition, the mitotic spindles disappear and cytokinesis starts, 
completing cell division. The main purpose of cytokinesis is the division of the cytoplasm 
through cleavage marking the completed separation of the daughter nuclei. Thus, one single 
cell has been divided into two daughter cells with the exact same genetic information as the 
parent cells. The created daughter cells will enter interphase for the beginning of the new cell 
cycle. 
 
2.2.2 Cell Cycle Checkpoints 
Cell cycle checkpoints are regarded as surveillance and quality control mechanisms in the cell 
cycle. They are localized in each phase of the cell cycle. Their purpose is to decide whether 
the cell can move into the next phase of the cell cycle based on an error-free completion of the 
previous phase in the cell cycle. As a result, the main responsibility of these checkpoints is to 
ensure faithful genome DNA replication as well as to protect, conserve and maintain the 
fidelity of the genome for the progeny cells [Giordano and Galderisi, 2010; Morgan, 2007; 
Nyberg et al., 2002; Stein and Pardee, 2004].  
 
There are three main checkpoints in the cell cycle: the mitotic spindle checkpoint, the S phase 
replication checkpoint and the multifaceted DNA damage checkpoint. All three checkpoints 
have their own particular structural characteristics and functionalities in the cell cycle. The 
responsibility of the mitotic spindle checkpoint is to ensure that the chromosomes are 
segregated accurately at the mitotic plate in order to prevent instability of the chromosomes. 
The S phase replication checkpoint is to successfully achieve the faithful replication of DNA 
at the S plate. Furthermore, the multifaceted DNA damage checkpoint senses various 
information about DNA damage and arrest cell cycle progression and facilitate the DNA 
repair pathway. In fact, the multifaceted DNA damage checkpoint plays the most important 
role in ensuring the fidelity of cell division. According to cell cycle processes, there are three 
main DNA damage checkpoints: the G1/S checkpoint; the S phase checkpoint and the G2/M 
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checkpoint. The following sections present more detailed information about cell cycle 
checkpoints, particularly the DNA damage checkpoints. 
 
2.2.2.1 Mitotic Spindle Checkpoint  
The mitotic spindle checkpoint is a regulatory mechanism that ensures the proper alignment 
of chromosomes entering the anaphase stage and exiting the mitosis [Skibbens and Hieter, 
1998; Stein and Pardee, 2004; Zacharie and Nasmyth, 1999]. The mitotic spindle checkpoint 
is composed of different types of proteins, such as, the MAD (mitotic arrest defective) and 
BUB (budding uninhibited in benzimidazole) families, and is also called the mitotic 
checkpoint complex (MCC) [Sudakin et al., 2001]. There are three significant duties for the 
MCC. First, the MCC is a sensor of misaligned chromosomes in the mitosis plate. Second, the 
MCC is a signal transducer which relays signals from the sensors. Third, the MCC is an 
inhibitor which must effectively monitor cell cycle progression according to the information 
relayed from the signal transducer. If the chromosomes are improperly attached to the mitotic 
spindle fibre (for instance, the mitotic spindle fibres only attach to one side of the centromere), 
the MCC has to block mitotic progression until there is accurate attachment between 
kinetochores and opposite spindle poles by the mitotic spindle fibres [Rieder et al., 1995]. 
 
Based on the above information, the MCC has the ability to control the progression of mitosis 
as well as exit from mitosis through regulating the activity of the anaphase by promoting 
complex/cyclosome (APC/C) [Harper et al., 2002; Zacharie and Nasmyth, 1999]. How does 
the spindle checkpoint inhibit these two mitotic aspects of the cell cycle? There are two 
important mitotic pathways regulated by the ubiquitin ligase APC/C: the mitotic metaphase-
to-anaphase transition and the mitotic exit transition. In terms of the mitotic metaphase-to-
anaphase transition, the responsibility of APC/C is to initialize the anaphase through the 
destruction of the securin protein PDS1 by CDC20 in order to inhibit the activity of the 
separin protein, ESP1. The reason is that ESP1 plays an essential role in promoting sister-
chromatid separation and mitotic metaphase-to-anaphase transition. For the progression of 
mitosis to enter the new cell cycle, the target of APC/C is to degrade the complex of CyclinB 
(CycB) and cyclin-dependent kinase (CDK, i.e. CDC2/CDK1) through CDH1/HCT1 
[Gardner and Burke, 2000; Musacchio and Hardwick, 2002]. 
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2.2.2.2 The S-phase Replication Checkpoint 
The S phase replication checkpoint plays an important role in monitoring the progression of a 
cell through the S-phase and ensuring the fidelity of DNA duplication. When the cell 
undergoes DNA replication stress, the main function of the replication checkpoint is to block 
DNA synthesis for the maintenance of the integrity of the existing replication fork as well as 
provide enough time for the rearrangement of the defective replication forks [Branzi and 
Foiani, 2007; Sogo et al., 2002]. In general, the activation of the replication checkpoint is 
regulated by hydroxyurea (HU), which is regarded as a ribonucleotide reductase inhibitor, 
which eventually results in the replication forks stalling due to a lack of nucleotide precursors. 
Furthermore, there are three main drownstream events in the cell cycle when the replication 
checkpoint is activated by HU: a) mitotic chromosome segregation would be delayed unless 
the chromosomal replication is accurately completed; b) stabilization of structural replication 
intermediaries is achieved through controlling the activation of the replication fork elongation, 
re-initiation and recombination. However, all these events may result in resolved 
intermediates and increased chromosomal instability; c) there is an induction in the expression 
of genes that makes a significant contribution to recovery, such as ribonucleotide reductase 
[Desany et al.,1998; Kelly and Brown, 2000; Stein and Pardee, 2004; Yarbro, 1992]. 
According to literature on the replication and DNA damage checkpoints, it can be seen that 
the replication checkpoints have common architectural features with the DNA damage 
checkpoint, such as the phosphoinositide 3-kinase related kinases (PIKKs) involved in the 
DNA damage response as well as in the replication checkpoint. Therefore, more details on the 
replication pathway will be discussed in the DNA damage checkpoint section. 
 
2.2.2.3 Multifaceted DNA Damage Checkpoints 
A multifaceted DNA damage checkpoint is used to recognize and respond to information on 
DNA damage and abnormal DNA structures through arresting cell cycle progression, and then 
facilitating the DNA repair pathway. During the cell cycle process, there are three main DNA 
damage checkpoints with their own function: the G1/S checkpoint, the S-phase checkpoint 
and the G2/M checkpoint. The G1/S checkpoint is used to detect DNA damage before the cell 
progresses into S-phase. The purpose of this is to delay entry into S for DNA damage repair 
and provide an accurate genome for the initiation of DNA replication. The S-phase 
checkpoint provides an opportunity to replicate a defect-free genome through repair 
mechanisms. Likewise, the G2/M checkpoint is used to detect damage of the newly 
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synthesized DNA before entry into mitosis, which ensures error-free chromosomal substrates 
for chromosome segregation. 
 
The DNA damage checkpoint pathway involves three main components: DNA damage sensor, 
signal transducer and signal effector. In general, when DNA damage happens under various 
endogenous and exogenous factors, the damage can be recognized by the sensor proteins 
which initiate a biochemical cascade of activity. The DNA damage signal can then be 
amplified and propagated by transducer protein kinases from the sensor to the downstream 
control mechanism. Finally, the effector proteins, the downstream targets of the transducer 
protein kinases, are identified and regulated in order to transiently slow cells progression 
through the cell cycle. The purpose of this is to provide enough time for DNA damage repair 
and recovery and maintain genomic integrity and chromosome stability [Liu et al., 2006; 
Nyberg et al., 2002]. 
 
2.2.2.3.1 Sensing DNA Damage and Signal Transduction  
The first step in the DNA damage checkpoint pathway is marked by the initiation of the 
activation of PIKKs like ATM (ataxia-telangiectasia mutated) and ATR (ataxia-telangiectasia 
and rad3-related). In general, ATM mainly responds to DNA double-stranded breaks (DSBs), 
the most important form of DNA damage. DSBs indicate that the base pair and the chromatin 
structure of two complementary strands of DNA is not strong enough to combine for a long 
time. This means that two complementary strands are simultaneously separated from each 
other at the DNA damage sites. Likewise, ATR focuses on all types of DNA damage, such as 
abnormal DNA structures and single strand DNA brake. Furthermore, ATR play an important 
role in the response to the stalled replication forks in DNA replication and synthesis [Nyberg, 
2002].  
 
How does the activated ATM/ATR efficiently propagate DNA damage signals to the 
downstream control mechanism? The main focus of this section is on the discussion of the 
interaction among checkpoint proteins in response to a DSB situation in order to efficiently 
amplify the initial DNA damage signal. DSBs are originally recognized by a tri-protein 
complex Mre11-Rad50-Nbs1 (MRN complex), then the MRN complex recruits to and 
activates ATM at the DNA damage site. Furthermore, ATM can be also activated by changes 
in higher order chromatin structures. The recruitment and activation of ATM phosphorylates 
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various early downstream target substrates; for instance, MDC1 (mediator of checkpoint 
signalling 1), H2AX (which is a variant of H2A, a major core histone in nucleosomes), 
BRCA1 (Breast cancer protein1) and 53BP1 (the checkpoint adapter protein, p53-binding 
protein 1). In terms of MDC1, it is localized to the DNA damage site for quick response to 
DNA damage, and then it has a direct interaction with -H2AX, which is to phosphorylate 
histone H2AX by ATM at the serine139 through its BRCT domain. With the recruitment of 
ATM molecules or limiting H2AX dephosphorylation at DNA damage site, MDC1 can 
further amplify the histone H2AX phosphorylation signal. Eventually, more and more DNA 
repair factors, such as BRCA1 and 53BP1 are recruited and accumulated in a significant 
numbers at the DNA damage site. Furthermore, H2AX and H2A ubiquitination play another 
key role in regulating and facilitating the recruitment and accumulation of DNA repair factors 
at the DSB site. Accumulation of the local ubiquitinations of H2AX and H2A mainly depends 
on the ring-finger protein, RNF8, associated with UBC13 as well as the complex E2 and E3 at 
the damage site. The phosphorylated RNF8 in its FHA domain can bind with MDC1 and 
directly recognize signals for the ubiquitininteraction motifs (UIM) of RAP80 (receptor 
associated protein 80) by promoting further addition of ubiquitin chains. The recruitment and 
accumulation of BRCA1 is mainly dependent on the combination of ABRA1, RAP80 and the 
BRCT domain of BRCA1 at the DNA damage site [Srivastava et al., 2008]. In addition, the 
activated ATM/ATR promotes the phosphorylation of their effector kinases, Chk2/Chk1, 
which results in different effects on the cell cycle transition in different phases in order to 
achieve a delay in cell cycle progression. 
 
2.2.2.3.2 G1/S Checkpoint 
The G1/S checkpoint mediates cell cycle progression from G1 to S by regulating the complex 
of CycE and CDK2, which is called CycE/CDK2 [Beck et al., 2010; Ohtsubo et al., 1995]. 
This is achieved by the stabilization and activation of p53 and the phosphorylation of Cdc25A. 
Figure 2-3 shows how the G1/S checkpoint regulates the activity of CycE/CDK2 to block cell 
cycle progression into S-phase. In Figure 2-3, it can be seen that there are two pathways to 
control the activation of CycE/CDK2. One is controlled by p53 through p21 and the other is 
dominated by Cdc25A. 
 
After DNA damage, the activated ATM/ATR can directly phosphorylate p53 at serine 15 
(Ser
15
). Meanwhile, ATM/ATR also activates Chk2/Chk1 by phosphorylating them at 
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Figure 2-3  Schematic depiction of how the G1/S checkpoint delays cell progression into 
S by regulating the activation of the CycE/CDK2 complex. The figure only shows the 
key proteins involved in regulating the activation of CycE/CDK2 in repsonse to DNA-
damage situations. 
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threonine 68 (Thr
68
) and serine 317/345 (Ser
317/345
), respectively. These activations of 
Chk2/Chk1 can also lead to the phosphorylation of p53 at serine 20 (Ser
20
) and threonine 18 
(Thr
18
). In addition, the phosphorylated Mdm2 at serine 395 (Ser
395
) makes a significant 
contribution to the stability and activity of p53 because the phosphorylated Mdm2, as the 
ubiquitin ligase, has already lost its ability to ubiquitinlate and degrade p53. As a result, the 
stability and activity of p53 leads to the transcription of p21 with its inhibitory signals on the 
CycE/CDK2 complex. Eventually, the inhibition of CycE/CDK2 delays G1/S transition 
[Bartek and Lukas, 2001; Beck et al., 2010; Liu et al., 2006; Nyberg et al., 2002].  
 
Moreover, the increased Chk2 activity phosphorylated by ATM can result in the 
phosphorylation of Cdc25A at serine 123 (Ser
123
), which promotes its ubiquitin-dependent 
degradation. The loss of Cdc25A inhibits the phosphorylation of CDK2 on tyrosine 15 (Tyr
15
), 
thus blocking its connection with CycE, an essential step for the S-phase progression. 
Furthermore, the degradation of Cdc25A also promotes its inhibition in phosphorylation of 
CDK4 at tyrosine 17 (Tyr
17
), which means that CDK4 does not combine with CycD. All these 
signals mark a transient delay in the S-phase entry in order to provide enough time for DNA 
damage repair and accurate cell cycle progression [Boutros et al., 2006; Mailand et al., 2000]. 
 
2.2.2.3.3 S-phase Checkpoint 
In regard to the S-phase checkpoint, there are two checkpoint pathways in the S-phase: a 
DNA replication checkpoint and an intra-S-phase checkpoint. The main function of the DNA 
replication checkpoint is to maintain the stability of the replication forks by repairing DSB 
and removing replication blockages. In general, this checkpoint can be activated by blocking 
replication forks collapses. The intra-S-phase checkpoint is mainly used to inhibit the 
initiation of DNA replication by blocking the firing of uninitiated DNA replication origins 
[Liu et al., 2006; Petermann and Caldecott, 2006]. In response to these blocks of the 
replication forks, the ATR/Chk1 pathway plays an important role in maintaining the accurate 
replication fork progression in the S-phase (see Figure 2-4).  
 
The blocking of replication forks results in the uncoupling of DNA polymerase (Pol) and 
helicase as well as long stretches of single strand DNA (ssDNA), which increases the 
accumulation of the ssDNA-binding replication factor (RPA) on chromatin [Walter and 
Newport, 2000]. Meanwhile, the ATR/Chk1 pathway is activated by the complex MRN 
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which generates RPA-coated ssDNA at DSBs. This signal promotes interaction between ATR 
and ATRIP and recruitment of ATR/ATRIP to RPA-coated ssDNA [Dart et al., 2004; 
Petermann and Caldecott, 2006; Zou and Elledge, 2003]. The activated ATR then 
phosphorylates the effector kinase, Chk1, at Ser
317/345
 as an important component of the S-
phase pathway, and the following replication and checkpoint proteins also provide an efficient 
environment to phosphorylate Chk1 by ATR:  
 
1. After replication is blocked, the accumulation of replication proteins like RPA and Pol on 
the chromatin promotes the phosphorylation of Chk1 by ATR [Lupardus et al., 1998]; 
2. After replication is blocked, the accumulation of the replication helicase complex, 
MCM2-7, on the DNA helicase is phosphorylated by ATR and also requires Chk1 
phosphorylation. Furthermore, there is an interaction among MCM7, a complex of 
ATR/ATRIP and Rad17. Rad17 is part of replication factor C (RFC) with its function of 
loading PCNA (the complex of Rad9, Rad1 and Hus1 and this complex is called 9-1-1) 
onto chromatin for normal replication. As a result, RPA accumulates Rad17 onto  ssDNA 
and then Rad17 recruits the 9-1-1 complex, which eventually leads to the loading of 9-1-1 
complex onto the DNA template [Dang et al., 2005; Kobayashi et al., 2004;  Zou et al., 
2002]; 
3. In response to replication blocks, checkpoint proteins, such as TopBP1 and Claspin, 
increase the phosphorylation of Chk1. TopBP1 is used to initiate DNA replication and 
regulate the activity of the checkpoint, while Claspin can connect with ATR in order to 
activate the interaction between Claspin and Chk1 [Chini and Chen, 2003; Kim et al., 
2005]. 
 
Based on the above information, Chk1 is efficiently phosphorylated through ATR. This 
results in its disconnection from chromatin. The phosphorylated Chk1 then promotes the 
activity of Cdc25A in order to delay progression through S by inhibiting the activity of CDK2 
without association with CycA (CycA/CDK2) [Karlsson-Rosenthal and Millar, 2006; Sanchez 
et al., 1997]. Moreover, the inhibitory phosphorylation of CDK2 also suppresses the loading 
of Cdc45 at the beginning of replication to achieve inhibition of the initiation of DNA 
replication. The reason is that the loading of Cdc45 at the origin can promote its association 
with RPA, and then Pol, on the chromatin at the beginning of DNA replication [Andreassen et 
al., 2006; Walter and Newport, 2000]. 
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Figure 2-4  The ATR/Chk1 pathway in response to DNA damage and stalled replication 
forks block the S-phase (Acknowledgement: This figure is Figure 2-4 in Petermann and 
Caldecott [2006]). 
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2.2.2.3.4 The G2/M Checkpoint 
The G2/M checkpoint mediates cell cycle progression from G2 to M by regulating a complex 
of CycB and CDK1 (CDC2), which is called CycB/CDC2. In fact, CDC2 must be 
phosphorylated at Thr
161
 or be dephosphorylated at Tyr
15
 or Thr
14
 to promote the association 
with CycB for the progression into mitosis [Arellano and Moreno, 1997; Smits and Medema, 
2001; Stein and Pardee, 2004; Wu et al., 2010]. Figure 2-5 shows how the G2/M checkpoint 
primarily functions to block CycB/CDC2 activity in order to delay the entry into mitosis. In 
Figure 2-5, there are various parallel pathways to regulate CDC2 activity including the 
regulation of Cdc25C, the kinases Wee1/Mik1 for blocking of CDC2 function, and other 
related proteins.  
 
In terms of the regulation of Cdc25C, DNA damage results in the activation of four different 
downstream kinases in order to block Cdc25c from dephosphorylating CDC2 at Tyr
15
 or Thr
14
 
and preventing the mitotic progression: 
 
1. The activated ATR promotes the activation of Chk1 by phosphorylating it at Ser317/345, 
and then Chk1 phosphorylates Cdc25C at Ser
216
 to promote its binding with 14-3-3. This 
complex prevents the dephosphorylation of CDC2 at Tyr
15
 and Thr
14
 by the Cdc25 C, 
thus blocking the binding of CycB and CDC2 [Gutierrez et al., 2010; Peng et al., 1997; 
Sanchez et al., 1997]; 
2. The activated ATM phosphorylates Chk2 at Thr68, thus resulting in the phosphorylation 
of Cdc25C at Ser
216
, inhibiting its activation and function of dephosphorylating CDC2 
[Gutierrez et al., 2010; Matsuoka et al., 1998]; 
3. Plk3 is regarded as a regulator of Cdc25C in the G2/M checkpoint pathway. It has the 
same functionality as Chk1/2 in inhibiting the activity of Cdc25C. When DNA damage 
happens, Plk3 activated by ATM can facilitate the phosphorylation of Cdc25C at Ser
216
 to 
achieve an inhibitory function [Gutierrez et al., 2010; Xie et al., 2001];  
4. Another protein, Plk1, plays an important role in promoting the progression into mitosis 
by phosphorylating Cdc25C to activate its function of dephosphorylating CDC2. 
However, the activated ATM/ATR phosphorylates Plk1, which inhibits its function to 
activate Cdc25C and block the binding of the CycB/CDC2 complex resulting in a 
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Figure 2-5  Schematic depiction of how the G2/M checkpoint delays cell progression into 
M by regulating the activation of the CycB/CDC2 complex. 
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decrease in CycB/CDC2 activity [Gutierrez et al., 2010; Smits et al., 2000; Van Vugt et 
al., 2001]. 
 
In addition, there are other proteins which play a significant part in transiently blocking G2/M 
transition. For instance; during DNA damage, ATM/ATR phosphorylates p53 on Ser
15
, which 
promotes the activation of p21 in order to inhibit the phosphorylation of CDC2 on Thr
161
 
through the activated p21. As a result, CDC2 loses its ability to combine with CycB and 
eventually results in the blocking of entry to mitosis [Nyberg et al., 2002; Smits and Medema, 
2001]. Furthermore, the phosphorylation of Wee1 on Ser
549
 as well as Mik by Chk1 facilitate 
the activation of phorphorylation on Try
15
 of CDC2. The purpose is to keep the complex of 
CycB/CDC2 in the inactive state and provide enough time for DNA repair and accurate cell 
cycle progression [Nyberg et al., 2002; Stein and Pardee, 2004; Wu et al., 2010]. 
 
2.3 Mathematical Concepts 
2.3.1 Importance of Mathematical Modelling 
According to the above analysis of cell cycle checkpoints, it can be seen that they are very 
complex, involving a huge number of proteins and enzymes as well as various interactions 
between proteins and enzymes under different environments. This makes it difficult to deeply 
study and understand the characterisation and interaction of these complicated cell cycle 
checkpoints pathways from only in vitro and/or in vivo experiments. Therefore, increasingly 
mathematical models and computational simulation techniques have become more important 
in investigating the mechanisms and functions of cell cycle checkpoint pathways and 
analysing the complex and dynamic behaviour of cell cycle checkpoint pathways. In general, 
there are multifaceted objectives for mathematical models in cell cycle checkpoint pathways. 
The first objective is to validate the current knowledge by comparing model predictions with 
experimental data. When discrepancies are found in these types of comparisons, our 
knowledge of the underlying networks can be systematically expanded [Covert and Palsson, 
2002]. The second objective is to study and investigate the inner workings of cell cycle 
checkpoint pathways, which are not accessible through biological experiments [Fuss et al., 
2005; Pritchard and Kell, 2002]. The third objective is to suggest some novel biological 
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experiments for testing the model’s hypothesis by reproducing the expected observations 
from the developed models [Klipp and Liebermerister, 2006; Yuh et al., 2001]. The fourth 
objective is to predict and design the most effective products based on the model’s predictions 
[Arkin, 2001]. For instance, the implementation of mathematical model predictions on 
targeted tumour therapy makes a significant contribution to selecting anti-cancer drugs and 
reducing the overall costs of the therapy [Robert et al., 2004].  
 
2.3.2 The Steps in Modelling Cell Cycle Checkpoints 
In general, there are three essential steps in modelling cell cycle checkpoint pathways: model 
design, model analysis and model validation (see Figure 2-6). The following section contains 
more details of each step in developing a mathematical model for cell cycle checkpoint 
pathways. 
 
 Model Design 
Designing the model is the most important step in mathematical modelling. The objective of 
this step is to decide the logical formulation of a mathematical model for the part of the cell 
cycle checkpoints under investigation. This is because the mathematical model should 
describe behaviour of important aspects of cell cycle checkpoints reflecting a deep 
understanding of the real cell cycle process. It involves decisions on which cell cycle 
checkpoint pathway should be modelled, which types of biochemical reactions are involved in 
the protein-protein interaction networks for regulating activity of the simulated checkpoint 
and what initial conditions should be used to activate the simulated checkpoint signal 
pathways. Once these three factors are decided, the assumptions for the developed 
mathematical model, variables, quantities and interaction relationships between variables of 
the developed mathematical model are then decided. 
 
 Model Analysis 
The model analysis step focuses on the study of the dynamic behaviour of the simulated cell 
cycle regulations under different conditions using computational techniques. The purpose of 
this step is to make the developed mathematical model promote an understanding of the inner 
workings of cell cycle checkpoints and provide insights into real biological processes or 
systems. Furthermore, the analytical results also provide opportunities for researchers to 
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Figure 2-6  The workflow of the mathematical model for cell cycle checkpoints. 
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intelligently select and explore real experiments in order to reduce experimental time and 
costs. 
 
The model analysis step is usually divided into two parts: the model parameter analysis and 
the model behaviour analysis. The model parameter analysis involves decisions on 
parameterisation and initialisation of the model, including all kinetic parameters (protein 
interaction rates or binding rates) and the initial conditions. Once these factors are specified, 
the mathematical model developed can be solved by numerical integration, and then used to 
concentrate on the analysis of model behaviour. The reason is that results from the model 
represent the corresponding behaviour of the simulated biological processes or systems. In 
fact, the developed mathematical models are mainly used to analyze and study the dynamic 
behaviour of a system in response to quantitative changes of the parameters in the 
mathematical model. Therefore, the investigation of qualitative changes in dynamic behaviour 
of a system in the presence of parameter variations is called bifurcation analysis. There are 
two main implications of the bifurcation analysis theory for cell cycle modelling: 
multistability analysis and sensitivity analysis [Strogaz, 2000]. Multistability means that there 
are more than one stable state in a system within a range of parameters. Multistability is an 
important property in controlling cell cycle progression and it involves a hysteretic switch to 
prevent cells from returning to the previous phase after the progression is completed. In the 
mathematical model, multistability analysis under kinetic parameter variations makes a 
significant contribution to the understanding of mechanisms underlying the cell cycle 
checkpoints [Novak and Tyson, 2003; Novak and Tyson, 2004]. Sensitivity analysis focuses 
on the role of individual parameters in the model, how individual parameters affect the whole 
model and how all these kinetic parameters simultaneously regulate the whole model. This 
involves the analysis of proteins included in the cell cycle checkpoints as well as their 
behaviour and effect in controlling the behaviour of cell cycle checkpoints. 
 
 Model Validation 
The model validation step compares the behaviour and data obtained from a computational 
simulation of the developed model with data generated from analogous experiments with the 
real cell cycle process or based on existing knowledge. For mathematical models, there are a 
series of hypotheses used in the models. Observations obtained from real biological 
experiments are used as evidence to ascertain whether the model’s hypotheses should be 
rejected or not. Moreover, real experimental observations can also suggest some novel 
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hypothesis in order to optimize the existing mathematical models. For example, a hypothetical 
kinase (Xic1 as a stoichiometric inhibitor of the complex CycE/CDK2) was added into the 
kinase model developed by Ciliberto et al. [2003] in order to reproduce the behaviour 
observed in real biological experiments. In Ciliberto et al.s’ [2003] model, they assumed that 
Xic1 can bind to all forms of CycE/CDK2 for inhibiting its activity. Furthermore, Xic1 bound 
to CycE/CDK2 was also used for the steady degradation of CycE. Based on these 
assumptions, the model simulation was consistent with experimental evidence that the 
degradation of CycE was a few hours after the degradation of Xic1 [Ciliberto et al., 2003]. 
 
2.3.3 Mathematical Structure of the Cell Cycle Checkpoint Models 
Most mathematical models for simulating the cell cycle checkpoint pathways are based on 
chemical kinetic theory involving interactions of linked reactions among proteins and 
enzymes in the cell cycle checkpoint pathways. The purpose of this is to show the dynamic 
behaviour of the reactive components. A set of mathematical equations are used to describe 
the reaction rates which represent the change of concentration of all participating chemical 
species in the pathway per unit time. A number of kinds of rate laws exist to describe different 
types of reaction mechanisms. The most common ones are the Mass-action rate law [Waage, 
1864], the Michaels-Menten rate law [Michaelis and Menten, 1913] and the Hill rate law [Hill, 
1910].  
 
Suppose the cell cycle checkpoint pathway consists of n chemical species 1 2, , nx x x  
participating in the reactions. In its most general form, the rate of the i
th  
reaction ( iv ) can be 
written as a function ( if ) of concentration (also denoted ix ) of all participating chemical 
species: 
1 2( , , )i i nv f x x x                                                                                                                (2-1) 
The rate laws are used to decide the actual format of iv  in the simulated pathway. 
 
2.3.3.1 Mass-Action Kinetics 
The law of mass action describes the relationship between the rates of chemical reactions and 
the molecular concentration of the reacting substances in typical elementary reactions with 
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only one transition state/ mechanistic step [Waage, 1864]. This states that the rate of the 
chemical reaction at a spatially homogeneous medium is directly proportional to the product 
of the effective concentrations of the participating molecules. For a simple reaction like 
kaA bB cC   ,                                                                                                                (2-2) 
A and B are reactants, C is the product, a, b and c are the number of molecules, and k is the 
rate constant of the reaction. Thus, according to the law of mass action, the rate of this 
reaction can be written as  
[ ] [ ]a bv k A B ,                                                                                                                         (2-3) 
where v  is the rate of the reaction and the square brackets “[]” are concentrations. Once v  is 
solved, we can use a set of ODEs to describe the change of concentration of all participating 
species in the system: 
[ ]d A
av
dt
   ,                                                                                                                          (2-4) 
[ ]d B
bv
dt
   ,                                                                                                                           (2-5) 
[ ]d c
cv
dt
  .                                                                                                                              (2-6) 
The powers a and b of the concentrations of the reactants are the kinetic orders of the 
reactants A and B, respectively, which reflect the stoichiometry of the reaction. The overall 
order of this reaction is the sum of a and b.  
 
The mass action rate law is only valid for elementary reactions with a single mechanistic step. 
In fact, most chemical reactions occur with the formation of intermediaries and/or through 
parallel reaction pathways and can be represented as a set of elementary reactions.  
 
2.3.3.2 Michaelis-Menten Kinetics 
In contrast to the mass action rate law, Michaelis-Menten kinetics are used to approximately 
describe the properties of enzyme-catalysed reactions that play an important role in 
biochemical systems [Michaelis and Menten, 1913]. Here, we consider an enzyme reaction as  
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k k
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S E ES P E   ,                                                                                                (2-7) 
where S is a substrate, P is a product, E is an enzymes or a catalyse, ES is a substrate-bound 
enzyme or the intermediate complex and k1, k2, k3 are rate constants. Based on the mass 
action rate law, the rates of change of concentration of S, E, ES and P can be written as: 
2 1
[ ]
[ ] [ ][ ]
d S
k ES k S E
dt
  ,                                                                                                      (2-8) 
2 3 1
[ ]
( )[ ] [ ][ ]
d E
k k ES k S E
dt
    ,                                                                                           (2-9) 
1 2 3
[ ]
[ ][ ] ( )[ ]
d ES
k S E k k ES
dt
    ,                                                                                      (2-10) 
3
[ ]
[ ]
d P
k ES
dt
  .                                                                                                                    (2-11) 
 
There are two key assumptions for the Michaelis-Menten Kinetics. The first key assumption 
is that the change of the concentration of the enzyme-substrate complex (ES) is much slower 
than those of the product (P) and the substrate (S). This assumption is also called quasi-
steady-state assumption. It indicates that the concentration of ES remains constant or the rate 
of the change of [ES] is equal to zero 
1 2 3
[ ]
[ ][ ] ( )[ ] 0
d ES
k S E k k ES
dt
    .                                                                                  (2-12) 
Therefore,  
1
[ ] [ ][ ]
M
ES S E
K
 , where 2 3
1
M
k k
K
k

 ,                                                                             (2-13) 
where MK  is called the Michaelis-Menten constant.  
 
The second key assumption is that the total enzyme concentration [ET] remains constant and it 
is the sum of the concentrations of the free (unbound) enzyme E and the substrate-bound 
enzyme ES over time. The total enzyme concentration can be written as  
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Substituting Eq.(2-14) into Eq.(2-13), we obtain an expression for [ES] 
([ ] [ ])[ ] [ ]
[ ] [ ] [ ]
[ ]
T
T
M M
E ES S S
ES ES E
K S K

  

.                                                              (2-15) 
By combining Eq.(2-11) and Eq.(2-15), the rate 
[ ]d P
v
dt
 for the product P can be written as  
3 3
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[ ] [ ]
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M
d P S
v k ES k E
dt K S
  

, or  
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[ ]
[ ]M
S
v v
K S


, where max 3[ ]Tv k E                                                                               (2-16) 
where maxv is the maximum reaction rate when all the enzyme molecules are in the form of the 
enzyme-substrate complex, ES at the substrate saturation. MK  is the Michaelis-Menten 
constant, as defined in Eq.(2-13). Eq.(2-16) is called the Michaelis-Menten equation, which 
shows that the rate of the product is hyperbolic with respect to the substrate concentration.  
 
There are some limitations of Michaelis-Menten kinetics. First, it is only achieved when these 
two key assumptions are satisfied. In particular, the quasi-steady-state assumption is not 
reached in many biochemical or cellular processes. In fact, the change of enzyme-substrate 
complex [ES] can be very small but not equal to zero. Secondly, Michaelis-Menten kinetics 
are appropriate for simple situations without intermediate/ product inhibition and 
allostericity/cooperativity in the system. 
 
2.3.3.3 Hill Kinetics 
Although Michaelis-Menten kinetics take a predominant part in analysing enzyme kinetics, 
they cannot appropriately describe the complex cell cycle checkpoint pathways because these 
pathways exist with many intermediates/product inhibition and allostericity/cooperativity in 
interactions of linked reactions among proteins and enzymes. Therefore, Hill-type functions 
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are introduced as a simple, convenient and useful way to simulate the activation and 
inhibition/repression phenomena in these pathways. 
 
In biochemistry, the Hill function is widely used to describe equilibrium binding in ligand-
receptor interactions. It was first formulated by A.V. Hill [1910] to describe how oxygen 
binds to a hemoglobin. The Hill function also provides a possible way to model the activation 
and inhibition in complex systems. In general, sigmoidal functions are used to formulate the 
Hill function for the rate ( v ) of the activation and inhibition/repression as 
[ ]
([ ])
[ ]
n
n n
x
v f x
K x

 

  for activation,                                                                                (2-17) 
and ([ ])
[ ]
1
n
v f x
x
K

 
 
  
 
  for inhibition/repression,                                                      (2-18) 
where   is the maximum expression level of the promoted activity. n is the Hill coefficient 
describing cooperativity. K denotes the half –saturation constant (i.e., the concentration of x  
occupies half of activation or inhibition), and is commonly known as the dissociation constant. 
When n is equal to 1, the Hill function has the same format as the Michaelis-Menten equation 
(Eq. (2-16)), which describes a noncooperative reaction. When n is larger than 1, the effect of 
the cooperativity can be observed based on the properties of the cooperative reaction, such as 
activation (positively cooperative reaction) or inhibition/repression (negatively cooperative 
reaction).   
 
For better understanding of the effect of the Hill coefficient, n, on the cooperativeness of the 
binding of the receptor protein with its ligands, we plotted the Hill function ( ([ ])v f x ) for 
activation and inhibition/repression against increased levels of [x], from 0 to 5, for four 
different n values: 1 (no cooperativity reaction), 2, 5 and 20 (the last three ‘n’s involve 
cooperativity reactions), respectively (Figure 2-7).  For simplicity, values of   and K are 
equal to 1. According to Figure 2-7, it is clear that the rate of activation (v) (Hill function) 
reaches its maximum/minimum under the activation/ inhibition situations, respectively, much 
more rapidly with the increase of n, which indicates that the Hill curve becomes more 
sensitive to the increasing n. In particular, the Hill curve is like an on-off switch when n 
becomes very large. 
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Figure 2-7  The effect of the Hill coefficient (n=1, 2, 5 and 20) on the Hill curve: (a) Hill 
functions for activation (positively cooperative reactions), and (b) Hill functions for 
inhibition/repression (negatively cooperative reactions). 
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2.3.4 Existing Models of Cell Cycle Checkpoints 
Over the last decade, there have been several successful mathematical models developed for 
cell cycle checkpoints in the mammalian cell cycle regulation, particularly for the G1/S 
checkpoint. Most of these models are quantitative and describe the system to represent 
interactions among proteins and reproduce experimental observations. They provide enough 
evidence that mathematical models can simulate and explain the complex behaviour of the 
cell cycle as well as provide important insights into the inner workings of these cell cycle 
checkpoints. The simulation of the G1/S cell cycle phase transition started in 1995 and was 
based on the simple protein-protein network involving CycE, CDK2, the retinoblastoma gene 
product (Rb) and the transcription factor, E2F [Hatzimanikatis, 1995]. With time, 
mathematical models became more and more complicated because some significant factors 
needed to be taken into account, such as CycD, CDK4/6, CDK inhibitory proteins (p21, p27 
and p16), the DNA-damage signal pathway and so on. For instance, Iwamoto et al. [2008] 
developed a complex mathematical model involving all essential proteins which control G1/S 
progression as well as proteins which include the DNA-damage signal transduction pathway. 
This made the mathematical model more comprehensive and powerful for exploring the 
potential behaviour of the whole G1/S transition pathway under DNA-damage situations. 
More details on the role of these proteins, such as Rb, E2F, CycD and CDK2, in the G1/S 
transition will be discussed in Chapter 3. Table 2-1 summarises the advantages and 
disadvantages of these existing mathematical models for the mammalian G1/S cell cycle 
phase transition. 
 
2.4 Artificial Neural Networks  
ANNs (ANNs) are considered a massively parallel-distributed information processing system 
that has similar characteristics to biological neural networks of the human brain to store, 
analyze and use experiential information and knowledge [Haykin, 1994]. ANNs have a high 
capability in approximating input-output mappings that are complex and nonlinear to arbitrary 
degrees of precision [Samarasinghe, 2006]. Typically, an ANN consists of computing 
elements called neurons and their connections depicted by ‘weights’ that are the internal 
parameters of the network. The incremental learning approaches used in ANNs make it 
possible for them to approximate all internal parameters iteratively and ANNs solve some 
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Table 2-1  Advantages and disadvantages of the past mathematical models for modelling the mammalian G1/S cell cycle transition. 
Source for the developed 
mathematical model 
Advantages Disadvantages 
A mathematical model for the 
G1/S transition of the 
mammalian cell cycle 
[Hatzimanikatis et. al., 1995] 
 Displays successfully real experimental observations, particularly in 
studying the effects of the CycE synthesis rate and the total E2F 
concentration on the appearance or not, of oscillatory solutions 
 Suggests strategies for rational manipulation of the cell cycle through 
bifurcation analysis  
 Considers the effects of the cell growth causing dilution of 
intracellular species    
 Simulates a very simple protein-protein 
networks just involving CycE, CDK2, Rb 
and E2F 
 Lacks the effects of cyclin dependent 
kinase inhibitors (CKIs) 
 Lacks the effects of cell volume in 
combination with the regulatory network  
A mathematical model of 
regulation of the G1 phase of 
Rb+/+ and Rb-/- mouse 
embryonic fibroblasts and an 
osteosarcoma cell line 
[Obeyesekere et al., 1997] 
 Displays the excellent agreement with current experimental 
observations in terms of how the activity of CycE/CDK2 responds 
to both Rb concentration and growth factors  
 Compares differences between normal cells, transformed cells and 
Rb-deficient cells 
 Involves more species to make the model a little bit  complex 
 Makes specific predictions for further experiments  
 A simplified version of the G1 phase of the 
cell cycle compared with a real situation 
 Ignores the crucial component of p27kip1 
and the phosphatise Cdc25A 
 Lacks an investigation of the cell cycle 
behaviour under unsaturated conditions 
 Lacks the effects of the growth factors on 
cyclin D synthesis  
Functional capabilities of 
molecular network components 
controlling the mammalian 
G1/S cell cycle phase 
transition [Kohn, 1998] 
 Provides functional insights useful for the interpretation of 
experiments and for guidance of experimental inquiry through a 
quasi-evolutionary sequence of simulations of hypothetical 
primordial systems (which starts with the simplest plausible 
functional system and adds functionality step by step in order to 
simulate the complexity of the mammalian G1/S cell cycle phase 
transition) 
 Provides a new approach involving unambiguous reaction 
diagrams, a convenient computer simulation method and a quasi-
evolutionary method  
 Ignores the functional characteristics of 
several factors, such as Rb phosphorylated 
at different sites has different properties   
 Ignores components of the network such as 
cdk inhibitor, p27
kip1
 and the phosphatise 
Cdc25A 
 Focuses on the important functional core to 
keep the network simple  
 Lacks information on the relevant rate 
constants  
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 Suggests some new functional concepts of relationship between Rb, 
E2f and cyclin-dependent kinase activities  
 Lacks details in the simulated reaction 
network  
 Limitations in the distribution of regulatory 
molecules within the cell 
The kinetic origins of the 
restriction point in the 
mammalian cell cycle [Aguda 
&Tang,1999] 
 Develops a detailed model mechanism for the G1/S transition in the 
mammalian cell cycle, which takes the effects of cdk inhibitor, 
p27
kip1
 and Cdc25A into account 
 Reproduces real experiments in terms of the relationship between 
the activity of CycE/CDK2 and the level of p27
kip1 
as well as the 
relationship between the activity of CycE/CDK2 and the Rb 
pathway 
 Suggests the core mechanism involving the coupled 
phosphorylation- dephosphorylation (PD) cycles between 
CycE/CDK2 and Cdc25A  
 Ignores the incorporation of signal 
transduction systems for G1/S transition 
 Ignores the participation of CycA  
 Lacks the effects of p16INK4a in the 
activities of E2F and CycE/CDK2 
 Difficult to define the actual rate 
expression for individual processes as well 
as the rate parameters  
A mathematical description of 
regulation of the G1-S 
transition of the mammalian 
cell cycle [Hatzimanikatis et. 
al., 1999] 
 Optimizes the preliminary model in 1995, such as considering 
effects of a Cyc/CDK complex inhibitor and the change of cell 
volume with time  
 Replicates a significant number of experiments in the  laboratory 
 Provides a solid foundation for further mathematical study of cell-
cycle control and related areas 
 A simple protein-protein network although 
the model adds a CycE/CDK2 complex 
inhibitor to the previous model  
 
A model of cell cycle 
behaviour dominated by 
kinetics of a pathway 
stimulated by growth factors 
[Obeyesekere et al.,1999] 
 Optimizes the previous model developed in 1997, such as, analysing 
effects of the growth factors on CycD under saturated or unsaturated 
growth factors  
 Reproduces the existing experiments on the effect of growth factors 
on cell cycle behaviour under saturated and unsaturated conditions 
 Gives some interesting predictions on the effect of growth factors in 
signal transduction pathway (leading to CycD synthesis) in the cell 
cycle  
 Suggests a new treatment plan for diseases governed by immortal 
cells 
 Lacks enough data to approximate the 
values of parameters in the mathematical 
model, particularly for  the efficiencies for 
the production of CycD and CycE  
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Kinetics behaviour of G1-to-S 
cell cycle phase transition 
model, [Tashima et al., 2003] 
 Based on the detailed mathematical model developed by Aguda and 
Tang [1999] but focuses on individual molecules through changing 
their corresponding parameters  
 Analyzes the dynamics of G1/S transition by means of the 
adjustment of individual parameters in the model 
 Proves some important results from Aguda and Tang model  
 Difficulty in interpreting model’s results in 
terms of  biological knowledge   
 
Regulation of the mammalian 
cell cycle; a model of the G1-
to- S transition [Qu et al., 
2003] 
 Divides the whole complicated G1/S transition regulatory network 
into individual simplified signal modules, and then reintroduces 
them into the full model in order to deeply analyze their dynamic 
properties as well as to decide their individual roles and their 
combined effects in the whole regulation network  
 Provides a wide degree of flexibility for the model to reproduce 
experimental observations and interpret the system’s dynamics     
 Simulates interactions among components of the model based on 
biologically realistic schemes not on phenomenological 
representations  
 Lacks experimental support to define 
parameters in the model   
 Ignores other regulatory interactions, such 
as Wee1 phosphorylated by activated CDK  
 Neglects nonuniform and dynamic 
distribution of proteins in the model 
A model for restriction point 
control of the mammalian cell 
cycle [Novak & Tyson, 2004] 
 Considers the interactions between cell growth and the dynamics of 
the CDK regulatory system   
 Compares the CDK-regulatory system in yeast and mammalian cells  
 Analyzes subtle interplays between two attributes of mammalian 
cell cycle: “sizer” and “timer” functions 
 Studies mutants of components in mammalian cell cycle, such as 
Rb, CycE 
 Does not use additional  signal 
transduction pathways to regulate 
proliferation in response to internal and 
external cues  
 Does not add the complicated details 
representing realistic cell cycle machinery 
and physiological circumstances 
Simulation for detailed 
mathematical model of G1-to- 
S cell cycle phase transition 
[Tashima et al., 2004] 
 Optimizes their previous model, developed in 2003, by adding 
CycA into the model and analyzes the effects of CycA activities 
 Provides some useful information for solving developmental 
mechanisms of cancer  
 Has an excellent agreement with the related experimental 
observations and biological knowledge 
 Ignores the effects of the phosphatise 
Cdc25A and DNA damage signal 
transduction  
 Ignores some important components of the 
network, such as p53 and Mdm2 
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Mathematical modelling of 
G1/S Phase in the cell cycle 
with involving the p53/Mdm2 
Network [Iwamoto et al., 
2006] 
 Adds DNA damage signal by p53/Mdm2 network into the previous 
mathematical model developed by Tashima et al. in 2004 
 Confirms the dynamics of the influence of DNA damage signal on 
checkpoint pathways  
 Compares time courses of some chemical species under the normal 
process and under a  DNA-damage situation 
 Does not verify the effect of  the intensity 
of DNA damage signal on the dynamics of 
E2F 
 Does not confirm the relationship between 
the intensity of DNA damage signal and 
the dynamics of these components: p16, 
p21 and p27 
A system biology dynamical 
model of mammalian G1 cell 
cycle progression [Haberichter 
et al., 2007] 
 Analyzes dynamic mechanisms of mammalian G1 cell cycle 
progression under constant growth factors   
 Simulates accurately the observed physiological data, kinetics and 
transitions  
 Compares differences between normal cells and tumour cells in a 
constant environment 
 Provides a foundation for the development of therapeutics  
 Does not explicitly incorporate kinases and 
phosphatases which regulate cdk activation 
into the model, such as Cdc25A   
 Lacks enough information to estimate 
precise values of the parameters 
Prediction of key factor 
controlling G1/S phase in the 
mammalian cell cycle using 
system analysis [Tashima et 
al., 2008] 
 Agrees with the related experimental observations and biological 
knowledge 
 Identifies the predominant factors that  affect  G1/S phase transition 
in the cell cycle 
 Incorporates the behaviour of  CycA into the mathematical 
modelling of the G1/S checkpoint 
 Has a precise understanding of the mechanisms regulating the 
dynamics of the G1/S phase transition  
 Does not take DNA damage signal 
transduction pathway into account  
 Needs further study on sensitivity analysis 
and stability of the proposed model for the 
G1/S phase transition  
Mathematical modelling and 
sensitivity analysis of G1/S 
phase in the cell cycle 
including the DNA-damage 
signal transduction pathway 
[Iwamoto et al., 2008] 
 Integrates the G1/S checkpoint with DNA damage signal 
transduction pathway  
 Evaluates the influence of the non-linear dynamics of DNA damage 
signal  
 Identifies the predominant factors in G1/S phase in response to 
different levels of DNA damage signal  
 Analyzes the stability of the G/S transition without and with DNA 
damage situations 
 Does not consider effective and 
compensating factors for the 
transformation from normal to damaged 
cells  
 Lacks the consideration of the DNA- 
damage repair process 
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Robustness of G1/S 
checkpoint pathways in cell 
cycle regulation based on 
probability of DNA-
damaged cells passing as 
healthy cells [Ling et al., 
2010] 
 Detects DNA-damage in cells and their repair mechanisms during 
cell division to understand how cells are replicated for gaining 
deeper understanding of conditions that cause cancer, characterised 
by uncontrolled cell proliferation 
 Investigates the  robustness of two critical proteins (E2F and CycE) 
of G1/S checkpoint in the presence of various levels of parameter 
perturbations under different levels of  DNA-damage intensities by 
analysing the probability of a DNA-damage cell passing as a 
healthy cell in the G1/S transition 
 Validates the model simulation results through comparing them 
with the experimental findings and the biological theory 
 Lacks the consideration of DNA-damage 
repair pathway  
 Does not make a connection between 
different intensities of DNA-damage signal 
in the model and the actual DNA-damage 
caused by different doses of UV-irradiation  
 
Mathematical modelling of cell 
cycle regulation in response to 
DNA damage: exploring 
mechanisms of cell-fate 
determination [Iwamoto et al., 
2011] 
 Integrates the G1/S model with the G2/M model in response to 
DNA damage signal transduction  pathway 
 Validates several numerically simulated time course  levels of 
individual biochemical species 
 Evaluates the effect of different intensities of DNA damage on cell 
cycle arrest 
 Analyzes which cells determine an appropriate cell fate, making a 
useful contribution to developing novel therapeutic systems for 
tumour tissues 
 Does not analyze in detail the relationship 
between p53 oscillation and the induction 
of cell apoptosis 
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problems that cannot be solved analytically by most mathematical models. With the 
development of neural networks, ANNs have become increasingly popular in many 
disciplines as a problem solving tool. More importantly, implementations of ANNs that have 
been successfully demonstrated in a variety of fields fall into a few simple categories [Maren 
et al., 1990; Hassoun, 1995]. 
Classification/Pattern Classification: Medical and disease diagnosis, character recognition, 
speech recognition, signature verification, spectra identification, classification of plant 
and animal species, blood cell classification and printed circuit board inspection etc. 
Forecasting/Prediction: Stock market predictions, economic predictions, weather forecasting, 
prediction of disease spread, prediction of properties and behaviour of biological 
materials, Forecasting inflows into rivers and lakes, electricity load forecasting, 
chemical reaction products and environmental risk assessment etc. 
Modelling: Engine idle-speed control, system control, process control, robot control, 
modelling land use change, signal compression, dynamic systems simulation and so on. 
 
However, very limited work has been done to investigate the capability of neural networks to 
directly learn and represent interaction reactions among proteins in biological networks. In 
this research we focus on developing and implementing new recurrent neural networks 
(RNNs) to directly represent chemical reactions in a simple biological network (p53-Mmd2 
oscillation system) as well as analyze and understand the internal workings among proteins 
involved in this biological network. In the following section, we discuss the fundamentals of 
ANNs, such as the basic idea behind RNNs, and more details on RNN development for this 
project will be described in a later chapter. A more general description of ANNs can be found 
in Maren et al., [1990], Hertz et al., [1991], Hagan et al., [1995], Hassoun [1995], Rojas 
[1996], Samarasinghe [2006] and many others. 
 
2.4.1 Recurrent Neural Networks (RNNs) 
RNNs became an important focus of neural network research during the 1990’s. A recurrent 
neural network can be considered as a class of network which has recurrent connections that 
unite to form a directed cycle (this means that network outputs create feedback 
loops/connections into the network as additional inputs) as well as delay elements [Fausett, 
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1994, Haykin, 1999]. The purpose of RNNs is to learn and exhibit the dynamic temporal 
behaviour of a system based on the present activity of the system, which is continuously fed 
back into the network to create the internal state of the network as its internal memory, and 
that the network should then use this internal memory to generate the next activity of the 
system. Therefore, RNNs are usually used to study and simulate nonlinear or linear dynamical 
systems. 
 
2.4.2 Recurrent Neural Networks Representing Chemical Kinetic 
Equations  
According to the discussion of mathematical modelling of chemical kinetic equations in 
Section 2.3.3, non-linear or linear ODEs are used to represent chemical kinetic theory 
involving interactions of linked reactions in a biological network. In general, numerical 
techniques, instead of the analytical techniques, are used to solve these ODEs to understand 
the dynamic behaviour of the system: the next task of the system is to generate the summation 
of the current activity of the system and change the system over time, using the following 
equation 
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where 1 2( , , )nf x x x is the function which describes the rate of change of  the 
thi  
participating chemical species in the biological network. When dt  becomes very small, from 
Taylor series expansion disregarding higher order terms, Eq. (2-19) for dt t   can be 
rewritten as  
1 2 1 2( 1) ( ) ( , , ) ( ) ( , , )i i i n i i nx t x t f x x x dt x t f x x x t       .                               (2-20) 
 
This characteristic of the numerical solution of ordinary differential equation techniques can 
be directly applied to a continuous-time recurrent neural network (RNN). More importantly, 
parameter estimation is the most difficult part of developing mathematical models for 
biological systems. Once an RNN is implemented to simulate chemical kinetic equations of a 
biological system, parameter estimation will become much easier and more feasible due to the 
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incremental learning approaches used in RNNs. There are some successful examples which 
demonstrate the application of RNNs to solve nonlinear projection equations in engineering. 
For instance, Kennedy and Chua [1988] developed a neural network for solving nonlinear 
programming problems based on the Kuhn-Tucker optimality conditions. Xia and Wang 
[1998] and Tao et al. [2001] also developed a two-layer neural network for solving nonlinear 
convex programming problems, indicating that the network can be globally convergent to an 
exact solution under a Lipschitz continuity condition and a strictly convex condition.   
 
2.5 Mathematical Formulation of Biological Robustness  
Although an abundance of research reports have been published on the role of robustness in 
multifactorial human disease [Gibson, 2009; Kitano, 2004b] and complex biological systems 
[Carlson and Doyle, 2002; Kitano 2004a], a mathematical foundation giving a unified 
perspective on biological robustness is still lacking. Kitano [2007] discussed the need for a 
complete mathematical formulation of biological robustness, and a mathematical theory. 
According to the concept of robustness, it can be defined as the ability of a system to maintain 
one or more of its functions under diverse perturbations. Therefore, the mathematical 
definition of robustness (R) of the system (s) may be written as a function (a) against a set of 
perturbations (P) as  
, ( ) ( )
s s
a P a
P
R p D p dp  ,                                                                   (2-21) 
where the function ( )p  is the probability for a particular perturbation ‘p’  to occur, and this 
should be equal when all perturbations occur with equal probability. The function ( )D p  is 
used to evaluate the system performance under a particular perturbation p , and P is the whole 
perturbation space. In terms of the evaluation function, ( )D p , it measures whether the system 
can maintain its function or performance against a perturbation and to what degree.  
( )D p  can be defined as: 
 
0,
( )
( ) / (0) ,
s
a
a a
p A P
D p
f p f p P p A
 
 
    
,                                                                (2-22) 
where A is a set of perturbations when the system fails to maintain its functions, which means 
that ( )D p  is equal to zero when a function cannot meet a defined requirement /criteria under 
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a particular perturbation. Otherwise, ( )D p  has a relative viability for a function under a 
certain perturbation compared with the non-perturbed state. For example, the production of 
the critical protein in a system has decreased to 80% under a particular perturbation against its 
production under non-perturbed conditions, which indicates that D(p) is equal to 0.8 for this 
specific perturbation.  
 
This mathematical definition of biological robustness concentrates on the stability and 
maintenance of the system’s function in response to diverse perturbations. However, 
robustness is a broader concept than stability and homeostasis. Therefore, more work is 
required to establish a mature theory of robustness by taking these factors into account; for 
example, phase transition and instability as an approach to achieve robustness, heterogeneity 
and the structured nature of biological systems, and the evolution of biological systems. 
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Chapter 3: A Mathematical Model of G1/S Transition 
Including the DNA-damage Signal Transduction 
Pathway 
In the following four chapters, the biological system under investigation is G1/S transition 
incorporating the DNA-damage signal transduction pathway, which is responsible for 
maintaining the stability of the cell cycle. Therefore, understanding the interaction between 
DNA-damage signal transduction and the G1/S checkpoint is a critical issue that affects the 
basis of life sciences. However, it is difficult to understand the interactions in this complicated 
biochemical network (the G1/S checkpoint) involving DNA-damage signals just from in vitro 
experiments; hence, we study a mechanistic mathematical model of the system and implement 
computational simulations for various levels of perturbations in the kinetic parameters of the 
model, followed by a systematic study and analysis of the model’s outcomes. The purpose is 
to study and explore the complex characterisation of G1/S transition. This chapter provides: 
first, a detailed background of the molecular components and interactions in the system; and 
secondly, a description of the mathematical model developed by Iwamoto et al. [2008] for 
G1/S transition including the DNA-damage signal. In Chapter 4, we define an analytical 
approach to investigate the robustness of G1/S transition in response to DNA-damage 
situations. In Chapter 5, we analyze and discuss results of a series of simulations and draw 
relevant conclusions. In Chapter 6, we study model’s ability to shed light on cellular 
senescence based on the results obtained from the mathematical simulation of the G1/S 
checkpoint through adjusting the corresponding kinetic parameters in the model. 
 
3.1 Biological Background of the G1/S Checkpoint Pathway and 
the DNA-damage Signal Transduction Pathway 
The cell cycle checkpoint pathways and the DNA-damage signal transduction pathway 
regulate the cell cycle in response to various endogenous and exogenous factors, which may 
directly or indirectly damage the components of genomic DNA [Dasika et al., 1999]. When 
normal cells undergo chemical or physical stresses resulting in DNA damage, the DNA-
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damage signal transduction pathway senses and propagates the “damage” signal to the cell 
cycle. Once the cell cycle recognizes the damage signal, the cell cycle checkpoints block cell 
cycle progression and provide sufficient time for the DNA repair mechanisms to complete 
their tasks successfully [Geva-Zatorsky et al., 2006; Iwamoto et al., 2008]. There are two 
approaches to blocking cell cycle progression in response to a DNA-damage signal: one 
depends on the activation of p53 and the other depends on the phosphorylation of Cdc25A, as 
discussed in Chapter 2. This study focuses on the former approach and the whole process is 
divided into the following five steps: (1) the DNA-damage signal activates the tumour 
suppressor protein, p53, because its (p53’s) negative feedback loop with Mdm2 cannot 
effectively and strictly control its stability, (2) the activated p53 sequentially promotes the 
activity of Mdm2 and p21, (3) p21, as a CDK inhibitor, binds to the binary complexes of 
Cyc/CDK, which play an important role in the cell cycle checkpoint pathway and control cell 
cycle progression, (4) the trimeric complex, p21/Cyc/CDK, inhibits the activity of Cyc/CDK 
leading to a blockage of cell cycle progression, and (5) p53 can also trigger the DNA-damage 
repair pathway or the apoptosis pathway by activating their cellular mechanisms. [Avkin et al., 
2006; Fridman and Lowe, 2003; Harris and Levine, 2005; Haupt et al., 2003; Shu et al., 2007]. 
When the cell cycle checkpoint pathway loses the ability to sense the DNA-damage signal, 
the defective and abnormal genome of a cell can pass through the cell cycle progression to 
future cellular generations. Thus, the disruption of the mediation between the cell cycle 
checkpoint pathway and the DNA-damage signal transduction pathway can make the genome 
unstable and predispose normal cells to malignant transformation, which eventually causes 
various diseases, in particular, human cancers. 
 
As discussed in Chapter 2, there are several cell cycle checkpoints with their own mechanisms 
to control cell cycle progression, for instance, G1/S, G2/M and G0
5
/G1 phase transition. 
These checkpoints have their own responsibility in the cell cycle: the G1/S checkpoint is used 
to control the initiation of DNA replication, the G2/M checkpoint is used to trigger mitosis 
and the G0/G1 checkpoint is used to sense the proliferation signal [Dasika et al., 1999; 
Hartwell and Kastan, 1994; Ikeda et al., 1996; Iliakis et al., 2003; Mckay et al., 2000; Stelling 
et al. 2004]. A cell generally stays in the G0 phase for a long time before it moves to G1. The 
reason for this is to accumulate nutrients and growth factors as well as propagate the 
proliferation signal for cell development [Iliakis et al., 2003; Molinari, 2000]. Furthermore, 
                                                 
5
 G0 phase is also called quiescence which means that the cell enter into a resting state, where the cell continues 
with its biological function but does not go through the rest of the cell cycle. The cell enters the G0 phase mainly 
due to a lack of growth factors or nutrients. 
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some important proteins, such as p27, CycD/CDK4/6 and p27/CycE/CDK2, in cell cycle 
regulation have already been accumulated in cells at this stage. After sensing the proliferation 
signal, cells enter the G1 phase and prepare for the initiation of DNA replication. Here, DNA 
is checked for any damage and the disruption of the G1/S checkpoint leading to non- 
recognition of the damage-signal can cause further problems to cell cycle progression. The 
G1/S phase checkpoint controls cell cycle progression into S phase. In the event of no DNA-
damage, transition is initiated through the release of E2F (The E2 promoter provides a direct 
assay for E2F transcription activating function [Helin, 1998]) that involves the preparation of 
important proteins that allow for the passage into S phase as well as DNA replication [Dyson, 
1998; Ikeda et al. 1996; Leone et al., 1999; Ohtani, 1999; Ohtani et al., 1995]. In the event of 
DNA-damage, this process is halted until the damage is repaired or the cell undergoes 
senescence or apoptosis [Bartek and Lukas, 2001a, b]. There are two questions to be answered: 
one is how the involved proteins regulate the cell cycle progression from G1 to S; the other is 
what the cell does in response to a DNA-damage signal. The following section provides more 
details in response to the above questions.  
 
3.1.1 What Happens in the Absence of DNA-damage? 
In the absence of a DNA-damage signal, cells usually stay in a quiescent (G0) state for a long 
time. As previously mentioned in Section 3.1, the purpose of this is to accumulate nutrients 
and growth factors as well as to propagate the proliferation signal. Once the proliferation 
signal is sensed in the early G1 phase, it triggers the synthesis of CycD increasing its 
concentration (See Figure 3-1). The CycD produced binds to CDK4 or CDK6 to form the 
complexes of CycD/CDK4 and CycD/CDK6, keeping them in an activated state (In this study, 
CycD/CDK4/CDK6 is used to represent these two complex proteins, CycD/CDK4 and 
CycD/CDK6, because they have quite similar physiological functions). There are two 
functions attributed to the CycD/CDK4/CDK6 complex: one function is to initiate the 
phosphorylation of Rb bound to E2F to obtain the hypophosphorylated form (Rb-PP/E2F) and 
the other function is to keep CycE/CDK2 in active form by (i) competing with CycE/CDK2 
for binding with free p27 to form the complex p27/CycD/CDK4/6 and by (ii) sequestering 
p27 from p27/CycE/CDK2 [Obaya and Sedivy, 2002].  The activated form of CycE/CDK2-P 
results in further hypophosphorylation of Rb-pp/E2F, promotes the dissociation of Rb-PPPP 
and E2F, and releases the activating E2F. The increase in level of free E2F promotes the 
synthesis of CycE in the mid to late G1 phase, which facilitates the association between CycE
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Figure 3-1  Simplified representation of the main protein interactions occurring in G1 
phase andG 1/S transition in the absence of a DNA-damage signal. 
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and CDK2 to form more of the complex CycE/CDK2. This results in increases in E2F activity 
and establishes a positive feedback loop between E2F and CycE; increased levels of E2F and 
CycE let the cell pass the G1/S transition and trigger S phase initiation [Hiebert et al., 1992]. 
The degradation of CycD occurs in the mid-G1 phase which promotes the release of p27 
bound to the complex CycD/CDK4/6. Furthermore, free-p27 is redistributed to the new 
complexes, such as CycE/CDK2 or CycA/CDK2. Although p27 can inhibit the activity of 
CycE/CDK2 or CycA/CDK2, the large amount of activated CycE/CDK2 can initiate p27 
degradation by phosphorylating it at threonine when p27 binds to CycE/CDK2 [Coqueret, 
2003]. This is why there is a significant degradation of p27 at the end of G1 due to the 
accumulation of CycE/CDK2 in the cell. E2F subsequently promotes CycA expression at the 
G1/S transition with a significant increase in the S phase. CycA is an important protein in the 
transition through the S phase as well as DNA replication [Obaya and Sedivy, 2002]. In S 
phase, the synthesized CycA also binds to CDK2 to form the complex CycA/CDK2. Once 
CycA/CDK2 is activated, it drives a negative feedback loop to inhibit the activity of E2F by 
phosphorylating E2F for its degradation. In addition, Rb-PPPP is dephosphorylated into Rb 
and E2F rebinds to Rb when the cell completes the G1/S transition progression. The purpose 
is to inhibit E2F activity and keep it in an inactivated form (Rb/E2F) in the S phase.  
 
3.1.2 What Happens When DNA Is Damaged? 
How do cells regulate the cell cycle transition from G1 to S in response to a DNA-damage 
signal? There are two different processes to remove DNA-damage from the cell cycle: a 
reversible form of cell cycle arrest/a state of temporary cell cycle arrest (DNA-damage repair) 
and an irreversible form of cell cycle arrest/a state of permanent cell cycle arrest (such as 
cellular senescence or apoptosis). As mentioned in Section 3.1, p53 plays an important role in 
response to the DNA-damage signal and to maintain the fidelity of the cell genome. In the 
normal cell cycle, a negative feedback loop between p53 and Mdm2 keeps p53 at a low and 
stable steady-state concentration through inhibiting p53 activity and enhancing the p53 
degradation rate [Barak et al., 1993; Haupt et al., 1997; Kubbutat et al., 1997; Wu et al., 1993]. 
However, this negative feedback loop cannot effectively and strictly control the level of p53 
when DNA-damage happens (see Figure 3-2). The accumulation of p53 in the nucleus leads 
to the arrest of cell cycle progression, repair of DNA damage or cellular senescence/apoptosis 
if repair is impossible. Depending on the different levels of DNA-damage, p53 has different 
functions in the cell cycle [Ciliberto et al., 2005; Geva-Zatorsky et al., 2006; Harris and 
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Figure 3-2  Diagram of key regulators in G1/S transition in response to DNA damage. 
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Levine, 2005; Lahav et al., 2004; Li and Ho, 1998]. In terms of low DNA-damage, the DNA-
damage signal promotes the activation of p53. The activated p53 promotes the transcription 
and synthesis of p21. The increased p21 binds to CycE/CDK2-P and CycA/CDK2-P to form 
p21/CycE/CDK2-P and p21/CycA/CDK2-P in order to inhibit their activation. As a result, 
Rb-PP/E2F cannot be further hypophosphorylated due to the loss of CycE/CDK2-P and 
CycA/CDK2-P, which inhibit the release of E2F and, consequently, synthesis of CycE and 
CycA, which are essential steps in the progression to the S phase [Dulic et al. 1994]. This 
temporarily blocks cell cycle progression and activates the cell cycle repair pathway in order 
to provide enough time for cells to repair DNA damage. With the removal of DNA-damage, 
the negative feedback loop of p53 and Mdm2 is fully restored and p53 returns to a low level. 
The decrease in p53 reduces the level of p21, which releases the complexes of CycE/CDK2-P 
and CycA/CDK2-P and makes the cell cycle return to the normal condition. With regard to 
high DNA-damage, p53 activated by the DNA-damage signal triggers the apoptosis pathway 
instead of DNA-damage repair pathway. In this case, the level of p21 is not as high as in the 
low-level DNA-damage case. The reason is that most p53 is used to activate the apoptosis 
pathway [Fridman and Lowe, 2003; Harris and Levine, 2005; Haupt et al. 2003; Li and Ho, 
1998]. 
 
Combining these two situations together, the completed structure of the G1/S checkpoint 
pathway integrating the DNA-damage signal transduction pathway is shown in Figure 3-3. 
According to Figure 3-3, it can be seen that the whole process in the G1/S transition is very 
complex, which contains a large number of interactions among many chemical species 
involved in the G1/S transition as well as the DNA-damage signal pathway. 
 
3.2 Description of the Mathematical Model  
A range of mathematical models have been proposed for the G1/S checkpoint pathway and 
the DNA-damage signal transduction pathway over the last twenty years (details of these 
models are in Chapter 2). However, most of these models study and analyze these two 
pathways individually. Only a few mathematical models concentrate on the dynamic 
behaviour of G1/S in response to the DNA-damage signal [Iwamoto et al. 2006; Iwamoto et al. 
2008]. 
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Figure 3-3  Schematic diagram of the structure of the G1/S checkpoint involving the DNA damage signal traduction pathway [Ling et al., 
2010]. 
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The latest mathematical model of the G1/S phase transition, published in 2008 by Iwamoto et 
al. [2008], simulates the G1/S phase transition involving the DNA-damage signal transduction 
pathway based on the biological finding that effectively combine Tashima et al.’s [2004] 
G1/S phase transition model and Lev Bar-Or et al.’s [2000] DNA damage signal transduction 
model. Tashima et al. [2004] focus on the chemical interactions among the biochemical 
species of the G1/S transition and their dynamic behaviour, while Lev Bar-Or’s model [2000] 
focuses on the dynamic behaviour of the DNA signal transduction mechanism, which is 
mainly based on the damped oscillation of p53 and Mdm2. Iwamoto et al. [2008] mainly 
analyze the dynamic behaviour of the key proteins, such as E2F, CycE, CycA, p21, p53, 
Mdm2, in the G1/S phase transition in response to three different levels of DNA-damage (no 
DNA-damage, low DNA-damage and high DNA-damage). Furthermore, they identify what 
the predominant kinetic parameters are in the G1/S transition under different DNA-damage 
levels based on a local sensitivity analysis. The purpose is to develop a measure and a 
criterion to evaluate the variation of chemical species with respect to the perturbations in each 
kinetic parameter. Variation is defined as a change in the steady-state value of each chemical 
species divided by the change of a particular parameter. The focus of this sensitivity analysis 
is to count the number of chemical species with variations larger than 0.1 or less than -0.1 
corresponding to the changes in model parameters. If the changes in kinetic parameters affect 
a larger number of steady-state chemical species, they are defined as predominant factors in 
the G1/S transition phase in the cell cycle. Meanwhile, Iwamoto et al. [2008] also analyzed 
changes in peak time of E2F in response to the different values of the specific kinetic 
parameter, k5, which corresponds to the synthesis of CycE promoted by E2F.  
 
Iwamoto et al.s’ model -hereafter simply referred to as the G1/S model- has 28 ODEs based 
on the mass balances with 75 kinetic parameters, which displays the interactions among the 
chemical species in the G1/S phase transition integrating the DNA-damage signal 
transduction pathway (see Figure 3-3). Michaelis-Menten and Hill kinetics are used to 
simulate the inhibiting effects of proteins in the G1/S model. Moreover, each ODE describes 
the time course of concentration for the corresponding chemical species. Now we take the 
protein (Rb) as an example of how ODE represents the change of concentration of Rb based 
on the equation given below: 
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where 18 21 22 23, , ,x x x x  represent p16, E2F, Rb-PPPP and Rb, respectively; the biochemical 
meaning of parameters is shown in Table 3-2. In this equation, we use Michaelis-Menten 
kinetics (the second term on the right side) to express p16 inhibition of the synthesis of Rb as 
shown in Figure 3-3. The change of concentration of the remainder of the participating 
molecular species in the G1/S transition can be written in the same way as above.  
 
The following content shows how ODEs represent chemical interations involved in the G1/S 
model based on small changes from Iwamoto et al.s’ [2008] model. We divide the complex 
G1/S model (see Figure 3-3) into four sub-models: inhibition model of CDK4/6 and CDK2 by 
p16 and p27, activation model of CDK2 by CycE and CycA, activation model of Rb/E2F 
cycle and DNA-damage signal transduction pathway in the G1/S transition. Therefore, ODEs 
are introduced with the description of each sub-model in order to easily and deeply 
understand this complex G1/S checkpoint pathway in response to the DNA-damage situation. 
Furthermore, the sequential order ODEs for the G1/S model is shown in Appendix A. We 
summarise the model variables corresponding to chemical species in the G1/S phase in Table 
3-1 and the biochemical meaning of these 75 parameters in Table 3-2.  
 
We first introduce interactions involved in the inhibition model of CDK4/6 and CDK2 by p16 
and p27 in the G1/S transition (see Figure 3-4). Proteins p16 and p27 are considered as CKIs 
in the G1/S transition, but they have different functions. P16 only binds to CycD/CDK4/6 in 
order to inhibit its activity through degrading CycD/CDK4/6. P27 can bind to these three 
complexes: CycD/CDK4/6, CycE/CDK2-P and CycA/CDK2-P to form the trimeric complex 
p27/CycD/CDK4/6, p27/CycE/CDK2-P and p27/CycA/CDK2-P. However, p27 only inhibits 
the activation of CycE/CDK2-P and CycA/CDK2-P. Moreover, both the binary complex 
CycE/CDK2-P and CycA/CDK2-P can promote p27 degradation. The following equations 
(Eqs. (3-1 to 3-8)) represent a series of chemical interactions involved in the sub-model of 
inhibition of CDK4/6 and CDK2 by p16 and p27:  
0
1 4 5 2 0 3 0 3( )   
dx
k k x k x k x x
dt
                                                                                          (3-1) 
3
4 5 13 5 3 0 3( )  
dx
k x k x k x x
dt
                                                                                                (3-2) 
5
3 0 3 19 15 21 11 4 5 13 5 18 5 14 20 5 10 44 5 18( )       
dx
k x x k x k x k x k x k x x k x x k x x
dt
                      (3-3) 
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Table 3-1  Description of variables in the G1/S Model. 
 
 
Model variables  Chemical species Model variables  Chemical species 
0x   CycD 14x   p21 
1x   CycE 15x   p21/ CycD/CDK4/6 
2x   CycA 16x   p21/ CycE/CDK2-P 
3x   CDK4/6 17x   p21/ CycA/CDK2-P 
4x   CDK2 18x   p16 
5x   CycD/CDK4/6 19x   Rb/E2F 
6x   CycE/CDK2 20x   Rb-PP/E2F 
7x   CycE/CDK2-P 21x   E2F 
8x   CycA/CDK2 22x   Rb-PPPP 
9x   CycA/CDK2-P 23x   Rb 
10x   p27 24x   p53 
11x   p27/ CycD/CDK4/6 25x   Mdm2 
12x   p27/ CycE/CDK2-P 26x   ‘X’ 
13x   p27/ CycA/CDK2-P 27x   ‘I’ 
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Table 3-2  Biochemical meaning of the kinetic parameters of the G1/S model. 
 
Parameter Biochemical meaning Parameter Biochemical meaning 
k1 synthesis rate of CycD k39 degradation rate of p21 
k2 degradation rate of  CycD k40 synthesis rate of p16 
k3 association rate of CycD/CDK4/6  k41 constant as influx or precursor  
k4 dissociation rate of CycD/CDK4/6 k42 rate of inhibition of synthesis p16 by Rb 
k5 synthesis rate of CycE k43 degradation rate of p16 
k6 degradation rate of  CycE k44 degradation rate of p16/ CycD/CDK4/6 
k7 association rate of CycE/CDK2 k45 association rate of Rb/E2F 
k8 dissociation rate of CycE/CDK2 k46 phosphorylation rate of Rb/E2F to form Rb-
PP/E2F through CycD/CDK4/6 
k9 synthesis rate of CycA k47 phosphorylation rate of Rb/E2F to form Rb-
PP/E2F through p27/CycD/CDK4/6 
k10 degradation rate of  CycA k48 phosphorylation rate of Rb/E2F to form Rb-
PP/E2F through p21/CycD/CDK4/6 
k11 association rate of CycA/CDK2 k49 rate of activation of E2F by CycE/CDK2-P 
k12 dissociation rate of CycA/CDK2 k50 rate of activation of E2F by CycA/CDK2-P 
k13 rate of CDK4/6 production through 
CycD/CDK4/6 
k51 rate of synthesis of E2F promoted by itself  
k14 rate of CDK2 production through  
CycA/CDK2-P 
k52 synthesis rate of E2F 
k15 rate of CDK2 production through  
CycA/CDK2 
k53 degradation rate of E2F 
k16 rate of CDK2 production through  
CycE/CDK2 
k54 rate of E2F degradation by CycA/CDK2-P 
k17 rate of CDK2 production through  
CycE/CDK2-P 
k55 dephosphorylation rate of Rb-PPPP to Rb 
k18 association rate of p21/ CycD/CDK4/6 k56 synthesis rate of Rb 
k19 disassociation  rate of p21/ CycD/CDK4/6 k57 degradation  rate of Rb 
k20 association rate of p27/CycD/CDK4/6 k58 constant as influxes or precursor 
k21 disassociation rate of p27/CycD/CDK4/6 k59 rate of inhibition of synthesis Rb by p16 
k22 phosphorylation rate of CycE/CDK2 to 
form CycE/CDK2-P 
k60 synthesis rate of p53 
k23 dephosphorylation rate of CycE/CDK2-P 
to form CycE/CDK2 
k61 rate of synthesis of p53 through DNA-
damage signal  
k24 association rate of p27/ CycE/CDK2-P k62 degradation rate of p53 
k25 disassociation  rate of p27/ CycE/CDK2-P k63 synthesis rate of Mdm2 
k26 association rate of p21/ CycE/CDK2-P k64 degradation rate of Mdm2 
k27 disassociation  rate of p21/ CycE/CDK2-P k65 dissociation constant in Hill function  
k28 phosphorylation rate of CycA/CDK2 to 
form CycA/CDK2-P 
k66 rate of synthesis of Mdm2 through ‘I’ 
k29 dephosphorylation rate of CycA/CDK2-P 
to form CycA/CDK2 
k67 degradation rate of ‘I’ 
k30 association rate of p27/ CycA/CDK2-P k68 synthesis rate of ‘X’ 
k31 disassociation  rate of p27/ CycA/CDK2-P k69 degradation rate of ‘X’ 
k32 association rate of p21/ CycA/CDK2-P k70 rate of p53’s sequence-specific DNA 
binding activity by DNA-damage signal 
k33 disassociation  rate of p21/ CycA/CDK2-P k71 association rate of p53 and Mdm2 
k34 synthesis rate of p27 k72 rate of DNA-damage repair 
k35 rate of p27 degradation by CycE/CDK2-P k73 rate of inhibition of degradation of p53 
and/or Mdm2 by DNA-damage signal 
k36 rate of p27 degradation by CycA/CDK2-P k74 rate of Mdm2’s ability to promote p53 
degradation 
k37 synthesis rate of p21 k75 rate of inhibition of Mdm2-mediated p53 
degradation under the initial damage signal 
k38 rate of synthesis of p21 through p53   
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Figure 3-4  Inhibition model of CDK4/6 and CDK2 by p16 and p27 in the G1/S Model. 
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For the activaction model of CDK2 by CycE and CycA in the G1/S transition (see Figure 3-5), 
the synthesis of CycE and CycA is promoted by the release of E2F in the later stage of G1 
phase. According to the experimental finding [Braken et al., 2004], the synthesis of CycA 
promoted by E2F requires some other co-activator at the same time. Therefore, we introduce 
the intermediate protein ‘X’ to display this requirement in the model. The produced CycE and 
CycA bind to CDK2 to form the binary complex CycE/CDK2 and CycA/CDK2. Once these 
two binary complexes (CycE/CDK2 and CycA/CDK2) are phosphorylated, they become the 
activated forms to take their responsibility in cell cycle regulation. For example: CycE/CDK2-
P controls cell progression into S phase while CycA/CDK2-P controls the DNA replication in 
the S phase.  The details of ODEs for the activation model of CDK2 are shown below (Eq. (3-
9 to 3-15)): 
1
5 21 8 6 6 1 7 1 4( )   
dx
k x k x k x k x x
dt
                                                                                     (3-9) 
2
9 26 12 8 10 2 11 2 4( )   
dx
k x k x k x k x x
dt
                                                                                (3-10) 
24
8 6 12 8 14 9 15 8 16 6 17 7 7 1 4 11 2 4( )       
dx
k x k x k x k x k x k x k x x k x x
dt
                              (3-11) 
6
7 1 4 23 7 8 6 16 6 22 6 7( )    
dx
k x x k x k x k x k x x
dt
                                                                   (3-12) 
27
22 6 7 25 12 27 16 23 7 24 7 10 26 7 4 17 7( )      
dx
k x x k x k x k x k x x k x x k x
dt
                                (3-13)
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Figure 3-5  Activation model of CDK2 by CycE and CycA  in the G1/S Model. 
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In the activation model of Rb/E2F cycle in the G1/S transition (see Figure 3-6), E2F is 
released through disassociation from E2F/Rb as follows: CycD/CDK4/6 and its related 
complexes (such as p27/ CycD/CDK4/6 and p21/CycD/CDK4/6) initiate the phosphorylation 
of Rb bound to E2F to obtain the hypophosphorylated form (Rb-PP/E2F). Furthermore, Rb-
PP/E2F can be further phosphorylated by the activated CycE/CDK2-P and CycA/CDK2-P in 
order to promote the dissociation of Rb-PPPP and E2F. The release of E2F promotes the 
synthesis of CycE, CycA and itself. However, the activated CycA/CDK2-P triggers the 
degradation of E2F to inhibit its activation. Once the cell enters the S phase, Rb-PPPP is 
dephosphorylated to Rb which rebinds to E2F to form the complex Rb/E2F. The following 
equations (Eqs. (3-16 to 3-20)) represent the chemical interactions in the activation model of 
Rb/E2F cycle: 
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                                                          (3-20) 
 
For the model of DNA-Damage signal transduction pathway in the G1/S transition (see 
Figure 3-7), the damaged signal activates p53 which breaks the negative feedback loop 
between p53 and Mdm2, making the negative feedback loop ineffective in strictly controlling 
the level of p53. The synthesis of p53 promotes the production of the interminate ‘I’, an 
unknown mechanism leading to a possible delay between the activation of p53 and the 
induction of Mdm2. The increased ‘I’ triggers the synthesis of Mdm2 but the synthesis of 
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Figure 3-6  Activation model of Rb/E2F cycle  in the G1/S Model. 
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Mdm2 inhibits the synthesis of ‘I’ as well as the activation of p53 through its (p53’s) 
degradation. In addition, p53 can promote the synthesis of p21 as one of the key CKIs to 
inhibit the activation of CycE/CDK2-P and CycA/CDK2-P through binding to these two 
complex proteins. The purpose of this binding is to delay cell progression and provide enough 
time for DNA-damage repair. The p21 also binds to CycD/CDK4/6 without inhibiting the 
activation of this binary complex. The details of ODEs for the DNA-damage signal 
transduction pathway model are shown below (Eqs. (3-21 to 3-28)): 
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The following two equations represent the kinetics of the signal for p53 activation (Eq. (3-29)) 
and the strength of Mdm2’s ability to inhibit the activation of p53 by promoting the 
degradation of p53 (Eq. (3-30)), 
72exp( )  signal DDS k t                                                                                                  (3-29) 
74 73 75( exp( ))    degradation k k signal DDS k t                                                           (3-30) 
where DDS is the initial intensity of the DNA-damage signal. In this case, the value of DDS 
is quantitatively defined as follows: 0 for no DNA-damage (normal situation), 0.003 for low 
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Figure 3-7  DNA-damage signal transduction pathway sub-model in the G1/S model 
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DNA-damage and 0.005 for high DNA-damage. In terms of the signal denoted in Eq.  (3-29), 
the complex process involved in subsequent resolution of the damage signal by cellular 
mechanisms of DNA damage repair is represented by a constant parameter k72 in order to 
keep the model as simple as possible. Therefore, we ignore the complex reactions involved in 
cellular mechanisms of DNA-damage repair in the real biology. In addition, the values of 
these 75 parameters and initial values of the model’s variables are tabulated in Tables 3-3 and 
3-4, respectively [Iwamoto et al., 2008].  In this research, “NDSolve” in Mathematica® is 
used to find a numerical solution to 28 ODEs and generate the dynamic behaviour of chemical 
species in the G1/S phase. 
 
3.3 Summary 
In this chapter, we provided a detailed background of the molecular components and 
interactions in the G1/S checkpoint pathway and the DNA-damage signal transduction 
pathway as well as a summary of the mathematical model for the G1/S transition involving 
the DNA-damage signal that will be the basis for this study. 
 
In terms of biological background of the G1/S transition, we described what happens among 
the molecular components in the G1/S transition under no DNA-damage and DNA-damage 
situations. In the absence of a DNA-damage signal, CycD/CDK4/6 initiates phosphorylation 
of Rb in the early G1 phase. It prepares for the realse of E2F at the G1/S transition. In the late 
G1 phase, CycE/CDK2 completes the further phosphorylation of Rb to release more E2F in 
order to let the cell pass the G1/S transition and promote S phase initiation. When DNA-
damage happens, p53 is activated and promotes the transcription and synthesis of p21. 
Furthermore, p21 can bind to CycE/CDK2 to inhibit the activation of this complex. As a 
result, the cell progression is temporarily blocked due to the uncompleted progress in the 
further phosphorylation of Rb for releasing E2F by CycE/CDK2. 
 
For the mathematical model of the G1/S transition, we gave a detailed summary of ODEs, the 
biochemical meaning of kinetic parameters, the initial conditions and the parameter values for 
the G1/S model. These factors can help us to understand the meaning of the G1/S model. 
More importantly, the G1/S model can be effectively used to investigate the robustness and 
dynamical behaviour of the G1/S transition in response to a DNA-damage signal.  
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Table 3-3  Kinetic parameter values for the G1/S model. 
 
Parameter Value Parameter Value Parameter Value 
k1 35 10  k26 22.25 10  k51 85 10  
k2 45 10  k27 41.75 10  k52 75 10  
k3 35 10  k28 21.9 10  k53 55 10  
k4 32.5 10  k29 45 10  k54 21 10  
k5 
27.5 10  k30 
32.5 10  k55 
85 10  
k6 
32.5 10  k31 41.75 10  k56 
55 10  
k7 
31.25 10  k32 
32.5 10  k57 
35 10  
k8 42.5 10  k33 41.75 10  k58 55 10  
k9 48 10  k34 85 10  k59 45 10  
k10 45 10  k35 21 10  k60 41 10  
k11 31 10  k36 31.5 10  k61 1.5  
k12 
42 10  k37 
55 10  k62 31 10  
k13 
45 10  k38 
21 10  k63 
49.4 10  
k14 
45 10  k39 
35 10  k64 
22 10  
k15 
45 10  k40 
32 10  k65 9.5  
k16 
45 10  k41 
55 10  k66 10  
k17 
32 10  k42 41 10  k67 
35 10  
k18 
45 10  k43 
45 10  k68 
25 10  
k19 
35 10  k44 
45 10  k69 
48 10  
k20 
45 10  k45 
55 10  k70 6  
k21 
55 10  k46 
32.5 10  k71 
34 10  
k22 22.5 10  k47 
32.5 10  k72 81 10  
k23 
31.75 10  k48 
32.5 10  k73 
17.72 10  
k24 
22.25 10  k49 
24 10  k74 
25.56 10  
k25 
41.75 10  k50 
32.5 10  k75 
22 10  
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Table 3-4  Initial conditions of the variables in the G1/S model. 
 
Chemical Species Initial Value Chemical Species Initial Value 
0x  23 10  14x  0  
1x  31 10  15x  0  
2x  54 10  16x  0  
3x  5  17x  0  
4x  13.5  18x  
31 10  
5x  2  19x  1.95  
6x  31 10  20x  
31 10  
7x  31 10  21x  0  
8x  44 10  22x  
21 10  
9x  41 10  23x  
25 10  
10x  6.3  24x  
22.65 10  
11x  31 10  25x  
42.35 10  
12x  1 26x  
41 10  
13x  41 10  27x  0  
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Chapter 4: Computational Methods of Investigation  
Robustness of biochemical pathways is crucial to the very existence of healthy cells, and the 
concept of robustness of living organisms has been discussed in many papers (see Kitano 
[2007] and Stelling et al. [2004], for example). We define robustness accordingly, as an 
emergent systemic property related to the ability of a system to sustain functionality amidst 
internal and external perturbations and uncertainties. Robustness is a broader concept than 
stability and homeostasis and the robustness of subsystems is essential for homeostasis of the 
whole system [Kitano, 2007]. Therefore, any investigation into the complex checkpoint 
pathways as a subsystem for systemic robustness begins with the identification of a 
performance measure(s) and a limited number of key proteins (biomarkers), as major 
indicators of the proper functioning of the system, in a biologically meaningful manner. We 
need to develop measures of performance for the system, which can be monitored as functions 
of the biomarkers selected. By perturbing the kinetic parameter space associated with the 
biomarkers and investigating the effects on the performance measures give us information on 
the robustness of the system. However, this approach is very difficult to implement in vivo or 
in vitro, justifying the use of mathematical models for the purpose. In this chapter, we focus 
on how to develop such an approach based on a mathematical model of the G1/S checkpoint 
pathway; more specifically, we identify two key biomarkers characterising the G1/S 
checkpoint. Then, we compute the probability (β) of a DNA–damaged cell passing as a 
healthy cell in the G1/S phase transition, and define 1-β as a performance measure associated 
with the G1/S checkpoint pathway, and investigate the β of the G1/S transition in the presence 
of various levels of perturbations in the key kinetic parameters associated with the model. 
 
4.1 Choice of Biomarkers for G1/S Transition  
In general, a biomarker is considered as an indicator of a biological state. Its characteristic is 
that it can be objectively detected and measured as an indicator of normal biological processes. 
In regard to the G1/S cell cycle phase transition involving the DNA-damage signal 
transduction pathway, E2F and CycE are used as our in silico biomarkers to analyze the G1/S 
transition pathway, particularly the peak times (PTs) of E2F and CycE. There are very good 
reasons, in addition to the ones mentioned in Chapter 3, for choosing the transcription factor 
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E2F. During the G1/S transition, the target of the activated E2F is to control the regulatory 
elements of the cell cycle (for example, two critical G1/S gene products are the G1/S Cyclin E, 
and the S Cyclin, CycA) for the completion of the G1/S progression, as well as to control 
essential components of the DNA replication machinery (such as dihydrofolate reductase, 
thymidine kinase and DNA polymerase alpha) involved in the initiation of DNA replication 
[Iliakis et al., 2003; Obaya & Sedivy, 2002; Ohtani, 1999; Ohtani et al. 1995]. In fact, the 
activation of E2F is directly regulated by the activity of Rb and indirectly regulated through 
the action of cyclins and their dependent kinases at the G1/S transition. The accumulation of 
E2F and CycE activity could be a critical event for making the decision on whether the cells 
enter into S phase or not [Lukas et al. 1996; Ohtani, 1999; Ohtani et al. 1995]. Taking the 
DNA-damage signal into account, the oscillation of p53 is an important indicator for the 
DNA-damage signal; however, p53 is not a significant factor for deciding whether a cell 
passes the G1/S transition or not. In fact, the p53 activated through the DNA-damage signal 
can promote the accumulation of p21 as one of the CDK inhibitors, resulting in the arrest of 
cell cycle progression. With the repair of DNA-damage, a cell re-enters the normal cell cycle 
progression, as before. However, delay due to repair of DNA-damage causes delays on these 
chemical species leading to delays in their peak times compared to healthy cells [Iliakis et al., 
2003]. Appendix B shows these delays in the behaviour of the key proteins (E2F, CycE, p53, 
p21 and CycA) in G1/S transition revealed from the mathematical model under different DNA 
damage situations. The reason for showing the behaviour of CycA is to validate the model 
results with the experimental findings and the related information will be dicussed in Chapter 
5. 
 
4.2 Analytical Method for Investigating the Dynamic 
Behaviour of G1/S Transition  
We have chosen predominant chemical species, such as E2F, CycE and p53, in the G1/S 
phase under different levels of DNA-damage as in silico biomarkers, and the PTs of E2F and 
CycE as two significant time-based measures to monitor the status of the system under 
different DNA-damage situations, such as no DNA-damage, low-level DNA-damage and 
high-level DNA-damage. The release of additional E2F can sequentially promote the 
synthesis of CycE, CycA and itself, which are essential proteins for the progression to S phase 
[Ikeda et al., 1996], while the PT of E2F signifies that the cell passes through the restriction 
point and prepares for the initiation of DNA replication; the PT of CycE usually occurs at the 
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G1/S transition and CycE is down regulated during the S phase [Keyomarsi and Herliczek, 
1997; Reed, 1997]. Local sensitivity analysis (LSA) is used to decide which kinetic 
parameters are the most significant to the selected key proteins in the G1/S phase under 
different DNA-damage conditions; global sensitivity analysis (GSA) is used to analyze how 
these selected significant kinetic parameters from LSA simultaneously regulate these key 
proteins in the G1/S phase transition under different DNA-damage conditions. Based on the 
results of GSA, statistical hypothesis testing with Type II error was used to compute β (the 
probability of a damaged cell passing as a healthy cell). The β will indicate not only the 
robustness of the checkpoint pathway model but also will lead to biologically meaningful 
interpretations of the results of the model. 
 
4.2.1 Local Sensitivity Analysis 
In LSA, only one kinetic parameter can be varied at a time within a predefined range (the 
range for all 75 kinetic parameters is from 50% to 150% at 10% intervals, with 100% as the 
standard condition), and the following criterion was used to evaluate the significance of the 
changed kinetic parameter (variation): 
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

 ,                                                                                     (4-1) 
 
where standardk  is the value of the kinetic parameter under the standard conditions, 
max
standardt  is 
the value of PT of the protein of interest, employing the standard set of kinetic parameters 
(SKP), newk  represents the changed value of the kinetic parameter from SKP and 
max
newt  
represents the PT of the  protein of interest corresponding to the changed kinetic parameter. 
The values of SKP are based on the published mathematical model for the G1/S transition in 
2008 [Iwamoto et al., 2008]. This study concentrates on the magnitude of Variation regardless 
of whether the variation is positive or negative because high Variations indicate significant 
influence on the protein of interest. 
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4.2.2 Global Sensitivity Analysis 
GSA provides information of the change of output in response to simultaneous variations in 
parameters. In real biochemical systems, rate constants of biochemical reactions in vivo seem 
to simultaneously vary based on the external environment [Stelling et al., 2004; Rand, 2008]. 
The characteristic of dependence of biochemical reactions on their rate constants indicates 
that GSA is suitable and appropriate for sensitivity analysis of biochemical systems and 
reactions [Rand, 2008]. In this investigation, the whole process of GSA is divided into three 
main steps: 
 
1. According to the analytical results of LSA, we appropriately choose the most significant 
kinetic parameters relevant to each of the interested chemical species. We then define the 
ranges for them to be varied simultaneously while keeping the remaining kinetic 
parameters constant under the standard conditions. For instance, the number of the most 
significant kinetic parameters for PT of E2F is 10 under no DNA-damage (normal or 
healthy cells). Thus, we simultaneously change these 10 parameters in a range and keep 
the remaining 65 parameters at their SKP levels. The range of the selected parameters is 
divided into four different levels: reference values %10 ; reference values %20 ; 
reference values %30  and reference values %50 . For example, reference values 
%10  means that the parameters are examined within 10% variations of their reference 
values. 
 
2. We randomly generate samples of parameter vectors for the most sensitive parameters in 
the defined levels of the range. For an individual range under each individual DNA-
damage situation (damage conditions or no damage), 3000 parameter vectors are 
generated and each parameter vector contains the values for the selected most significant 
parameters affecting a protein. For instance, if we investigate the change in PT of E2F in 
response to simultaneous variations in its most significant 10 parameters within a range 
of %10  under no DNA damage, each parameters vector contains 10 elements 
displaying the values for the corresponding significant parameters randomly drawn 
within the %10  range. In order to guarantee that each individual parameter can be 
evenly distributed in the defined range, as well as to ensure that the generated sample 
parameter vectors are representative of the real variability, Latin Hypercube Sampling 
(LHS) is used to generate samples of random parameter vectors [McKay et al,. 2000]. 
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3. Once the 3000 sample parameter vectors are generated from LHS, we run the model and 
record PTs of the in silico biomarkers in order to calculate the frequency distribution and 
then to estimate the corresponding probability density function (PDF) using the Gaussian 
density function (In this case, we checked several difference density functions, such as 
Gaussian, Gamma, Beta, Exponential and Lognormal density functions. Results indicate 
that Gaussian density function is the most suitable for our study). Gaussian density 
function can be characterised completely by the mean and standard deviation. 
 
4.2.3 Evaluation of β: Statistical Hypothesis Testing with Type II 
Error 
Statistical hypothesis testing is used to determine whether an observed experiment provides 
conclusive evidence to accept a proposition (which is called a null hypothesis). A Type II 
error (  ) is committed when a researcher fails to reject a null hypothesis that is false. In this 
investigation, a Type II error indicates the probability that a cell is considered healthy when, 
in reality, it is affected and damaged. In general,   is used to represent the probability of 
committing a Type II error, while the power ( 1 ) of the test represents the probability of 
not committing a Type II error (i.e. damaged cells are declared damaged) [Black, 2007]. 
There are three main steps in determining the probability of a Type II error (see Figure 4-1): 
 
1. We need to determine the critical value hct  to accurately distinguish healthy cells based 
on the PDF under no DNA-damage situation. In testing the null hypothesis, this value is 
used as the boundary to separate the non-rejection region from the rejection region. We 
accept the null hypothesis when the PT is less than or equal to the critical value, hct , and 
rejects the null hypothesis when PT exceeds hct . The standardized critical value of 
healthy cells is based on Eq.(4-2): 
  
hc
hchctZ


0                                                                                                             (4-2) 
where 0Z  is equal to 1.645 at the 5% level of significance ( ), hc  is the mean and hc  
is the standard deviation of the peak time of the protein of interest, estimated from the 
PDF of healthy cells (see Section 4.2.2).  
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2. After determining hct , the next step is to extend the critical value ( hct ) from the PDF of 
healthy cells to the PDF of damaged cells, which has two different scenarios: low-level 
DNA-damage and high-level DNA-damage. The purpose of this is to calculate the 
standard variate 
1Z  based on Eq.(4-3) for determining the probability of a Type II error, 
 
dc
dchctZ


1                                                                                                             (4-3) 
 
where dc  is the mean and dc  is the standard deviation estimated from the PDF of the 
damaged cells under different damage levels. 
 
3. The probability of committing a Type II error,  , is the area to the left side of hct  in the  
PDF of damaged cells (or less than or equal to
1Z  in the standard PDF of damaged cells 
with zero mean and unit standard deviation) (see Figure 4-1). This probability also 
indicates how often a cell is considered as healthy when, in fact, it is defective and 
damaged. This also indicates the proportion of damaged cells passing through the cell 
cycle as healthy cells. 
 
4.3 Mathematical Definition of Robustness  
According to Eq. (2-21), we define the robustness of our system under different perturbations 
as follows: 
 
  (1 )i i i
i
R p p     ,                                                                                                   (4-4) 
 
where R is robustness of the system (the larger the R, the more robust of the system).  ip    
is the probability of a particular perturbation occurrence. More importantly, all perturations 
for the system occur with equal probability. 1 i   is used to evaluate the performance 
measure under a particular perturbation ip . In this research, it measures whether the G1/S 
checkpoint does not allow damaged cells passing it as healthy cells against diverse 
perturbations. For example, there is 30% damaged cells passing the G1/S transition as healthy 
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Figure 4-1  Calculating  Type II error based on PDF of healthy cells and damaged cells. 
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cells under a particular parameter perturbation, which indicates that the G1/S checkpoint can 
only accurately distinguish 70% damaged cells not passing this checkpoint as healthy cells 
against this particular parameter perturbation.
 i
p  is a perturbation of the ith significant 
biomarker variable. In our case, we have two biomarker variables -- CycE and E2F (meaning 
that i is equal to two) -- whose PTs are perturbed. For each biomarker, the total number of 
perturbations for the system is based on the number of PT perturbations as well as parameter 
perturbations. The ip  represents the difference in PT between the standard and perturbed  
values of SKP for the i
th
 significant biomarker variable. The ip  
is obtained for several 
perturbation occurrences (parameter conditions) for the calculation of robustness. 
 
4.4 Summary  
We have presented in this chapter the general framework of computational methods for 
investigating the robustness and dynamical behavior of G1/S transition in response to DNA-
damage situations. We started with the definition of biomarkers (E2F and CycE) in the G1/S 
checkpoint pathway, and then discussed details of the analytical approach, which includes 
LSA, GSA, Type II error and the mathematical definition of robustness. The next chapter will 
make use of this method and apply it to the G1/S checkpoint pathway in detail. 
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Chapter 5: Robustness and Dynamical Behaviour of 
G1/S Transition: Analysis, Results and Discussion 
As discussed in Chapter 4, an analytical approach has been developed to investigate the 
robustness and the dynamic behaviours of the G1/S checkpoint pathway. This chapter first 
shows results from the parameter sensitivity analysis, to identify the significant kinetic 
parameters associated with the in silico biomarkers, based on the mathematical model of the 
G1/S checkpoint pathway with different levels of DNA-damage. Then, the robustness of the 
G1/S checkpoint pathway with or without DNA-damage is defined, based on the probability 
(  ) of DNA-damaged cells passing as healthy cells in the presence of various levels of 
perturbations in the key kinetic parameters of the in silico biomarkers associated with the 
mathematical model. Finally, this chapter also discusses the results from the model and 
validates the results in comparison with the currently established biology as well as some 
experimental findings.   
 
5.1 Most Significant Parameters of Biomarkers Revealed 
by LSA 
The six heat maps in Figure 5-1 show results revealed by LSA under three different DNA-
damage levels. Figure 5-1 (a) shows the influence of the variations of the 75 kinetic 
parameters on the peak time of E2F, while Figure 5-1 (b) illustrates results of the PT for CycE. 
Each heat map contains values for all 75 parameters over the whole parameter range. All 
parameter are changed within the %50  range of SKP at 10% intervals. Therefore, there are 
10 values corresponding to each parameter, and each heat map contains 750 ( 1075 ) small 
squares. The blue colour in the heat map indicates higher variation and the higher significance 
of the kinetic parameters for the PTs of the biomarkers whereas the white colour indicates 
lower values of variation and less or no significance of the kinetic parameters for PTs. In this 
study, we only focused on the magnitude of Variation as mentioned in Section 4.2.1. Thus, 
the white colour in the heat map indicates that the absolute value of Variation is less than 0.01. 
Table 5-1 summarizes the most significant kinetic parameters for PTs of the two chosen 
biomarkers (E2F and CycE) under normal (no damage) and two different DNA- 
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Figure 5-1  Local parameter sensitivity for biomarkers in the G1/S phase transition 
involving DNA-damage signal transduction pathway: (a) influence of 75 kinetic 
parameters on PT of E2F; (b) influence of 75 kinetic parameters on PT of CycE (each 
heat map contains values for all 75 parameters in the defined parameter range from 
50% to 150% of SKP at 10% interverals. There are 10 values for each parameter so 
each heat map has 750 small squares ( 1075 ). The numbers (1 to 10) in each heat map 
indicate the individual parameter change range, for example, 1 means 50% of SKP and 
10 means 150% of SKP ). 
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Table 5-1  The most significant kinetic parameters for PTs of the in silico biomarkers 
(E2F and CycE) revealed by LSA under three different DNA-damage situations. The 
bottom Venn diagram shows the relationship of the most significant kinetic parameter 
under no damage and two different DNA-damage situations. 
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damage situations. 
 
In terms of normal cells (no DNA-damage), the kinetic parameter k24 (association rate of the 
p27/CycE/CDK2-P complex) has the most critical influence on the PT of E2F, followed by 
k49 (rate of activation of E2F by CycE/CDK2-P), k25 (dissociation rate of the 
p27/CycE/CDK2-P complex), k5 (synthesis rate of CycE), k22 (rate of activation of 
CycE/CDK2-P or phosphorylation rate of CycE/CDK2 to form CycE/CDK2-P), k20 
(association rate of p27/CycD/CDK4/6-P), k1(synthesis rate of CycD) and k7 (association 
rate of CycE/CDK2). For the PT of CycE in normal cells, k24 remains the most important 
kinetic parameter, followed by k25, k49, k28 (rate of activation of CycA/CDK2-P), k22, k9 
(synthesis rate of CycA), k68 (synthesis rate of the intermediary ‘X’, which achieves the 
observed delay in PT between CycE and CycA (see Appendix B)), k20, k5 and k1.  
 
According to the above results, it can be seen that the reversible reaction between p27 and 
CycE/CDK2-P (which corresponds to kinetic parameters k24 and k25) is a critical process in 
controlling the concentration of E2F, which qualitatively supports the experimental findings: 
p27-related reactions are important to maintain the stability of the G1/S transition [Bloom and 
Pagano, 2003; Obaya and Sedivy, 2002; Sherr and Roberts, 1999]. For example, when the 
rate of association between p27 and CycE/CDK2-P (k24) becomes faster than that of the 
dissociation of the p27/CycE/CDK2-P complex (k25), this indicates that more free 
CycE/CDK2-P could bind to p27 resulting in the inhibition of CycE/CDK2-P activity. Once 
the activity of CycE/CDK2-P is inhibited, it causes a delay in the release of E2F and disrupts 
the G1/S progression. In contrast, when k25 becomes faster than k24, it shows that the 
dissociation of the p27/CycE/CDK2-P complex results in the release of more CycE/CDK2-P 
than the level obtained from using SKP in cells, which promotes the release of E2F through 
phosphorylating Rb as well as the G1/S progression. Therefore, data analysis reveals that p27 
and CycE/CDK2-P are essential to control the activity of E2F in the G1/S phase transition. 
This is why the remaining significant parameters mostly relate to p27 and CycE/CDK2-P. 
 
The most significant kinetic parameters for PTs of E2F and CycE under low-level and high-
level DNA-damage situations are shown in Table 5-1, the results indicate that there are 15 and 
14 significant parameters for PT of E2F under the low-level and high-level DNA-damage, 
respectively. For the PT of CycE under these two different DNA-damage conditions, the 
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number of the most significant parameters is 17 and 16, respectively. Compared to the normal 
cell cycle progression, the number of the most significant kinetic parameters has increased for 
both biomarkers under DNA-damage situations. However, the most significant kinetic 
parameters for normal cells still remain at the two different DNA-damage levels. 
 
The increase in kinetic parameters for the DNA-damage situation is mainly related to p21 as 
well as the negative feedback loop between p53 and Mdm2, such as k26 (association rate of 
p21/CycE/CDK2-P), k38 (rate of synthesis of p21 through p53), k39 (degradation rate of p21), 
k61 (synthesis rate of p53 through the DNA-damage signal), k65 (dissociation constant in the 
Hill function), k67 (degradation rate of the intermediary ‘I’, which is an unknown mechanism 
leading to a possible discrepancy between the activation of p53 and the induction of Mdm2) 
and k70 (rate of the sequence-specific DNA binding activity of p53 caused by DNA-damage 
signal [Lev Bar-Or et al. 2000]). Thus, in response to DNA damage, p53 is activated by the 
DNA-damage signal. The activated p53 promotes the synthesis of p21 that plays a critical role 
in inhibiting the activity of CycE/CDK2-P, which results in delay in the release of E2F and 
retards the cell cycle progression into the S phase. This observation is in good agreement with 
the experimental findings [Dulic et al. 1994].  
 
As mentioned in Chapter 3, p53 has different functions for the low-level and high-level DNA-
damage. Therefore, we further investigate the influence of the kinetic parameters related to 
p21 (k26, k38 and k39) on PTs of E2F and CycE for these two different intensities of DNA-
damage (see Figure 5-2). According to results shown in Figure 5-2, the kinetic parameters 
related to p21 become a little less sensitive to the high-level DNA-damage than to the low-
level DNA-damage. Although the values of variation for these three kinetic parameters do not 
look very different for the low- and the high-levels of DNA-damage (Figure 5-2), there is a 19 
to 25%  decrease in the rate of variation for these three kinetic parameters for the high-level 
DNA-damage compared to the low-level DNA-damage. This result is in good agreement with 
the experimental findings and the biological theory that the synthesis of p21 is mainly 
enhanced and induced after the low-level DNA-damage [Li and Ho, 1998]. Its purpose is to 
induce cell cycle arrest and provide enough time for DNA repair before reactivating the cell 
cycle progression. For the high-level DNA-damage, the apoptosis pathway is triggered to 
maintain the fidelity of the genome of cells [Ciliberto et al., 2005; Geva-Zatorsky et al., 2006; 
Lahav, 2004; Li and Ho, 1998]; therefore, high levels of p21, as needed in the low-level 
DNA-damage, are not required. According to the results obtained from the mathematical 
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Figure 5-2  The influence of the kinetic parameters related to p21 on in silico biomarkers 
in the G1/S phase transition involving the DNA-damage signal transduction pathway: (a) 
influence on PT of E2F; (b) influence on PT of CycE (the vertical axes display the 
variation in the kinetic parameter related to p21, the horizontal axes shows the 
parameter vector (one parameter change range, such as 50% of SKP, is regarded as one 
parameter vector. There are 10 parameter vectors corresponding to the defined range, 
from 50% to 150% of SKP at 10% intervals, and the legend displays the related kinetic 
parameters under two different DNA-damage conditions). 
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model, the maximum level of p21 for the low- and high-levels of DNA-damage, based on the 
SKP, are 1.856 and 1.488, respectively. This indicates that there is a significant decrease 
(nearly 20%) in the maximum level of p21 for the high-level DNA-damage compared to the 
low-level DNA-damage.  
 
According to results revealed from the LSA of the developed mathematicalmodel, it can be 
seen that the developed model reveals the cell cycle arrest in response to DNA-damage 
situations as well as the slight difference in the behaviour of p21 with the low-level and high-
level DNA-damage. This means that it is possible to analyze the effects of different intensities 
of DNA-damage on G1/S transition based on the developed mathematical model. 
 
5.2 Analysis of Type II Error Based on GSA 
In this section, significant parameters obtained from LSA for E2F and CycE are varied 
simultaneously to study the effect on PTs. Figure 5-3 illustrates the PDF of PT for E2F with 
no DNA-damage and low DNA-damage under the four defined levels of the 8 and 15 
significant parameters: reference values %10 ; reference values %20 ; reference 
values %30  and reference values %50 , respectively. The PDF of PT of E2F with no 
DNA-damage and high DNA-damage situation is displayed in Figure 5-4. In Figures 5-3 and 
5-4, the red line is the critical value in testing the null hypothesis, which is used as the 
boundary separating the non-rejection region from the rejection region in the PDF of PT for 
E2F with no DNA-damage.  
 
For the PDF with no DNA- damage, the area left of the red line is the non-rejection region 
while the area right of it is the rejection region. We focus on the area in the PDF of PT for 
E2F with the low-level and high-level DNA-damage, which falls within the non-rejection 
region of normal cells. Furthermore, this area represents the probability of committing a Type 
II error,  . According to Figures 5-3 and 5-4, it can be seen that the value of   increases 
with the level of parameter range. Moreover, the value of   with the high-level DNA-
damage is slightly larger than that for the low-level DNA-damage for the same level of 
parameter change (the differences in probability, based on the PDF of PT for E2F between the 
low-level and high-level DNA-damage for the four levels of ascending parameter change, are 
0.025, 0.147, 0.113 and 0.05, respectively (see Table 5-2)). 
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Figure 5-3  The PDF of PT for E2F with no DNA-damage (normal or healthy cells) and 
the low-level DNA-damage under the four defined levels of parameter range: (a) 
reference values %10 , (b) reference values %20 , (c) reference values %30 , and (d) 
reference values %50 .  
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Figure 5-4  The PDF of PT for E2F with no DNA-damage (normal or healthy cells) and 
the high-level DNA-damage under the four defined levels of parameter range: (a) 
reference values %10 , (b) reference values %20 , (c) reference values %30 , and (d) 
reference values %50 .  
 86 
 
 
 
 
 
 
Table 5-2  The probability of committing a Type II error (  ) based on the PDF of the 
PTs for E2F and CycE in response to simultaneous variations of the most sensitive 
parameters under different DNA-damage situations (The   could indicate how often a 
cell is wrongly considered as healthy when,  in fact, it is defective and damaged). 
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Figures 5-5 and 5-6 show the PDF of PT for CycE with no DNA-damage and DNA-damage 
situations (the low-level and high-level DNA-damage, respectively) under the same parameter 
ranges. According to the results from the behaviour of CycE, there is the same trend as for the 
behaviour of E2F. This indicates that the probability of committing a Type II error,  , 
increases when the level of parameter range increases. Furthermore, the probability of 
damaged cells passing as healthy cells under the high-level DNA-damage is a little larger than 
that under the low-level DNA-damage. The differences in   , calculated on the PDF of PT 
for CycE for these two different DNA-damage situations for the four parameter perturbation 
levels, are 0.009, 0.125, 0.118 and 0.084, respectively (see Table 5-2). In these figures, the 
horizontal axes show PT of the chosen biomarker in terms of timesteps. According to the 
experimental findings reported by Ohtsubo et al. [1995], the time lag between the expression 
of CycE and CycA in normal cells is about 9.5 hours.  We also analysed the PT of CycA (see 
Appendix B) from our model to calculate model-time to real-time, and validate the observed 
PTs. In our model, there are about 1250 timesteps between the PTs of CycE and CycA under 
no DNA-damage situation. Thus, one hour in real time might correspond to 131.6 time steps 
in the developed model. Based on results revealed by the proposed model for no DNA-
damage condition, this indicates that the PTs for CycE and CycA are calculated as 12.3 hours 
and 21.82 hours real time, respectively. These PTs for CycE and CycA have a good 
agreement with experimental observations in Ohtsubo et al. [1995] where CycE and CycA 
reach their peak levels at 12-16 hours and 20-24 hours, respectively, after the initiation of G1 
progression. 
 
A summary of the probability of committing a Type II error based on the PDF of PT for E2F 
and CycE, in response to simultaneous variations of the most sensitive parameters, is shown 
in Table 5-2. The reason for the investigation of PTs of the chosen biomarkers under different 
ranges of parameter values is that living cells display heterogeneity; moreover, even the same 
cell can show completely different properties under different external environmental 
conditions. By changing parameters, we study the behaviour of a realistic cell population.  As 
shown in Table 5-2, the value of   based on E2F is very low when the parameters are 
examined within the range of %10 . It seems that we can accurately distinguish healthy cells 
from defective/damaged cells when simultaneous parameter variations are within a range of 
%10 . For the change of parameter within a range of %20 , the value of   for E2F is 
0.218 for the low-level DNA-damage and 0.365 for the high-level DNA-damage, respectively. 
This indicates that there is a low risk of wrongly identifying damaged cells as 
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Figure 5-5  The PDF of PT for CycE with no DNA-damage (normal or healthy cells) and 
the low-level DNA-damage under the four defined levels of parameter range: (a) 
reference values %10 , (b) reference values %20 , (c) reference values %30 , and (d) 
reference values %50 .  
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Figure 5-6  The PDF of PT for CycE with no DNA-damage (normal or healthy cells) and 
the high-level DNA-damage under the four defined levels of parameter range: (a) 
reference values %10 , (b) reference values %20 , (c) reference values %30 , and (d) 
reference values %50 .  
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healthy and letting the defective and abnormal genome of cells pass through the cell cycle 
progression to future cellular generations, which can potentially result in cancer. However, 
when the level of change in parameters exceeds %20  the results reveal that it is very 
difficult to distinguish between normal cells and defective cells because β ranges from 0.429 
to 0.689. For the healthy cell, the overexpression or underexpression of some significant 
chemical species due to the large variation in significant parameters have a significant 
influence on the PTs of E2F and CycE in the G1/S transition. For instance, the 
overexpressions of CycE can accelerate E2F accumulation as well as entry into S phase while 
the underexpession of CycE can delay E2F accumulation as well as S phase entry. Therefore, 
the range of PTs for E2F becomes much larger for the larger variation in parameters. In 
addition, the same situation also happens for the DNA-damage conditions, which results in 
more overlapping of PDFs of PTs under normal and DNA-damage conditions and indicates 
that β becomes large with the increase of parameter ranges.  
 
Table 5-2 also shows the value of   based on the PDF of the PT for CycE under different 
DNA damage conditions. The   based on the PDF of the PT for CycE is a little smaller (   
in the range of 0.003 and 0.065) for the two damage levels than that based on PT of E2F 
except in the range of %20 . With regard to the range of %20 , differences in the 
probability based on the PTs of these two proteins under two different DNA-damage levels 
are 0.071 and 0.093, respectively. However, there is a good agreement between the two 
biomarkers in terms of a large percentage of damaged cells that pass the G1/S checkpoint 
when the variation of parameters equals or exceeds 30% . 
 
We also evaluated the probability of committing a Type II error based on the PDF of the PTs 
for E2F and CycE in response to simultaneous variations in all the 75 parameters under 
different DNA-damage situations as shown in Table 5-3. Comparison of results from these 
two different sample parameter vectors reveals that the values of   based on the PDF of the 
PTs of E2F and CycE are quite similar to each other. This indicates that simultaneous 
variations of the most significant kinetic parameters play an important role in influencing the 
behaviour of the PTs of E2F and CycE and simultaneous variations in the kinetic parameters 
that are not relevant to E2F and CycE have less or no significance for PTs. As a result, all 
sample parameter vectors in GSA for all our investigations are generated based on the most 
sensitive parameters to calculate the probability of committing a Type II error (  ).  
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Table 5-3  The probability of committing a Type II error (β) based on the PDF of the 
PTs for E2F and CycE in response to simultaneous variations of all 75 parameters under 
different DNA-damage situations (Theβcould indicate how often a cell is wrongly 
considered as healthy when,  in fact, it is defective and damaged). 
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From what has been discussed above, the simulation results indicate that the probability of a 
damaged cell wrongly passing as a healthy cell becomes much larger (more than 0.38) when 
the level of parameter change exceeds 20% . Thus, over 38% of cells with DNA-damage 
pass as normal cells is a very large percentage. However, this finding has support by the 
experimental observation. It is estimated that each gene in an organism is mutated once in 
20,000 cells [Vijg and Dollé, 2002]. Considering that an organism consists of trillions of cells, 
there are probably millions of cells that are oncogenically primed at any given time. These 
dangerous cells are disposed of through apoptosis and cellular senescence. Cellular 
senescence is a robust inhibition of cell proliferation in response to oncogenic stress such as 
DNA damage. However, Collado and Serrano [2010] state that this irreversible process 
happens not in the pre-tumoral stage (initial proliferation of cells carrying oncogenes) but in 
the pre-malignant tissue where a non-invasive tumour is formed. This shows that a large 
number of damaged cells undergo proliferation without being caught at DNA damage 
checkpoints. Our simulation results, in terms of a large percentage of damaged cells that pass 
the G1/S checkpoint, agree with this finding. 
 
5.3 Robustness of the G1/S Checkpoint Pathway 
5.3.1 Analysis of Robustness with Respect to Different Thresholds 
of Biomarkers 
In general, the PTs of proteins are the focus of most research studies. This can be used as an 
indicator robustness of the G1/S checkpoint. Specifically, it can be proposed that if the G1/S 
pathway is resistant to variations in PT (within limits) of key proteins, then it is robust in 
managing the cell entry into S. Therefore, we perturbed PT within a range in an effort to 
quantify the robustness of G1/S checkpoint. Specifically, we calculate the values of   for 
four different thresholds of PT for the two biomarkers (E2F and CycE) under the given 
parameter perturbation regimes for different DNA-damage situations. Table 5-4 shows the 
value of   based on the PDF of E2F under different DNA-damage conditions for four 
different thresholds; for example, PT-20%, PT-10%, PT+10% and PT+20%, respectively. It 
can be seen that the results from different thresholds are quite similar to each other and also 
agree with the findings based on the PDF of PT (orignal) for E2F. Table 5-5 displays the 
value of   based on the PDF for CycE four different thresholds of PT under different DNA-
 93 
 
Table 5-4  The probability of committing a Type II error (  ) based on the PDF of four different thresholds of PT, such as, PT-20%, PT-10%, 
PT+10% and PT+20%, using the behaviour of E2F under different DNA-damage conditions (The   indicates how often a cell is wrongly 
considered as healthy when, in fact, it is defective and damaged). 
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Table 5-5  The probability of committing a Type II error (  ) based on the PDF of four different thresholds of PT, such as, PT-20%, PT-10%, 
PT+10% and PT+20%, based on the behaviour of CycE under different DNA-damage conditions (The   indicates how often a cell is wrongly 
considered as healthy when, in fact, it is defective and damaged). 
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damage conditions. Results revealed that the probabilities of committing a Type II error are 
exactly same for different thresholds for the two damage conditions. According to results for 
the two biomarkers, it can be seen that   is not affected by the changes in PT up to 20% , 
indicating the robustness of the G1/S checkpoint in the presence of various levels of 
perturbations in the key kinetic parameters associated with the model. 
 
5.3.2 Analysis of Robustness Based on its Mathematical Definition 
As the changes in threshold values of the PTs would not change i  significantly (Tables 5-4 
and 5-5), we ignore the variations in PT. Therefore, we assume that the probability of a 
perturbation is equally likely (i.e.   1/ nip    ) and n represents the number of 
perturbations in four different thresholds of PT in response to four differen levels of variations 
in parameters under normal and DNA-damage situations (it means that n equals to 16). 
According to the mathematical definition of robustness in Section 4.3, robustness for healthy 
cells ( 0   for normal cells in this case), the cells with the low-level and the high-level 
DNA-damage, are shown in Figure 5-7. As a result of the activation of the signalling 
pathways in the presence of DNA-damage to different degrees, the robustness of the G1/S 
checkpoint pathway decreases, as expected. 
 
5.4 Summary 
In this chapter, we demonstrated the functional influence of the most significant biochemical 
parameters on the PTs of the critical proteins (E2F and CycE) in the G1/S transition with 
different intensities of DNA-damage signals. The results from LSA verified the consistency of 
the analysis with the current knowledge of biology and the experimental observations, which 
helped us better understand the mechanism of the G1/S transition involving the DNA-damage 
signal.  
 
The LSA of the model was used to clarify the influence of individual kinetic parameters in the 
model on the PTs of the selected two important key proteins in the G1/S transition and the 
response of cells to different intensities of DNA-damage. According to the LSA, kinetic 
parameters related to p27 (such as k24, k25 and k20) and CycE (such as k49 and k22) played 
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Figure 5-7  Robustness of the G1/S checkpoint pathway. 
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a significant role in affecting the PTs for E2F with no DNA-damage, while the influence of 
the PTs for CycE involved some additional kinetic parameters related to CycA (such as k28, 
k9 and k68). The reason for these observations was that the release of additional E2F 
depended mainly on the hyperphosphorylation of Rb-PP/E2F through the activation 
CycE/CDK2-P in the G1/S transition and p27, as CDK inhibitor, controlled the activity of 
CycE/CDK2. Moreover, the release of E2F promoted the synthesis of CycE and 
CycA.Considering the case of DNA- damage, the kinetic parameters related to p21 (such as 
k26, k38, and k39) and p53 (such as k61, k65 and k67) became more important than normal 
cells. All these parameters revealed how the DNA-damage signal was involved in the G1/S 
transition: once DNA-damage occurred, the DNA damage signal promoted the activation of 
p53, which resulted in the synthesis of p21 as a critical factor to retard cell cycle progression 
in the G1/S phase through binding to CycE/CDK2-P and CycA/CDK2-P and delaying the 
release of the activation of E2F. 
 
The results from the GSA, based on four defined levels of parameter range, revealed that 
when there is a 10%  variation in parameters within the cell population, only a small 
percentage (less than 2.9%) of damaged cells pass as healthy cells and we can accurately 
distinguish most healthy cells from defective cells. However, when the variation of 
parameters equals or exceeds 30% , over 38% damaged cells can pass cell cycle as normal 
cells. Provided that there are probably millions of cells oncogenically primed at any given 
time, these dangerous cells are disposed of through apoptosis and cellular senescence. 
However, the very recent experimental findings [Serrano, 2010] stated that the irreversible 
process of senescence happened not in the pre-tumoral stage but in the pre-malignant tissue 
where a non-invasive tumour was formed. This revealed that a large number of damaged cells 
undergo proliferation without being caught at DNA damage checkpoints. Our simulation 
results, in terms of the large percentage of damaged cells that pass the G1/S checkpoint, 
agreed with this possibility and opened a new avenue to continue our research with the 
mathematical model to explore its ability to shed light on senescence. 
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Chapter 6: Investigation of Cellular Senescence 
through The Mathematical Model of G1/S Transition 
We revealed that the results obtained from the proposed model have a good agreement with 
the experimental findings and the biological theory based on our analytical approach in the 
previous chapter, indicating that the proposed model can reveal the behaviour of the G1/S 
phase. We also mentioned that damaged cells are caught through activation of cellular 
senescence in the pre-malignant tissue where a non-invasive tumour is formed. Furthermore, 
some current experimental evidence pointed out that the inhibition of some critical factors in 
the G1/S phase can lower the bar for triggering cellular senescence in cancerous cells. 
Therefore, it was of interest to find out whether the mathematical model can highlight cellular 
senescence and formulate scenarios for adjusting the threshold for senescence to evaluate its 
efficacy and outcomes in tems of its ability to prevent damaged cells from passing the G1/S 
checkpoint. In this chapter, we begin with a definition of cellular senescence. Then, we 
discuss how to use the mathematical model of G1/S transition to highlight cellular senescence 
under DNA damage situations, more specifically; we compute the probability of a DNA-
damaged cell passing the G1/S phase transitions in response to lowering the threshold for 
senescence. Finally, we investigated the possibility of lowering the bar for triggering cellular 
senescence in cells based on the model’s analytical results. 
 
6.1 Cellular Senescence  
Cellular senescence is considered to be an irreversible state of cell cycle arrest whereby a 
normal cell loses the ability to divide and promote cell proliferation. This phenomenon was 
first described by Hayflick and Moorhead [1961] more than five decades ago. They showed 
that normal cells entered an irreversible state of cell growth arrest in response to the 
uncontrolled proliferative capacity of normal cells. According to our current knowledge of the 
cell cycle, cellular senescence is a physiological mechanism employed by cells for thwarting 
the proliferation of cancer cells, and Serrano [2010] aptly points out that “Encouraging 
cancer-prone cells to senesce (before reaching pre-tumoral or pre-malignant stages) might 
therefore be a way to nip this disease in the bud”.  
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Serrano [2010] states that cancer progresses in three stages beyond the healthy stage: pre-
tumour, pre-malignant and malignant, where the transition from one stage to the next was 
generally accompanied by increased levels of senescence induced stresses. He points out that 
most human and mouse tumour cells, however, stop proliferating and undergo senescence at 
the pre-malignant stage, where a non-invasive tumour is formed, indicating that it is at this 
level that senescence inducing stresses reach sufficient intensity to be effective. This also 
suggests that once allowed through the cell cycle, many of the cells carrying oncogenes are 
allowed to further proliferate in the pre-tumoral stage – the first stage of tumorigenesis- with 
little or no senescence. Moreover, mutations that disable senescence are instrumental in the 
transition from oncogene-harbouring cells to the malignant stage, highlighting the importance 
of senescence in countering malignancy. Summarising the work of Lin et al. [2010] and 
Campaner et al. [2010] who elucidate the molecular mechanism of cancer associated 
senescence, Serrano [2010] emphasises the clinical relevance of lowering the bar for 
senescence in curing cancer and raises hopes for, and questions about, possibilities for doing 
it so that oncogenically primed cells are targeted early, before reaching the pre-malignant 
stage, as happens normally. Considering the prevalence of cancer today, manipulating the 
threshold for senescence to encourage cancer cells to senescence early can lead to better 
protection against cancer. Thus, a deeper understanding of the pathway to cellular senescence 
plays an important role in exploiting this route for effective cancer treatment. 
 
Both Lin et al. [2010] and Campaner et al. [2010] found that the inhibition of the activity of 
cyclin-dependent kinases (CDKs), such as CDK4, CDK6 and CDK2, played a significant role 
in establishing cellular senescence in order to protect cells against cancer, particularly in 
inhibiting CDK2’s activity as a critical factor in lowering the bar for triggering senescence in 
cancerous cells. All these CDKs are important proteins that mediate the initiation of the G1 
phase and control the G1/S transition in the cell cycle. They also mentioned that senescence-
inducing stressors inhibit the activity of CDKs by controlling their inhibitory proteins (called 
CDK inhibitory kinases or CKIs), which include p21, p27 and p16 [Collado et al. 2007, 
Malumbres & Barbcid, 2009]. Furthermore, Skp2 inhibition might be critical in lowering the 
bar for senescence in oncogenically primed cells based on the current studies [Serrano, 2010, 
Lin et al., 2010, Campaner et al., 2010]. Skp2 can mediate the degradation of some CKIs, 
such as p21 and p27, and Skp2 inhibition can increase the expression of CKIs in the cell cycle 
which results in inhibiting the activity of CDK2s. 
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6.2 Analytical Method for Investigating Cellular 
Senescence Based on the Mathematical Model 
Although there is some experimental evidence pointing out that the inhibition of CDK2 or 
Skp2 can be the critical trigger for senescence, currently, there are no any mathematical 
models developed to highlight cellular senescence under DNA-damage situations. Senescence 
in this respect leads to an exciting question: Can a mathematical model highlight cellular 
senescence and formulate scenarios for adjusting the threshold for senescence to evaluate its 
efficacy and outcomes for controlling proliferation? This investigation is presented in the 
following pages. 
 
In this study, the mathematical model developed is used to investigate the behaviour of PTs 
for the chosen biomarkers (E2F and CycE) of the G1/S transition in response to CDK2-
deficient situations. The purpose is to confirm whether the developed model can highlight 
cellular senescence in response to lowering the critical point (CDK2 inhibition) for cellular 
senescence. We use the same method as described in Chapter 4. We keep the parameter sets 
in Table 5-1, only reducing CDK2 in three different levels (for example, CDK2-10%, CDK2-
30% and CDK2-50%, respectively) under two DNA-damage situations (low-level and high-
level DNA-damage) and calculate β of a DNA-damaged cell passing the G1/S transition. We 
then compare the values of β under the normal CDK2 level and low CDK2 levels. If β 
decreases with decreasing levels of CDK2, our model can represent the phenomenon 
attributed to cellular senescence and supports the hypothesis that lowering CDK2 is an 
effective means of promoting senescence in damaged/cancerous cells.  
 
Next, we interrogate the model to investigate whether it represents and supports the 
relationship between CDK2 and CKIs: the increasing expression of CKIs is an effective way 
to inhibit the activity of CDK2 under senescence-inducing stressors [Lin et al., 2010, 
Campaner et al., 2010]. There are two different ways to validate the relationship between 
CDK2 and its CKIs under DNA-damage situations using the mathematical model: one is to 
focus on what the behaviour of CKIs, such as p16, p21 and p27, is in response to reducing 
CDK2 levels; the other is to focus on the behaviour of CDK2 in response to increasing the 
expression of its CKIs by adjusting their corresponding kinetic parameters in the 
mathematical model in relation to: initial condition, production rate and degradation rate. We 
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also study the effectiveness of simultaneously changing CDK2 and CKIs in lowering the 
senescence bar. 
 
Finally, we investigate the robustness of CDK2 in lowering the bar for cellular senescence 
through two different approaches: one is to analyze the values of β for different thresholds, 
and the other is based on the mathematical definition of robustness from Section 4.3.  
 
6.3 Analysis of the Effectiveness of CDK2 in Lowering the 
Bar for Cellular Senescence 
Table 6-1 summarizes the probability β of damaged cells passing the G1/S checkpoint based 
on the PDF of the PTs for biomarker E2F under two different DNA-damage conditions for 
three reduced CDK2 levels: -10%, -30% and -50%, respectively. Table 6-2 displays the 
values of   for the three decreased CDK2 levels based on the PDF of PT for CycE under two 
different DNA-damage conditions. According to the results of the behaviour of E2F and CycE 
under reduced and normal CDK2 levels, the probability of committing a Type II error 
(probability of a damaged cell passing the G1/S transition) decreased with the inhibiting 
activity of CDK2; more importantly, there is a significant decrease in   based on the PTs for 
E2F and CycE when the CDK2 level is reduced to 50% of the normal level. 
 
According to Table 5-2, under normal CDK2 level, the percentage of tumour cells passing the 
G1/S transition increases with the level of DNA-damage and the range of parameters, both 
biomarkers indicate similar trends for β. For example, when the level of DNA-damage is 
high, E2F and CycE indicate that 68.9% and 65.8%, respectively, of damaged cells pass the 
G1/S for 50%  perturbation to the key parameters. In contrast, Table 6-1 indicates that for 
the same damage conditions and parameter ranges, this percentage, based on E2F, can be 
reduced to 42.2% by decreasing the CDK2 levels by 50%. This amounts to a reduction of 
38.8%. For the low-level DNA-damage, lowering CDK2 by 50% amounts to a 42.7% 
reduction in damaged cells passing the G1/S transition. The trend observed above is 
confirmed by the trends in PDF of PT for CycE in Table 6-2. Here, a 50% reduction of CDK2 
level under a high-level DNA-damage situation results in a 64.59% reduction in the 
percentage of damaged cells passing the G1/S transition. For the low-level DNA-damage, a  
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Table 6-1  The probability β of a damaged cell passing the G1/S checkpoint based on the 
PDF of PT for E2F for three reduced CDK2 levels: CDK2-10%, CDK2-30% and CDK2-
50%, under two DNA-damage conditions (The β indicates the level of activation of 
senescence and corresponding effect on how often a damaged cell passes G1/S). 
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Table 6-2  The probability of β of damaged cells passing the G1/S checkpoint based on 
the PDF of PT for CycE for three reduced CDK2 levels: -10%, -30% and -50%, under 
two DNA-damage conditions (The β indicates the level of activation of senescence and 
corresponding effect on how often a damaged cell passes G1/S) . 
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50% reduction of CDK2 produces a 64.63% reduction in the percentage of damaged cells 
passing the G1/S checkpoint. These results indicate the possibility that the damaged cells 
enter an irreversible state of cell cycle arrest, such as cellular senescence or apoptosis, in 
response to low CDK2 levels, which is consistent with Campaner et al. [2010] who show that 
mice deficient in CDK2 became more sensitized to cellular senescence under the oncogenic 
stress caused by the Myc oncogene or oncoprotein. Thus, our model supports the biological 
findings that relate CDK to senescence.  More importantly, it reveals the effect of reducing 
CDK2 levels in terms of the reduction in the percentage of damaged cells passing the G1/S 
checkpoint; i.e., the effectiveness of lowering CDK2 in thwarting proliferation. 
 
6.4 Analysis of the Effectiveness of CKIs in Lowering the 
Bar for Senescence 
6.4.1 Behaviour of CKIs in Response to Reducing CDK2 Levels 
Here, we investigate the behaviour of CKIs in response to reduced CDK2 levels, by reducing 
CDK2 in three different levels under two different DNA-damage conditions; for example, 
CDK2-10%, CDK2-30% and CDK2-50%, respectively. Analytical results show that the 
change of CDK2 has little or no effect on p16 and p27 at either the low-level or the high-level 
DNA-damage. The reason is that most p27 molecules bind to the CycD/CDK4/6 complex at 
the beginning of the G1 phase and only a few p27 molecules bind to the CycE/CDK2-P 
complex near the G1/S transition. However, variation in CDK2 has a significant effect on p21 
level in these two DNA-damage situations. In the event of DNA-damage, p21 is activated by 
p53 which results in a dramatic effect on the concentration required to promote its binding to 
the CycE/CDK2-P complex for arresting cell cycle. Figure 6-1 shows the behaviour of p21 
for four levels of CDK2 under the low- and high-levels of DNA-damage as well as p21’s 
behaviour in healthy cells. It shows that the p21 level under damage conditions is much 
higher than that under no DNA damage (healthy cell) due to an increase in production in 
response to DNA damage. Furthermore, the p21 level in the high-level DNA damage is lower 
than that in the low-level DNA damage (20-25% difference between the maximum levels) 
because p53 is used to trigger the apoptosis pathway for high-level DNA damage. Under both 
DNA damage conditions, the effect of lowering CDK2 is initially insignificant on the p21 
level, which remains constant until closer to the G1/S transition (at around 1500 time steps – 
about 11.36 hours- in Figure 6-1), for all four CDK2 levels. Then, the reduced CDK2 
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Figure 6-1  The behaviour of p21 in response to four different CDK2 levels for (a) low-
level DNA-damage and (b) high-level DNA-damage (For reference purposes, p21 level 
for no DNA-damage under normal CDK2 level (healthy cell) is also shown in the figure). 
The p21 level in the high-level DNA damage is lower than that in the low-level DNA 
damage (20-25% difference between the maximum levels) because p53 is used to trigger 
the apoptosis pathway for high-level DNA damage. 
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level comes into effect influencing the behaviour of p21. Increasing CycE production in the 
cell cycle requires increasing level of CDK2 for binding to CycE to form the CycE/CDK2 
complex and this complex can further associate with p21 to form the triple complex, 
p21/CycE/CDK2. This process results in a dramatic decrease in the p21 level; however, the 
p21 level increases at the end of the G1 phase because the CycE level decreases in the S phase 
thereby releasing more p21 in the cell cycle transition. Reducing CDK2 levels results in the 
production of less CycE/CDK2 to associate with p21 thereby increasing the concentration of 
p21. For this reason, the p21 level in the cell cycle is the highest for a 50% reduction in 
CDK2 levels compared to the two smaller reductions. 
 
6.4.2 Behaviour of CDK2 in Response to Increasing Expression of 
its CKIs 
Now we turn to investigating the behaviour of CDK2 in response to increased levels of its 
CKIs. First we analyze the effect of the degradation rate of CKIs on the CDK2 
concentration by decreasing their corresponding kinetic parameters in the mathematical model. 
According to our model results, presented in Figure 6-2, there is an effect from adjusting the 
degradation rate of p21 on the variation of CDK2 for DNA-damage situations. However, 
variation in the degradation rate of p27 and p16 has little or no effect on CDK2 levels under 
these two DNA-damage conditions (not shown). Based on the study of the behaviour of 
CDK2 in response to the reduced degradation rate of p21, as shown in Figure 6-2, the 
influence of the degradation rate of p21 on CDK2 is dominant during the G1/S transition. The 
reason is that the concentration of CDK2 is mainly controlled by CycE in the G1/S transition. 
For example, at the beginning of G1 in the cell cycle of a healthy cell, the CycE level is kept 
at a low level which keeps CDK2 and CycE in balance. However, the concentration of CycE 
significantly increases during G1/S transition, which results in an imbalance between CycE 
and CDK2; therefore, more CDK2 is required to associate with CycE. In the DNA-damage 
situation, however, p21 is activated in the G1 phase and plays an important role in reducing 
CDK2 levels. The reason is that increased p21 binds to the CycE/CDK2 complex to inhibit 
E2F, which in turn inhibits CycE levels, leading to a delayed and slower production of CycE 
under damage conditions compared to the healthy condition. This reduces the need for as high 
CDK2 levels as in the healthy condition. Therefore, lower p21 degradation rates lead to 
higher CDK2 levels, as indicated by Figure 6-2. Higher levels of free CDK2 indicate the 
presence of low CycE levels giving rise to further delays in the 
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Figure 6-2  The behaviour of CDK2 in response to the variation in the degradation rate 
of p21 for (a) low-level DNA-damage and (b) high-level DNA-damage (For reference 
purposes, CDK2 level for no DNA-damage under normal degradation rate of p21 
(healthy cells) is also shown in the figure). 
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progression of these cells through the G1/S transition. According to Figure 6-2, there is a 
small difference in free CDK2 levels between the low-level and high-level DNA damage 
conditions. Although there is a significant difference in the amount of p21 in the two different 
DNA-damage situations shown in Figure 6-1, only part of p21 can bind to CycE/CDK2-P or 
CycA/CDK2-P to control free CDK2 in cells because the increased CycE/CDK2-P and 
CycA/CDK2-P can promote the degradation of p27. The p27 degradation can cause the 
release of more free CycD/CDK4/6 which binds to p21 to form p21/CycD/CDK4/6. 
Therefore, CycD/CDK4/6 competes with these two complex proteins (CycE/CDK2-P and 
CycA/CDK2-P) to bind with p21 in cells. This is the reason for smaller difference in CDK2 
levels between the two damage conditions.    
 
Next, we focus on the effect of production rate of CKIs on CDK2 levels. Results revealed 
by the mathematical model show that the production rate of CKIs has little or no effect on the 
CDK2 concentration for low-level and high-level DNA damage situations (not shown). 
Finally, the initial conditions of CKIs are used to analyze their relationship to CDK2. The 
analytical results show that only the initial condition of p27 has a significant effect on the 
variation of CDK2 under DNA damage situations as shown in Figure 6-3. According to 
Figure 6-3, variation in the initial condition of p27 has a more significant effect on CDK2 
behaviour than that caused by variation in the degradation rate of p21, as shown in Figure 6-2. 
The increased initial concentration of p27 makes available more free p27 for binding with the 
CycE/CDK-P complex to inhibit its activity after p27 associates with CycD/CDK4/6 during 
the G1 phase. This inhibites the activation of E2F, the critical protein in G1/S which, in turn, 
inhibits the accumulation of CycE required for the completion of the G1/S progression. 
Inhibition of CycE also decreases the rate of CDK2 in response to increased initial 
concentration of p27. Thus, CDK2 can be lowered by adjusting the initial conditions of p27 to 
trigger early senescence. Thus, analysis of the CKIs reveals that the initial level of p27 and 
the degradation rate of p21 affect significantly CDK2 and can be targets for lowering the 
senescence bar. 
 
According to the investigation of the effect of CKIs on the behaviour of CDK2 under two 
different DNA-damage situations from the model’s simulation, results indicates that the 
degradation rate of p21and the initial rate of p27 contribute to inhibiting the activation of 
CDK2 in cells. These results qualitatively support the experimental findings and the 
biological theory that p21 and p27 as cell cycle Cip/Kip inhibitors prevent cell cycle  
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Figure 6-3  The behaviour of CDK2 in response to the variation in the initial condition 
of p27 for (a) low-level DNA-damage and (b) high-level DNA-damage (For reference 
purposes, CDK2 level for no DNA-damage under normal initial condition of p27 
(healthy cells) is also shown in Figure 6-3).  
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progression and suppress tumour growth by inhibiting the activation of CycE/CDK2 and 
CycA/CDK2 to regulate the level of CDK2 in cells [Sherr and Roberts, 1999; Obaya and 
Sedivy, 2002; Denicourt and Dowdy, 2004]. Additionally and importantly, an advantage of 
the model is that it reveals the spectrum of the behaviour of CDK2 as it relates to varying 
levels of p21 and p27 in the whole region of G1/S transition. 
 
6.4.3 Analysis of the Effectiveness of CKIs Alone and Simultaneous 
Variation of CDK2/CKIs on Lowering the Senescence Bar 
Relying on the outcome of the analysis of the relationship between CDK2 and CKIs, the focus 
of this step in our research is to analyze the percentage of damaged cells that can be prevented 
from passing G1/S by further lowering the senescence threshold through regulating the CKIs 
and the combination of CDK2 and CKIs. The value of β, in response to individually changing 
CDK2 or CKIs (in our case, p21 degradation rate and p27 initial condition) based on the 
behaviour of E2F for a parameter range of 30%  , is shown in Figure 6-4, which reveals that 
the increase in the initial condition of p27 makes the most significant contribution to reducing 
the probability of a damaged cell passing the G1/S for two different DNA-damage situations, 
followed by the reduced CDK2 levels and the decreased p21 degradation rate, with the 
differences between the latter two being minor. Comparing the 30% change of CDK2 or CKIs 
with their 50% counterpart, the results show that a 50% change in CDK2 or CKIs can reduce 
a larger percentage of damaged cells passing G1/S. In terms of values of β based on the 
behaviour of CycE for parameter range 30%  (see Figure 6-5), we obtain similar results to 
those revealed by the behaviour of E2F, except that the reduction in CDK2 level makes a 
larger contribution to decreasing the percentage of damaged cells passing the G1/S checkpoint 
than increases in the initial condition of p27. These simulation results, in response to the 
effectiveness of CKIs alone, are in good agreement with the experimental findings that Skp2 
inactivation that leads to oncogenic-stress-driven senescence critically depends on p27, p21 
and Atf4 [Lin et al., 2010]. Lin et al. [2010] pointed out that upregulation of p27, p21 or Atf 4 
contributes to promoting cellular senescence upon Skp2 inactivation. Furthermore, Lin et al. 
(2010) found that the concomitant upregulation of p27, p21 and Atf4 can be considered as a 
required powerful engine to trigger cellular senescence under the Skp2 deficiency situation. 
The most important advantage of modelling is that, while supporting the above biological 
findings, the model simulations allow us to ascertain and quantify the reduction in the 
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Figure 6-4  The probability β of a damaged cell passing the G1/S checkpoint in response 
to only changing CDK2 or CKIs (i.e. p21 degradation rate and p27 initial condition) for 
three different ranges of normal, 30% and 50% (i.e., CKD2 or p21 degradation rate 
reduced or p27 initial condition increased by 0%, 30% and 50%, respectively - using the 
behavior of E2F for parameter range 30%  under different DNA-damage conditions: 
low level DNA-damage and high level DNA-damage. Results from figure indicates that 
the increase in initial condition of p27  makes the most significant contribution to 
reducing β, followed by the reduced CDK2 levels and the decreased p21 degradation 
rate. Compared to 30% change, a 50% change in CDK2 or CKIs can reduce a larger 
percentage of damaged cells passing G1/S. 
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Figure 6-5  The probability β of a damaged cell passing G1/S checkpoint in response to 
only changing CDK2 or CKIs (i.e. p21 degradation rate and p27 initial condition) for 
three different ranges of normal, 30% and 50% - specifically, CKD2 or p21 degradation 
rate reduced or p27 initial condition increased by 0%, 30% and 50%, respectively - 
using the behavior of CycE for parameter range 30%  under different DNA-damage 
conditions: low level DNA-damage and high level DNA-damage.  
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percentage of damaged cell passing the G1/S checkpoint in response to different levels of 
CKIs.  
 
After analysis of separately changing CDK2 or CKIs, we concentrated on the effect of the 
combination of CDK2 and CKIs on β for two different change ranges (30% and 50%). For 
example, simultaneously reducing CDK2 and p21 degradation rates as well as simultaneously 
reducing CDK2 and increasing p27 initial condition. Figure 6-6 displays the results of the 
combination of CDK2 and CKIs based on the behaviour of E2F for parameter range 30% , 
which indicates that the combination of CDK2 and p27 initial condition makes a much greater 
reduction in the percentage of damaged cells passing G1/S than the CDK2 and p21 
combination. For a 50% change to CDK2 and p27 levels, the percentage of damaged cells 
passing G1/S is almost equal to zero for the two different DNA-damage situations.  
 
Probing into the G1/S checkpoint pathway can shed light into the above observations, as 
follows. Taking the characteristics of the G1/S pathway into account, the accumulation of E2F 
is regulated directly by the activity of Rb and indirectly through the action of cyclins and their 
dependent kinases (such as CycD/CDK4/6 to initiate the phosphorylation of Rb, CycE/CDK2-
P and CycA/CDK2-P to further hypophosphorylate Rb for the release of E2F) at the G1/S 
transition. The reduction of CDK2 alone can decrease the concentration of CycE/CDK2-P or 
CycA/CDK2-P in cells to delay the release of E2F under no DNA-damage conditions. In 
response to CDK2-deficiency in DNA-damage situations, the synthesis of p21, triggered by 
the DNA-damage signal, further inhibits the activation of CycE/CDK2-P or CycA/CDK2-P 
and results in a further delay in the activation of E2F.  
 
For the combination of CDK2 and p27 under DNA-damage situations, p21 is already 
activated by the DNA-damage signal. If the concentration of p27 is kept at the standard level, 
it further delays the accumulation of E2F, caused by the activated p21. If the concentration of 
p27 increases, more CycE/CDK2-P and CycA/CDK2-P will be associated with p27, which 
results in a longer delay in the accumulation of E2F. In terms of the combination of CDK2 
and p21, the total concentration of p21 (which is mainly activated by DNA-damage singal) is 
much less (more than three times less) than that of p27 in cells. Therefore, less CycE/CDK2-P 
and CycA/CDK2-P are required for binding with p21 compared to p27, which makes the 
effect of p21 less significant than p27. This is why the combination of CDK2 and p27  
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Figure 6-6  The probability β of a damaged cell passing G1/S in response to  
simultaneously changing CDK2 and CKIs (i.e. p21 degradation rate and p27 initial 
condition) for three different ranges of normal, 30% and 50% - specifically, CKD2 and 
p21 degradation rate both reduced by 0%, 30% and 50%, respectively, or CDK2 
reduced and p27 initial condition increased by 0%, 30% and 50%, respectively- using 
the behaviour of E2F for the parameter range 30%  under two different DNA-damage 
conditions. It can be seen that the combination of CDK2 and p27 makes a much greater 
reduction in β than the CDK2 and p21 combination. For a 50% change of CDK2 and 
p27, β is almost equal to zero for both DNA-damage situations. 
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makes a larger contribution to reducing the percentage of damaged cells passing the G1/S 
transition. Thus, the combined targeting of CDK2 and key CKIs is a powerful way to lower 
the senescence bar. As far as we know, the combined effect CDK2 and CKIs has not been 
studied experimentally. Therefore, the results from our analysis suggest some novel biological 
experiments for validating the effectiveness of the combined targets in a practical setting. The 
above observed trend is confirmed by the trends in the PDF of PT for CycE in Figure 6-7. 
Comparison with the results revealed by the behaviour of E2F (Figure 6-6) indicates that the 
combination of CDK2 and CKIs has slightly larger effect on CycE than E2F.  
 
We also investigate the values of β in response to changing CDK2 or CKIs alone as well as 
the combination of CDK2 and CKIs based on biomarkers for a larger parameter range of  
50%  to compare with the outcome for 30%  parameter change in the previous analysis.  
The details of β under parameter range 50%  are shown in Appendix C. Results for the 
chosen biomarkers under this 50%  situation show a good agreement with results revealed 
under the parameter range 30% . The only difference is that the percentage of damaged cells 
passing G1/S under parameter range 50%  is larger than that under parameter range 30% . 
The probable reason is that the variation of parameters in 50%  range makes a more 
significant effect on PTs of the chosen biomarkers than that in 30%  range.  All these results 
indicate that our model can highlight the possibility of lowering the bar for cellular 
senescence by regulating CDK2 levels and their corresponding significant CKIs. 
 
6.5 Robustness of CKD2 in Triggering Cellular 
Senescence  
6.5.1 Analysis of Robustness with Respect to Different Thresholds 
of Biomarkers 
We also evaluated the probability (β) of damaged cells passing the G1/S checkpoint for four 
different thresholds of PT for the activity of the two biomarkers, E2F and CycE (PT 10%  
and PT 20% ), under different DNA-damage situations in response to different reduced 
CDK2 levels. Table 6-3 displays the range of β values based on the PDF for the four different 
thresholds of PTs for E2F under different DNA-damage situations in response to different 
reduced CDK2 levels. According to Table 6-3, the results for the different thresholds are quite
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Figure 6-7  The probability β of a damage cell passing G1/S in response to 
simultaneously changing CDK2 and CKIs (i.e. p21 degradation rate and p27 initial 
condition) for three different range (normal, 30% and 50%- specifically, CKD2 and p21 
degradation rate both reduced by 0%, 30% and 50%, respectively, or CDK2 reduced 
and p27 initial condition increased by 0%, 30% and 50%, respectively - using the 
behaviour of CycE for the parameter range 30%  under two different DNA-damage 
conditions. 
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Table 6-3  The range of the probability (β) of a damaged cell passing G1/S based on the PDF for  four different thresholds of PT (PT-20%, PT-
10%, PT+10% and PT+20%) for E2F under different DNA-damage conditions in response to three reduced CDK2 levels (The values 
corresponding to perturbed PT are shown as a range in each entry of the table). 
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similar to each other and similar to the results based on the PDF of PT for E2F in Table 6-1. 
As for β, for the different thresholds of PT for CycE under different DNA-damage situations 
and different reduced CDK2 levels, the results in Table 6-4 follow exactly the same trend 
asshown by E2F, that β is not affected by the perturbation in PT up to 20% , indicating the 
robustness in lowering the senescence bar through reduced CDK2. 
 
6.5.2 Analysis of Robustness Based on its Mathematical Definition 
Since the changes in threshold values of PTs for the two biomarkers would not change i  
significantly, as shown in Tables 6-3 and 6-4, we ignore the variations in PT. Therefore, we 
assume that the probability of a perturbation is equally likely (i.e.   12ip   ). For example, 
if we have a total of n perturbations,  
1
ip
n
   . According to the mathematical definition of 
the robustness of (Section 4.3), the robustness of CDK2 in triggering cellular senescence 
under the low-level and high-level DNA-damage situations is shown in Figure 6-8. Results in 
Figure 6-8 indicate that the robustness of CDK2 in triggering cellular senescence under the 
low-level DNA-damage situation is slightly higher than that under the high-level DNA-
damage situation. This means that a system under the low-level DNA damage is more robust 
than the high-level DNA-damage in regard to the reduced CDK2 level triggering cellular 
senescence against various levels of perturbations in the key kinetic parameters associated 
with the model. For both DNA-damage situations, the robustness of CDK2 in triggering 
cellular senescence increases as expected with the reduced CDK2 levels. 
 
6.6 Summary 
We have demonstrated that the mathematical model incorporating the G1/S checkpoint 
pathway and DNA damage signal transduction pathway supported the possibility of lowering 
the bar for cellular senescence. It showed that CDK2 and its CKIs (p21 and p27) can be 
targets for achieving this. Specifically, by analysing the time to reach the maximum (PT) 
concentration of E2F and CycE, as two critical proteins in the G1/S transition, we 
demonstrated that lowering CDK2 levels influences the PT of these critical proteins, which 
we used to assess the change in the probability of a damaged cell passing the G1/S checkpoint. 
We then investigated the relationship between CDK2 and its CKIs for the two
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Table 6-4  The range of the probability (β) of a damaged cell passing G1/S based on the PDF for four different thresholds of PT (PT-20%, PT-
10%, PT+10% and PT+20%) for CycE under different DNA-damage situations in response to three reduced CDK2 levels (The values 
corresponding to perturbed PT are shown as a range in each entry of the table). 
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Figure 6-8  Robustness of CDK2 in triggering cellular senescence based on the 
probability of DNA-damaged cells passing the G1/S checkpoint. 
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DNA-damage signals as well as the effects of CKIs and the combination of CDK2 and CKIs 
on the probability of a damaged cell passing the checkpoint.  
 
The results based on the PDF of the PTs for the chosen biomarkers (E2F and CycE) for three 
reduced CDK2 levels (CDK2-10%, CDK2-30% and CDK2-50%) under two DNA-damage 
conditions revealed that reducing CDK2 levels can reduce the percentage of damaged cells 
passing the G1/S checkpoint, indicating that CDK2 can be a target for lowering the threshold 
for senescence to bring forward the entry of damaged cells into an irreversible state of cell 
growth arrest and prevent the proliferation of cancerous cells. More specifically, a 50% 
reduction of CDK2 can cause a 65% reduction in the percentage of damaged cells passing the 
checkpoint. These results showed that the model can highlight the possibility of lowering the 
bar for cellular senescence by lowering the CDK2 level. 
 
In the search for other effective ways to bring forward cellular senescence, the model revealed 
some useful relationships between CDK2 and its CKIs (in terms of production rate,  
degradation rate and initial conditions) under DNA-damage situations. Specifically, the 
results revealed that CDK2 has a strong relationship with p21 (degradation rate) and p27 
(initial condition). Additionally, the model revealed a spectrum of behaviour for CDK2 in 
terms of varying levels of p21 and p27 through the whole region of G1/S transition. This 
gives us some insights into how to further trigger cellular senescence in oncogenically primed 
cells through targeting these key CKIs individually or in combination with lowered CDK2 
levels and reduced degradation rate of p21, and/or increased initial level of p27 before cells 
start proliferating. Individually, p27 appeared to be more than twice as effective as p21 in 
resisting damaged cells passing the G1/S, based on the behaviour of both E2F and CycE. The 
behaviour of the two biomarkers revealed a small discrepancy in the effect of individually 
varying CDK2 levels in that CDK2 is slightly more effective than even p27 according to 
CycE, making CDK2 the most effective individual target. Nonetheless, both E2F and CycE 
showed that the combination of CDK2 and p27 was much more effective than that of CDK2 
and p21, with a 50% change in the former arresting almost all damaged cells before they 
passed G1/S. 
 
In terms of the investigation on the robustness of CDK2 in triggering cellular senescence, 
results of the values of β for damaged cells passing the G1/S checkpoint for four different 
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thresholds of PT of the two chosen biomarkers revealed that β was not affected by the 
changes in PT up to 20%  indicating that CDK2 activity was robust in lowering the 
senescence bar. According to the mathematical definition of robustness, results revealed that 
the robustness of CDK2 in lowering the cellular senescence bar increased with reduced CDK2 
levels for both DNA-damage situations. However, the robustness of CDK2 in triggering 
cellular senescence under the low-level DNA-damage was slightly higher than that under the 
high-level DNA-damage. 
 
The results revealed from the mathematical model were consistent with the current knowledge 
of biology and experimental observations, and add a detailed view of the efficacy of important 
targets in lowering the senescence bar. More importantly, the model investigation on the 
effect of a combination of CDK2 and CKIs on the percentage of damaged cells passing the 
G1/S transition gave us some ideas to explore a powerful and effective way to further trigger 
cellular senescence in oncogenically primed cells. Biologists may wish to verify these 
findings to validate the effectiveness of the targets in a practical setting. We hope that further 
analysis will help us better understand cellular senescence for exploiting its mechanisms for 
an effective cancer treatment by lowering its threshold. 
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Chapter 7: Implementation of Artificial Neural 
Networks for Representing the P53-Mdm2 
Oscillation System 
The p53 tumour suppressor protein is a critical protein in cancer studies and the p53-Mdm2 
negative feedback loop constitutes the core module for most activities of p53 protein-related 
networks. Although there are many mathematical models (based on ODEs) to explain and 
analyze the oscillation phenomena in p53-Mdm2 interaction during the past decade, the 
common characteristic of these proposed mathematical models for the parameter estimation 
uses various ODE solver packages from professional software to obtain the appropriate 
solutions. The ANN technique has never been implemented in parameter estimation for the 
developed models in biological networks until now. In this chapter, the ANN technique is 
initially discussed for parameter estimation of four proposed mathematical models (Models 
III-VI published in Geva-Zatorsky et al. [2006]) for p53-Mdm2 regulation. Then, we evaluate 
the success of the proposed ANN model by comparing results from the networks with those 
from the corresponding ODE based models. Finally, we study the behaviour of the p53-
Mdm2 oscillation system through the analysis of the robustness of this system (in this case, 
we only focus on Model VI) using the developed ANN.  
 
7.1 Overview of the P53-Mdm2 Oscillation System 
The tumour suppressor protein p53 known as the “guardian of the genome” [Vogelstein et al., 
2000] plays an essential role in preserving the integrity of the genome and preventing the 
development of cancer through transcribing genes which induce cell cycle arrest, mediate 
DNA damage repair, promote cellular senescence and trigger apoptosis in response to various 
cellular stresses, such as DNA damage and oncogene activation  [Harris and Levine, 2005; Jin 
and Levine, 2001; Lane, 1992; Toledo and Wahl, 2006; Vogelstein et al. 2000]. More 
importantly, approximately 50% of all malignancies carry a p53 mutation, and the tumours 
without the mutated p53 are mainly caused by the inactivated p53 function through a failure 
in another mechanism [Horn and Vousden, 2007]. Therefore, studies of the p53 system have 
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attracted the attention of many researchers in biology and life science for three decades 
[Bourdon et al., 2003]. 
 
In the p53 system, the E3 ubiquitin liagase Mdm2 protein is a core player in the regulation of 
p53. Under normal/unstressed conditions, the p53 protein is kept at low levels primarily 
through the negative feedback with Mdm2: p53 triggers the synthesis of Mdm2 by activating 
Mdm2 transcription, while Mdm2 keeps p53 at a stable steady-state concentration by 
inhibiting p53 activity and promoting p53 ubiquitination and degradation (See Figure 7-1(b)) 
[Barak et al., 1993; Haupt et al., 1997; Kubbutat et al., 1997; Wu et al., 1993].  Under various 
cellular stresses, the damage signal involves activation of a protein kinase, ATM, which can 
directly phosphorylate p53 at Ser15 [Banin et al., 1998]. The ATM also activates Chk2, which 
results in the phosphorylation of p53 at Ser20 [Hirao et al., 2000]. Both phosphorylated sites 
of p53 make a significant contribution to its activation and stability. This makes it difficult for 
the negative feedback loop with Mdm2 to effectively and strictly control the level of p53. The 
accumulation of p53 in the nucleus activates several stress response programmes which 
include the arrest of cell cycle progression, DNA damage repair and cellular 
senescence/apoptosis if repair is impossible (See Figure 7-1 (a)) [Ciliberto et al., 2005; Geva-
Zatorsky et al., 2006; Harris and Levine, 2005; Lahav et al., 2004; Li and Ho, 1998]. With the 
complete removal of DNA-damage, the negative feedback loop of p53 and Mdm2 is fully 
restored and p53 returns to its low level. 
 
In the past decade, a large number of mathematical models have been developed for 
explaining and investigating oscillatory behaviours in the p53-Mdm2 system. They mainly 
focus on the following two aspects: (i) the damped oscillatory behaviours in cell populations, 
and (ii) the undamped oscillatory behaviours in individual cells in response to various cellular 
stresses [Lev Bar-Or et al., 2000; Monk, 2003;  Lahav et al., 2004; Wagner et al., 2005; 
Ciliberto et al., 2005; Ma et al., 2005; Geva-Zatorsky et al., 2006;  Ramalingam et al., 2007; 
Samuel and Basile, 2007;  Batchelor et al., 2008; Proxtro and Gray, 2008; Yang et al., 2009]. 
Almost all mathematical models are based on ODEs, which describe the change of 
concentration of all participating chemical species in the protein interaction network in the 
system. Although they can be used to study various dynamic and kinetic processes of the p53 
system and provide useful insights on the inner workings of the system, there are still some 
limitations in the current methods and models: the most common one is parameter estimation. 
Most mathematical models are established based on chemical kinetic theory which describes
 125 
 
 
 
 
Figure 7-1  Network diagram of the p53 signalling pathway. (a) p53’s response to DNA 
damage: in response to DNA-damage signal, ATM can directly transfer DNA-damage 
signal or through activating Chk2, to p53. The accumulation of p53 in the nucleus 
activates several stress response programmes including cell cycle arrest, DNA damage 
repair and cellular senescence/apoptosis; (b) p53-Mdm2 negative feedback loop: p53 is a 
transcription factor that promotes the synthesis of Mdm2, while Mdm2 inhibits p53 
activity and promotes p53 ubiquitination and degradation. 
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the reaction rates of interactions in biological system. Due to the lack of kinetic parameter 
values from experimental measurements, the best kinetic parameter values of models are 
generated by minimizing the difference between simulation data and experimental data, which 
results in the representation of real biological systems by models without high precision. For 
overcoming this difficulty, Artificial Neural Network (ANN) can proposed as a feasible 
method. The main advantage of neural networks is precisely the accurate parameter 
estimation. Another important feature is ANNs ability to represent nonlinear interactions. 
Here, we use one of the best-characterized systems in human cells (the p53-Mdm2 oscillation 
system that focuses on the p53-Mdm2 negative feedback loop (See Figure 7-1 (b))) as an 
example to help us understand how to develop ANN to represent the four mathemtaicl models 
(Models III-VI) proposed by Geva-Zatorsky et al. [2006] which can generate the 
characteristic of oscillations that were found in the p53-Mdm2 system.  
 
7.2 Design of Artificial Neural Networks  
Artificial Neural Networks (ANNs) can be viewed as a mathematical model to simulate 
natural and biological systems on the basis of mimicking the information processing methods 
in the human brain. It is well known that ANNs are very capable of approximating input-
output mappings that are complex and nonlinear to an arbitrary degree of precision 
[Samarasinghe, 2006]. This makes ANNs very efficient in representing the behaviour of a 
range of phenomena. The incremental learning approaches in ANNs make it possible for them 
to approximate all internal parameters iteratively. ANNs solve some complex nonlinear 
problems that cannot be solved analytically by most mathematical models. All these 
characteristics of ANN make it a feasible approach to deal with the “parameter estimation” 
problem in the traditional mathematical model of the p53 system. There are five types of task 
to simulate the p53 system using ANN as follows: 
1. Understand the protein interactions involved in the p53 system; 
2. Develop an ANN to represent the exact behaviour of interactions in the p53 system; 
3. Estimate model parameters and compare them with previously reported parameter values; 
4. Compare the temporal behaviour of p53 and Mdm2 with that generated from the ODE 
based model; 
5. Investigate the dynamic behaviour and robustness of the ANN based p53-Mdm2 
oscillation system. 
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The following section discusses each step in the development of ANN for the p53-Mdm2 
oscillation system. 
 
7.2.1 Understanding Interactions in the P53 System 
Deriving a formal abstraction of the p53 system is a crucial step in developing an ANN model. 
This step requires the definition of system boundaries and the components of the system. 
More importantly, it is necessary to determine what types of interaction with the environment 
should be included. Once detailed and comprehensive information about interactions among 
proteins involved are incorporated into the simulated system (see Section 7.1), the next step is 
to develop the ANNs.  
 
7.2.2 The Development of an ANN 
In terms of developing an ANN model for the p53 system, three factors require attention: the 
number of neurons needed, the structure of the network and the learning algorithm. 
 
7.2.2.1 Number of neurons needed 
In general, ANNs are nonmodular which means that the number of neurons in an ANN is case 
dependent [Hopfield, 1982; Alon, 2003]. This number is adjusted during training until the 
network output converges on the actual output based on a criterion such as least square error 
minimization. However, the first advantage of the ANN proposed in this study is that the 
number of neurons is decided before network training; the number of neurons depends on the 
chemical species involved and their corresponding reactions in the p53 system. This means 
that the number of neurons in the ANN can be fixed once we understand the existing chemical 
reactions in the simulated system, which is the first step in developing the mathematical 
model for studying and capturing its essential characteristics. Thus our approach makes a 
point of departure from traditional neural network development by fixing the number of 
neurons thereby making the network an exact representation of the reactions involved in the 
protein network. 
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7.2.2.2 Structure of Neural Networks 
For demonstrating how to determine the structure of the network based on the chemical 
reactions of the p53 system, we take one of Geva-Zatorsky et al.’s [2006] proposed models 
(Model V) as an example for detailed explanation. Model V consists of three differential 
equations (Eqs. (7-1 to 7-3) which explain the reactions between p53 ( x ), Mdm2 precursor 
(
0y ) and Mdm2 ( y ). The details of the model variables and parameters together with their 
descriptions are presented in Table 7-1 and the structure of this p53-Mdm2 network is shown 
in Figure 7-2. According to Figure 7-2, there are two feedback loops on p53: one is a negative 
feedback loop to represent the effects of Mdm2 on p53; the other is a linear positive feedback 
loop representing an upregulating effect on p53 from the action of additional p53 system 
components (which are not shown in Figure 7-2). The delay between p53 and Mdm2 is due to 
transcription of Mdm2 and is achieved by Mdm2 precursor ( 0y  such as Mdm2 mRNA) in this 
model.  
xy
dx
x xy
dt
   ,                                                                                                                   (7-1) 
0
0 0y
dy
x y
dt
   ,                                                                                                                  (7-2) 
0 0 y
dy
y y
dt
   .                                                                                                                  (7-3) 
From the numerical treatment and finite difference method, Eqs. (7-1) to (7-3) can be 
transformed into: 
( 1) ( ) ( )xy
t
x t x t x xy dt

     ,                                                                                        (7-4) 
0 0 0 0( 1) ( ) ( )y
t
y t y t x y dt 

    ,                                                                                    (7-5) 
0 0( 1) ( ) ( )y
t
y t y t y y dt 

    .                                                                                       (7-6) 
 
According to Eq. (2-20), when  dt  is small enough, Eqs. (7-4) to (7-6) can be rewritten in a 
matrix form to represent these ODEs as  
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Table 7-1  Description of variables and parameters in Model V of Geva-Zatorsky et al.’s 
[2006] for the p53-Mdm2 oscillation system.  
Model Variables and Parameters Description 
x  nuclear p53 
0y  Mdm2 precursor 
y  nuclear Mdm2 
  linear p53 production rate  
0  Mdm2 maturation rate  
x  Mdm2-independent p53 degradation rate 
y  Mdm2 degradation rate 
xy  Mdm2-dependent p53 degradation rate 
y  p53-depdendent Mdm2 production rate 
 
 
 
      Figure 7-2  Schematic diagram to illustrate the p53-Mdm3 system for Model V. 
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.                                             (7-7) 
Thus, Eqs. (7-7) can be simplified as:  
( 1) ( )X t X t W A t    ,                                                                                                      (7-8) 
where 0
x
X y
y
 
 
 
  
 represents the chemical species in the p53 system,  
0
0
0 0
0 0
0 0
xy
y
y
W

 
 
  
 
  
  
 represents the chemical species’ related kinetic constants in the 
model system, and 
0
( )
( )
( )
( ) ( )
x t
y t
A
y t
x t y t
 
 
 
 
 
 
 represents the current state of the system resulting from the 
existing relationships among the chemical species in the system. The product of 
W A represents the change of each chemical species in the system at time t . As discussed in 
section 2.4.2, the activity of the system at time 1t   can be calculated by Eq. (2-19) as 
1 2( 1) ( ) ( , , )i i i n
t
x t x t f x x x dt

    . When dt  becomes very small, from the Taylor series 
expansion disregarding higher order terms, the activity of the system at 1t   can be 
considered as the linear combination of the current activity of the system and the product of 
the change of the system during the time increment and dt  using Eq. (2-20) as 
1 2( 1) ( ) ( , , )i i i nx t x t f x x x t    .  
 
Figure 7-3 shows the architecture of the developed recurrent ANN for Model V of the p53-
Mdm2 oscillation system. The model consists of four inputs ( x , 0y , y , xy ) and three linear 
neurons that receive inputs as specified in Eq. (7-8). The connections between inputs and 
neurons represent the relevant kinetic constants. Each neuron represents one equation in Eq. 
(7-7) and computes the weighted sum of inputs and products of the weighted sum and t . 
The final result is obtained by adding the neuron outputs to the initial system state.  In Figure 
7-3, we can find the second advantage of the proposed ANN in that the weights of ANNs 
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Figure 7-3  Architecture of the developed recurrent ANN for Model V of the p53-Mdm2 
oscillation system given in Eq. (7-8). 
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represent the corresponding kinetic constants of the chemical species, indicating that the 
developed ANN can directly estimate the values of kinetic constants of chemical reactions in 
the system during training. Thus, the most difficult problem of parameter estimation in the 
ODE-based mathematical models of the biological system can be easily solved by the ANN 
technique; more importantly, the ANN represents the protein network exactly and the 
successfully trained ANN can be used to study and analyze the dynamic behaviour of the p53-
Mdm oscillation system through adjusting the respective kinetic constants in the proposed 
ANN. 
 
7.2.2.3 ANN Learning Algorithm 
In a neural network, the unknowns are the weights and in our case, they depict the parameters 
of the system. The unknowns are estimated by showing the network inputs and corresponding 
outputs repeatedly and adjusting the weights incrementally using a learning algorithm. The 
inputs and outputs in this case are generated from the ODE version of the model (Once 
experimental method become more powerful, these data can directly come from 
experperimental measurements). These are called training vectors. Each vector contains 
values for the four inputs ( x , 0y , y , xy ) for time t and the corresponding output  ( x , 0y , y ) 
for the next time step. In general, it is advisable to use simple algorithms that yield quick and 
accurate solution. As the studied Model V of the p53-Mdm2 system only requires a linear 
ANN (i.e. linear neurons), a backpropagation algorithm in batch mode is used as the learning 
algorithm to update the weights of the network. It basically minimizes the network’s global 
error between the actual network outputs and their corresponding desired outputs based on 
gradient descent error minimisation. The network’s global error (E) between its output and 
actual output is given by
 
 
2
2 2 2
1 2
1 1
1
2
K N
k ij ij
j i
E E E E T Z
NK  
 
      
  
  ,                                                            (7-9) 
where jE  represents the error of neuron j, ijT  and ijZ  are the actual output and the network 
output, respectively, of the 
thj   neuron for the 
thi  training vector, K is the number of neurons, 
and N is the total number of training vectors. Basically, error  E  represents the total mean 
square error across all the neurons in the model. The objective of learning is to minimise this 
error through incremental adjustment of weights. 
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The method of modifying a weight is the same for all weights; here we show the change to an 
arbitrary weight as an example. The change to a single weight jiw  of a connection between 
input i  and neuron j  in the neural network based on batch learning is defined as 
1
( )
k
ji p
p ji
dE
w
dw


    ,                                                                                                         (7-10) 
where 
ji
E
w


 is the error gradient with respect to weight jiw . The   is called the learning rate 
with a constant value between 0 and 1, and it controls the rate of weight adjustment. k  is the 
total number of input vectors. Thus, the new weight for the next batch (which is denoted by 
1n
jiw
 ) can be presented as  
 1n n n
ji ji jiw w w
                                                                                                                    (7-11) 
 
The process that propagates the error information backwards into the network and updates 
weights of the network is repeated until the network minimizes the global error between the 
actual network outputs and their corresponding desired outputs. In the learning process, the 
weights of the network converge on the optimum values. A particular feature of an ANN in 
this case is that it uses a simple first order learning algorithm based on error gradients to map 
accurately the required system behaviour. 
 
7.3 Evaluating the Success of ANN Models  
In this study, the focus is on the development of an ANN model to represent the mathemtaicl 
models proposed by Geva-Zatorsky et al. [2006]. Geva-Zatorsky et al. [2006] examined six 
model families to capture the observed oscillations and variability in the p53-Mdm2 system in 
response to DNA damage caused by gamma irradiation. We focus on four of these (Models 
III-VI) in this research. All four models contain a negative feedback loop between p53 and 
Mdm2: p53 transcriptionally activates Mdm2 and the activated Mdm2 promotes the 
degradation of p53. Models III-VI only focus on the chemical reactions between p53 and 
Mdm2. The number of parameters in Models III-V are five, six and five, respectively. 
However, Model VI (with six parameters) takes a checkpoint mechanism into account. It is 
achieved by two negative feedback loops: (i) a direct feedback loop between p53 and Mdm2, 
and (ii) a longer feedback loop impinging on an upstream regulator of p53 in response to the 
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active damge signal. The values of parameters involved in these four original models were 
selected by reproducing an effective average individual cell measurements of nuclear p53 and 
Mdm2 following gamma irradation revealed from the real experimental observations [Geva-
Zatorsky et al., 2006]. The structure and mathematical details of Models III, IV and VI are 
shown Figure 7-4. The details of the model variables and parameters together with their 
description for the three models are presented in Appendix D. Figure 7-5 displays the 
corresponding architectures of the developed ANNs as well as the corresponding 
mathematical (matrix) forms to represent ODEs of Models III, IV and VI. The following 
section explains how we developed the ANNs and estimated the values of parameters in the 
mathematical models (Models III-VI) of the p53-Mdm2 oscillation system. 
 
We first analyzed the four models (III-VI) by numerically showing their ODEs. Figure 7-6 
displays the p53 and Mdm2 oscillations generated by these mathematical models. It shows 
that  the four models can capture the oscillatory behaviour of the p53-Mdm2 feedback loop 
and represents four possible oscillatory reponses. The structure of ANNs has already been 
decided based on the ODEs of the proposed mathematical models (III-VI) representing the 
rate of  change of concentration of all participating chemical species in the p53-Mdm2 
oscillation system (See Figures 7-3 and 5).  
 
The last step required, according to section 2.4.2, is the determination of a value for dt   that 
is small enough. The reason for this is that the activity of the system at the time 1t   is 
calculated as in Eq. (7-7) (i.e. the linear combination of the current activity of the system 
( ( )x t , 0 ( )y t , ( )y t , ( ) ( )x t y t ) and the product of the changes in the system during a time 
increment and t  ). Based on the analysis of these four different Models III-VI as shown in 
Figure 7-6, we define the values of t  as 0.002, 0.001, 0.005 and 0.002 (hours), respectively 
(In this case, we fixed the maximum value of dt for the four models depending on whether 
oscillations in p53 and Mdm2 levels generated by Eq. (7-7) have a prefect agreement with 
those directly generated from ODEs solutions). Once the value of t  are fixed, the developed 
ANNs are trained to learn their corresponding mathematical models, while weights (directly 
representing the chemical kinetic parameters of reactions in the p53-Mdm2 system) are 
updated until each proposed network reaches global minimum error. Figures 7-7 and 7-8 
illustrate the behaviour of p53 and Mdm2 obtained from the ANN along with the respective 
ODE solutions. According to these two figures, ANN results for p53 and Mdm2 and those 
from ODE solutions are in perfect agreement. 
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Figure 7-4  The structure and mathematical details (ODEs) of Models III, IV and VI of 
Geva-Zatorsky et al.’s [2006] for the p53-Mdm2 oscillation system. 
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Figure 7-5  Architecture of the developed recurrent ANNs and the corresponding mathematical form for the representation of Models III, IV 
and VI . 
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Figure 7-6  Numerical solutions of ODE-based Models III-VI showing oscillations in p53 and Mdm2 levels undergo oscilation in response to 
DNA damage stresses: (a) Model III, (b) Model IV, (c) Model V and (d) Model VI. 
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Figure 7-7  The predicted p53 concentration from ANNs for the four different models superimposed on the solutions from the corresponding 
ODEs: (a) Model III, (b) Model IV, (c) Model V and (d) Model VI. A perfect agreement between the two solutions is seen. 
 139 
 
Figure 7-8  The predicted Mdm2 concentration from ANNs for the four different models superimposed on the solutions from the 
corresponding ODEs: (a) Model III, (b) Model IV, (c) Model V and (d) Model VI.  A prefect agreement between the two solutions can be seen. 
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We extracted the weights from the developed ANNs and compared them with the kinetic 
constants used in the ODEs. All weights perfectly match the corresponding kinetic constants, 
as shown in Table 7-2. All these results reveal that the developed ANNs are successful in 
parameter estimation based on very small dt . However, very small dt  does not currently 
represent accurately possible measurements in a real system. In fact, realistic experiments 
generally record the change of chemical species in constant time intervals like a few minutes 
(this time interval is referred to as  t  in the ANNs). For the p53-Mdm2 oscillation system 
here, the constant time interval for the real experiments is about 0.3 hours [Geva-Zatorsky et 
al., 2006]. Compared to t  used in the developed ANNs, the realistic constant time interval is 
much larger. We retrained the ANN models with the data for a larger time interval of 0.3 
hours but the results did not agree well with the corresponding results from ODEs.  Therefore, 
a new question arose as to whether it was possible to develop ANNs to estimate the chemical 
kinetic parameters for reactions in the p53-Mdm2 oscillation system for a larger time interval 
( dT )? The answer to this question is “Yes” but certain modifications are needed to the 
original ANN. The modified ANN is still based on a small t ; however, we needed to be 
made to install a “switch” into the ANN before the final output of the network was calculated. 
This is the same recurrent neural network involving feedback as before but with a timer 
switch as represented in the right hand side of Figure 7-9 and the structure of this network is 
shown in Figure 7-9 where the right hand side implements the above described switch. 
 
In this kind of ANN, there are two output layers: one is the inner output layer whose output is 
used as input into the next time step; and the other is the final output layer whose output is the 
network output that is used for the error calculation and weight update. The following 
equation represents the network output: 
( ) ( 1) ( ), for = , 1,2,3,4,5,.......
t
Z n X t X t dT n n n
dT

    

 ,                     (7-12) 
where Z is the final output of the network, X is the inner output of the network, n is the n
th
  
final output. The purpose of this switch is to accumulate the results of the inner output layer 
over the time interval dT  before deciding that the network can enter the final output layer. 
The network can only enter the final output layer when the summation of the small time 
intervals t  equals the large time interval dT  at which point error calculations and weight 
updates are made. Figures 7-10 and 7-11 illustrate the behaviour of p53 and Mdm2 obtained 
from the modified ANNs superimposed on the ODE solutions. The results indicate that the
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     Table 7-2  The comparison of model parameters between ODE and ANN based on a small t  . 
Parameters 
ODE ANN 
III IV V VI III IV V VI 
0  - 0.8 20%  1.1 25%  - - 0.796 1.11 - 
x  0 0 - - 0 0 - - 
y  24 0.8 25%  0.9 30%  0.7 20%  24.97 0.798 0.91 0.72 
xy  120 - 3.7 50%  1.4 20%  118.25 - 3.68 1.36 
x  2.3 0.9 35%  - 0.9 60%  2.27 0.9 - 0.88 
y  24 1.1 55%  1.5 60%  1.0 10%  24.89 1.11 1.51 1.0 
s  - - - 2.7 30%  - - - 2.75 
S  - - - 0.9 25%  - - - 0.91 
k  - 1.7 20%  - - - 1.7 - - 
  - - 2.0 25%  - - - 1.99 - 
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Figure 7-9  Architecture of the developed ANN for Model V of the p53-Mdm2 oscillation 
system based on the larger time interval ( dT ) given in Eq. (7-12). 
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Figure 7-10  The aproximated p53 concentration derived from ANNs for the four different models based on a large dT  (0.3 hours) 
superimposed on the corresponding ODE solutions: (a) Model III, (b) Model IV, (c) Model V and (d) Model VI. A perfect agreement can be 
seen in the model outcomes. 
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Figure 7-11  The aproximated Mdm2 concentration derived from ANNs for the four different models based on a large dT  (0.3 hours) 
superimposed on the corresponding ODE solutions: (a) Model III, (b) Model IV, (c) Model V and (d) Model VI. A perfect agreement can be 
seen in the model outcomes. 
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ANN outcomes agree with the ODE solutions in representing the behaviour of p53 and Mdm2. 
We also compared the model parameters calculated based on the larger time interval dT  with 
the corresponding kinetic constants in the ODE based models as shown in Table 7-3. The 
results indicate that the estimated constants are in almost perfect agreement with the 
corresponding kinetic constants used in the ODEs. 
 
7.4 Robustness of the P53-Mdm2 System Based on the 
Developed ANNs 
We define robustness here as the ability to sustain oscillatory behaviour in the p53-Mdm2 
system. The robustness of the p53 oscillation system with respect to various perturbations in 
the model parameters can be achieved by the autocorrelation function which measures the 
degree of periodicity of time evolution for a given variable. For the constant parameter set 
obtained from training, we can compute the autocorrelation function. Based on the 
autocorrelation function, we can calculate the time corresponding to a 50% decrease in the 
initial correlation values, called the half-life of the correlation, under this particular condition. 
Meanwhile, we also compute the periods for this system (time interval between a pair of 
successive peaks) as well as their mean value, called the “mean period”. 
 
In terms of the robustness of the p53-Mdm2 oscillation system, we define the ratio of the half-
life and the mean period (HoMP) as a measure of the robustness of this system in the presence 
of various levels of perturbations in its model parameters (See Appendix E for the details of 
HoMP calculation). In general, molecular fluctuations reduce the half-life of autocorrelation 
functions and diffuse the phase of the oscillations [Baras, 1997; Baras, et al., 1990; Gonze et 
al., 2002]. This is the resaon why we use HoMP as a measure of the robustness of the p53-
Mdm2 oscillation system. Here, we assume that the system is robust if the system can keep 
HoMP for various internally or/and externally caused perturbations the same as that (HoMP = 
4) under the reference parameter values. We tested the robustness of the ANN-based p53 
systems for Model VI. We generated perturbations by changing model parameters to 
investigate the robustness of the system. The following section discusses the results for the 
robustness of the p53 oscillation system for Model VI in response to changes in model 
parameters made in two different ways: the individual parameter changes and the 
simultaneous parameter changes with different ranges. 
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     Table 7-3  A comparison of model parameters between ODE and ANN based on a larger time interval dT  .
 
Parameters 
ODE ANN 
III IV V VI III IV V VI 
0  - 0.8 20%  1.1 25%  - - 0.8 1.1 - 
x  0 0 - - 0 0 - - 
y  24 0.8 25%  0.9 30%  0.7 20%  24.96 0.8 0.9 0.7 
xy  120 - 3.7 50%  1.4 20%  118.27 - 3.68 1.43 
x  2.3 0.9 35%  - 0.9 60%  2.27 0.9 - 0.9 
y  24 1.1 55%  1.5 60%  1.0 10%  24.97 1.1 1.5 1.0 
s  - - - 2.7 30%  - - - 2.7 
S  - - - 0.9 25%  - - - 0.9 
k  - 1.7 20%  - - - 1.7 - - 
  - - 2.0 25%  - - - 2 - 
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7.4.1 The Robustness of the P53-Mdm2 System in Response to 
Individual Parameter Changes 
To investigate the robustness of the system in response to individual parameter changes, we 
changed only one parameter at a time within the 50%  range in 10% intervals and calculated 
HoMP values for these 11 cases. The purpose is to investigate the influence of the change in 
the value of a parameter in disrupting the oscillatory behaviour of the p53-Mdm2 system. 
Figures 7-12 (a) and (b) show the results of the influence of individual parameter changes on 
HoMP for p53 and Mdm2, respectively, indicating that the behaviours of p53 and Mdm2 have 
quite similar trends; the value of HoMP increases with increases in the parameter values, but 
all parameters allow the system to reach its original HoMP value of 4.0 beyond 20%  of the 
parameter value. Therefore, the system is robust with respect to parameter changes around the 
original values up 50%  (original value is represented by the 6
th
 increment in Figures 7-12 (a) 
and (b)). This reveals that the robustness of the p53-Mdm2 system is not susceptible to 
perturbations in the individual parameters of the model in this range, which is in good 
agreement with the model sensitivity analysis results reported by Geva-Zatorsky et al. [2006] 
who state that Models IV-VI can generate sustained or weakly damped oscillation over a 
broad range of parameters.  
 
One parameter, s  (Mdm2-dependent signal inactivation rate), was different from the other 
parameters in that the HoMP for 50%  of s  was significantly lower than the original HoMP 
(Specifically, about 50% of the original HoMP as shown in Figures 7-12 (a) and (b)). 
Therefore, we compared the behaviour of p53 and Mdm2 under a 50% reduced parameter 
value and the reference value of  s  (see Figures 7-12 (c) and (e)). For 50%  of s
 , both p53 
and Mdm2 concentrations reach a fixed point with time making the whole system stable. In 
this case, we represent the behaviour of p53-Mdm2 for only 48 hours. This is the reason why 
the exact fixed stable point cannot be seen in Figures 7-12 (c) and (d). For a lager time range, 
the system will reach a fixed stable point. However, for the reference values of s ,  the 
concentrations of p53 and Mdm2 each comprise an oscillator that follows a cyclical path in 
phase space called a limit cycle that keep the whole system stable (Figures 7-12 (e) and (f)). 
This type of stability in the system exists for all parameter perturbations beyond 20%  of 
parameter values. In terms of the intermediate value of HoMP (3 in this case) for 40%  of 
s  , the behavious of p53 and Mdm2 are shown in Appendix F. 
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Figure 7-12  The analytical results from the proposed ANN model based on local 
sensitivity analysis (a and b): The influence of individual parameter changes on HoMP 
based on the behaviours of p53 and Mdm2, respectively. (c and e): Phase plane 
trajectories of p53 and Mdm2 under 50% reduced parameter value for s  and the 
reference value for s , respectively. (d and f): Temporal performances of p53 and 
Mdm2 under the 50% reduced parameter value for s  and the reference value for s
 , 
respectively. 
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7.4.2 The Robustness of the P53-Mdm2 System in the Presence of 
Various Levels of Perturbations to All Paramters (GSA) 
In Chapter 4, we discussed why it was important to analyze the system’s behaviour in 
response to simultaneous variation in parameters. In this investigation, we randomly 
generated 1000 samples of parameter vectors for the model parameters in three defined levels: 
reference values %10 ; reference values %30 and reference values %50 . Figure 7-13 
illustrates the distribution of HoMP from the behaviours of p53 (Figure 7-13 (a, c and e)) and 
Mdm2 (Figure 7-13 (b, d and f)) under the three defined levels of parameter range, 
respectively. According to Figure 7-13, the p53-Mdm2 system is very robust for %10  
perturbation in all parameters (HoMP is almost equal to 4, which means that the half-life is 
close to four times the mean period of the p53-Mdm2 oscillation) as revealed by the 
behaviour of both p53 and Mdm2. With increases in perturbation of the model parameters, the 
robustness of the system becomes more susceptible and sensitive, which means that the p53-
Mdm2 system generates less oscillatory behaviour when the parameters are examined within 
a range of %30  to %50 . However, these may represent fixed stable points similar to that 
shown in Figure 7-12 (c). We also compute the mean of HoMP for 1000 samples under the 
three parameter ranges, and the results are given in Figure 7-13 (g). It shows that the 
robustness of the system as measured by HoMP in the presence of different parameter 
perturbations decreases with the severity of perturbations but the system stays more robust 
compared to the case of individual parameter perturbations presented in the previous section. 
For example, HoMP in Figure 7-13 (g) is above 2.8. 
 
7.5 Summary 
We have demonstrated that ANNs can be successfully developed to represent the p53-Mdm2 
system and to solve the parameter estimation problem in the traditional ODE system. The 
ANN estimates of parameters agree with the kinetic constants used in the ODE-based models.  
More importantly, we investigated the robustness of the p53-Mdm2 system by studying the 
influence of individual parameter changes on HoMP which indicated the propensity to disrupt 
the oscillatory behaviour of the p53-Mdm2 system. 
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Figure 7-13  The analytical results from the proposed ANNs based on GSA. (a, c and e): 
The distribution of HoMP based on the behaviour of p53 under three defined parameter 
ranges. (b, d and f): the distribution of HoMP based on the behaviour of Mdm2 under 
three defined parameter ranges. (g): the mean HoMP for 1000 samples under three 
parameter ranges as a measure of the robustenss of the p53-Mdm2 oscillation system.
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The developed recurrent ANNs representing Models III-VI proposed by Geva-Zatorsky et al. 
[2006] showed a good agreement with results from the ODE solutions for small t . 
Furthermore, the modified recurrent ANN accurately represented p53-Mdm2’s behaviour for 
larger time steps (0.3 hours) that are representative of time scales in experimental 
measurements. These results demonstrated that the ANN technique can be used for 
representating real biological networks and parameter estimation of mathematical models for 
these real biological networks. These two aspects are novel contributions of the thesis to the 
field of computational systems biology. 
 
In terms of the investigation of the robustness of the p53-Mdm2 oscillation system, the values 
of HoMP, used as a measure of the system’s robustness in the presence of various levels of 
perturbations in model parameters, revealed that HoMP (HoMP = 4) was not affected by the 
changes in parameter values in the range [-20%, 50%], indicating that the proposed ANN 
suggested a sustained or weakly damped oscillation over a broad range of parameters. This 
agreed with Geva-Zatorsky et al.’s [2006] observations from the corresponding ODE models. 
Furthermore, parameter s  (Mdm2-dependent signal inactivation rate) with a -50% change 
made a significant contribution to adjusting the stability of the system. For this condition, the 
system remained at a stable fixed point to keep the whole system stable instead of entering a 
limit cycle. Results of the investigation of the robustness of the p53-Mdm2 system based on 
simultaneously changing model parameters within %50  range indicated that HoMP 
decreased with increased range of perturbations in the model parameters but the HoMP is 
more resilient to change than when individual parameter varies. 
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Chapter 8: Conclusions and Future Directions 
The overall theme of this thesis was to integrate our knowledge of mathematics, biology and 
ANN techniques to study, model and gain insights into biological networks. The main 
objective of this research was to investigate a mathematical model for the G1/S cell-cycle 
checkpoint pathway incorporating the DNA-damage signal transduction pathway in cell 
division as well as the implementation of an ANN technique for the p53-Mdm2 oscillation 
system. Analytical approaches were developed for the G1/S checkpoint pathway and the p53-
Mdm2 oscillation system, depending on the level of detail of the systems and the particular 
research questions asked. The simulated results from our approaches have indicated that they 
can be successful in gaining novel insights into the behaviour of these two biological systems. 
We now give a general overview of what we have achieved and the contribution of these 
achievements and future directions that can follow from the current work. 
 
8.1 General Overview 
The first focus of the current work was to investigate the robustness and the behaviour of the 
critical proteins under parameter perturbations of the G1/S checkpoint pathway with different 
levels of DNA-damage. To fulfil this goal, we first used a mathematical model for this system 
based on a model developed by Iwamoto et al. [2008], consisting of 28 ODEs with 75 kinetic 
parameters (Chapter 3). Then, to characterise the dynamic behaviours and the robustness of 
the system in the presence of various levels of perturbations in the kinetic parameters, we 
identified the critical proteins (E2F and CycE in this case) of the system as our biomarkers 
and proposed an analytical approach including Local Sensitivity Analysis (LSA), Global 
Sensitivity Analysis (GSA) and statistical Type II error (Chapter 4).  
 
Finally, the resulting model was extensively tested and compared with the experimental data 
(Chapter 5). We summarised the findings of the model in the following three aspects. (1) We 
extensively tested the influence of individual kinetic parameters on the chosen biomarkers in 
the G1/S transition and the response of the cells to different intensities of DNA-damage: 
kinetic parameters related to p27 and CycE were the most significant factors affecting the 
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behaviour of the chosen biomarkers under no DNA-damage situation. In response to a DNA-
damage situation, the kinetic parameters related to p21 and p53 became more important than 
for the normal cells. All these findings demonstrated the ability of the model to correctly 
predict experimental outcomes. (2) We used an analytical approach to GSA and Type II error: 
we focused on investigating the probability of accurately distinguishing healthy cells from 
defective cells on four defined levels of parameter range. The simulation results indicated that 
the percentage of damaged cells passing as healthy cells became very large (more than 38%) 
when the level of change of parameters exceeded 20% . This had a good qualitative 
agreement with experimental findings which stated that a large number of damaged cells 
undergo proliferation without being caught at DNA damage checkpoints. (3) We used two 
different approaches to analyze the robustness of the G1/S checkpoint: one was based on 
different thresholds of biomarkers, and the other was based on the mathematical definition of 
robustness. Results revealed from the behaviour of the two biomarkers were that the 
probability of damaged cells passing as healthy cells was not affected by the changes in peak 
time up to 20% , indicating the robustness of the G1/S checkpoint under parameter 
perturbations in response to different DNA-damage situations. The results based on the 
mathematical definition indicated that the robustness of the G1/S checkpoint pathway 
decreased with the increased intensity of the DNA-damage signal. 
 
The second focus of the current research was to validate whether the mathematical model 
incorporating G1/S checkpoint pathway and DNA damage signal transduction pathway can 
highlight cellular senescence and formulate scenarios for adjusting the threshold for 
senescence to evaluate its efficacy and outcomes (Chapter 6). We started with the biological 
definition and some experimental observations. The purpose was to define critical factors 
(such as CDK2 and Skp2) in triggering cellular senescence in order to develop a hypothesis 
based on the proposed model. In our research, we analyzed the cellular senescence through 
lowering the critical trigger - CDK2. To do this, we focused our investigation on the 
behaviour of two important proteins (E2F and CycE) for several reduced CDK2 levels under 
two DNA-damage conditions by calculating the probability of DNA-damaged cells passing 
the G1/S checkpoint. A comparison of the values of the probability (β) under the normal 
CDK2 level and low CDK2 levels revealed that reducing CDK2 levels can reduce the 
percentage of damaged cells passing the G1/S checkpoint; in particular, a 50% reduction of 
CDK2 achieved a 65% reduction in the percentage of damaged cells passing the checkpoint. 
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We then analyzed the relationship between CDK2 and its corresponding CKIs in order to help 
find other effective ways to bring forward cellular senescence. Results showed that the 
degradation rate of p21 and the initial concentration of p27 can be effectively used to lower 
CDK2 levels to lower the senescence threshold. Specifically, p27 was the most effective in 
lowering the percentage of damaged dells passing the G1/S checkpoint and CDK2 and p21 
had similar effects according to the behaviour of E2F, while CycE behaviour indicated that 
CDK2 and p27 had similar effects with p21 having a smaller influence. However, both E2F 
and CycE revealed that simultaneous variation of CDK2 and CKIs produced a dramatic reduction 
in damaged cells passing G1/S; CDK2/p27 combination almost totally arrested the passage of 
damaged cells through the checkpoint. These model findings can be validated by biologists in 
order to ascertain the real efficacy of these targets for treating cancer.  
 
In addition, the same approaches as before were used to analyze the robustness of CDK2 in 
triggering cellular senescence. Results from different thresholds of biomarkers indicated that 
the percentage (β) of damaged cells passing G1/S checkpoint was not affected by the 
perturbation in their PT up to 20%  indicating the robustness in lowering the senescence bar 
through reduced CDK2. The results from the mathematical approach revealed that the 
robustness of CDK2 in triggering cellular senescence increased with the reduced CDK2 levels 
for the DNA-damage situation. 
 
The final focus of the current thesis was to implement an ANN approach for simulating the 
p53-Mdm2 oscillation system as well as analysing the robustness of this system (Chapter 7).  
We first described the behaviour of p53-Mdm2 negative feedback loop under normal and 
DNA-damage conditions. Then, we described why we use ANN approach instead of the 
traditional approach using ODEs, and described how to develop ANNs for biological systems. 
Specifically, the incremental learning approaches used in ANNs made it possible for them to 
solve the most difficult parameter estimation problem in a mathematical model. More 
importantly, the structure of the proposed ANNs can directly represent the relationship of the 
chemical species involved in reactions in the simulated biological network. We developed and 
validated ANNs to represent four different mathematical models of the p53 and Mdm2 
oscillation system proposed by Geva-Zatorsky et al., [2006]. Results from the ODE solutions 
and the proposed ANNs indicated that the proposed ANNs can successfully represent the 
behaviour of the p53-Mdm2 oscillation systems and accurately solve the parameter estimation 
problem. Finally, we used the developed ANNs to investigate the robustness of the p53-
 155 
Mdm2 oscillation system. According to the analytical results from LSA on HoMP, the 
measure of robustness of the system, the p53-Mdm2 oscillation system was very robust. The 
system can generate sustained or weakly damped oscillations over a broad range of 
parameters. Furthermore, s   (Mdm2-dependent signal inactivation rate) played an important 
role in changing the stable configuration of the system from remaining in a limit cycle giving 
rise to oscillations to entering a stable fixed point with decreasing values of  s  . The GSA of 
the developed ANNs revealed that the ANN can generate stable and sustained oscillations 
when parameter variation was within a range of 10% ; however, the robustness of the system 
became very sensitive with larger perturbations of the parameters. The results revealed from 
the mean of HoMP for the p53-Mdm2 model indicated that the robustness of the system 
decreased as expected from the behaviour of both p53 and Mdm2 in response to increased 
parameter perturbations. However, HoMP was more resilient to simultaneous parameter 
change, which is more realistic biologically. 
 
8.2 Contributions 
The contribution of this thesis spanned two topics through modelling and analysis of two 
systems: 
 Advanced our understanding of the G1/S transition incorporating the DNA-damage 
transduction pathway by building and validating models incorporating current knowledge; 
 Analyzed the influence of the kinetic parameters associated with the in silico biomarkers 
based on the mathematical model of the G1/S transition under different levels of DNA-
damage situations, and identified the most significant kinetic parameters for the chosen 
biomarkers through the developed LSA approach;  
 Evaluated the probability of DNA-damaged cells passing as healthy cells in the presence 
of various levels of perturbation in the key kinetic parameters of the in silico biomarkers 
associated with the mathematical model based on a combination of GSA and Type II 
error approach; 
 Formulated a mathematical expression for defining the robustness of the protein signaling 
networks;  
 Confirmed that the mathematical model of the  G1/S transition incorporating DNA-
damage signal transduction pathway can highlight cellular senescence; 
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 Demonstrated the potential of lowering the bar for triggering cellular senescence in cells 
based on the model’s analytical results; 
 Developed ANNs for the p53-Mdm2 oscillation system and solved the parameter 
estimation problem faced by the current mathematical models for biological networks. 
 
8.3 Future Directions 
The work described in this thesis suggested several directions for future work. 
 As discussed in Section 2.2, there are two different ways to inhibit the activity of 
CycE/CDK2 in order to delay the G1/S transition in response to DNA-damage situation: 
one is based on the p53-p21 pathway and the other is based on the Chk2-Cdc25A 
pathway.  The current model only focuses on the p53-p21 pathway. However, the Chk2-
Cdc25A pathway plays an equally important role in controlling cell cycle progression as 
well as cell cycle arrest under DNA-damage situations. Therefore, it is important to 
extend the existing model to this pathway. The purpose of this is to extend our 
understanding of how cells control themselves in response to DNA damage through these 
two pathways. 
 
 In terms of the DNA-damage transduction pathway, the current model revealed that the 
damage signal directly affects the activity of p53. In fact, the DNA-damage signal first 
activates both ATM and ATR. The activated ATM and ATR then promote the synthesis 
of p53 and Chk2 (in Chapter 2). The G1/S checkpoint pathway then combines with the 
p53-p21 pathway and Chk2-Cdc25A pathway for the cell cycle arrest. Therefore, it is 
necessary to establish the mathematical model to simulate the dynamic behaviour of the 
reactions among the DNA-damage signal, ATM/ATR, p53 and Mdm2. Furthermore, the 
equation denoting the DNA-damage signal should take a cellular mechanism of damage 
repair into account; however, it currently just uses a rate with a constant repair value. In 
fact, the DNA-damage repair is a complicated process. In our study, we do not 
incorporate into our model: (1) specific DNA-damage repair pathways to reflect the fact 
that different types of damage can be repaired by different pathways [Friedberg, 1995], 
and (2) the direct and indirect important role that p53 may play in DNA-damage repair 
processes [Smith et al., 1995]. Future work therefore could focus on these directions. 
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 The current model mainly focuses on the dynamic behaviour of the G1/S transition 
incorporating the DNA-damage transduction signal. Although the reconstructed model 
has a good predictive performance of the G1/S transition, it cannot represent the dynamic 
behaviour of the whole cell cycle regulation process. In order to have a deep 
understanding of cell cycle regulation in response to DNA-damage situations, a model 
that combines G1/S and G2/M transitions should be developed. Thus, we can develop 
two sub-models: one is the G1/S model and the other is the G2/M model. The details of 
the G2/M transition are shown in Chapter 2, and the differential equations can be 
assumed to follow chemical reactions involved in the G2/M transition. 
 
  In Chapter 6, we demonstrated that the G1/S model can highlight cellular senescence 
through lowering the critical trigger - CDK2 and then investigated the potential of 
lowering the bar for triggering cellular senescence in oncogenically primed cells. Most 
results from the model have not been validated by realistic experimental observations; 
therefore, it is necessary to set up some real biological experiments as evidence for 
ascertaining the effectiveness of the targets. Meanwhile, these established experiments 
can help us optimize or advance the current model in order to better understand the 
behaviour of cellular senescence.   
 
 In Chapter 7, we developed ANNs to simulate the p53-Mdm2 oscillation system. The 
developed ANN requires the estimations for initial weight values and time increments (dt) 
for each model. Small random values can be confidently used for initial weights; however, 
time increments need to be selected carefully depending on the temporal behaviour of the 
p53 and Mdm2. We do not have a precise benchmark to confirm whether the proposed 
neural network is the most optimum with the highest possible accuracy but ANNs were 
developed to mimick the ODEs models which they did with excellent accuracy. The 
proposed ANNs could represent the ODEs for this network with just linear activation 
functions (linear neurons) and a simple learning algorithm was able to estimate parameter 
values with remarkable accuracy. However, more powerful activation functions and 
learning algorithm have the potential to represent more complex chemical reactions that 
may be more realistic for biological systems. Therefore, there is much scope for 
improving and optimizing the developed neural networks in the future. 
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 The investigation of the mathematical model for the G1/S checkpoint pathway as well as 
the p53-Mdm2 oscillation system was based on deterministic simulations in the current 
study. However, investigating the stochastic properties of the biological network is 
another critical concept in systems biology. In terms of the stochastic simulations, we 
needed to focus on three questions: (1) What are the origins and consequences of intrinsic 
noise? (2) How do the chemical species in individual cells change under the different 
levels of extrinsic noise? (3) What is the difference between the deterministic and 
stochastic simulations of the dynamic behaviour of the system in order to gain more 
insights into the real system? We believe that it is worthwhile to tackle these issues as the 
answers will give us insights into the dominant reactions that drive the system’s dynamics 
and therefore allow us to determine the most responsible chemical species that control the 
whole process. 
 
8.4 Conclusions  
Although the study of highly dynamic, interacting and complex biological systems is a 
challenging topic, it is becoming a critical focus in the current biological research. 
Furthermore, it is very difficult to understand the dynamics and functions of the underlying 
biological and biochemical processes in the complicated biological networks just from in vitro 
experiments. However, the mathematical modelling and simulation-based approaches have 
the potential to study, explore and understand such processes. More importantly, the 
mathematical model based on chemical kinetic theory of reactions invovled in the biological 
network played a crucial and reliable role in revealing the complexities of the simulated 
system. In this thesis, we have shown how the model developed can be used to investigate and 
understand the dynamic behaviour of the G1/S checkpoint pathway in response to DNA-
damage signals; how the G1/S model can explore the potential to trigger cellular senescence 
in oncogenically primed cells and how ANN can be developed to represent properties of the 
p53-Mdm2 oscillation system. More importantly, we highlighted how ANN can accurately 
represent the biological networks and solve the parameter estimation problem of the 
traditional ODEs. 
 
Although our investigation concentrated on a small subset of a specific problem in the G1/S 
checkpoint pathway as well as the DNA-damage signal pathway of cell cycle regulation, there 
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is indeed a large array of challenging and exciting biological phenomena in cell cycle 
regulation that require exploration. We believe that the success of the mathematical models 
presented in the thesis will encourage more biologists and mathematicians to look beyond the 
difficulties of interdisciplinary work and to investigate the benefits of integrated approaches 
in systems biology. Therefore, there are more opportunities to explore and provide valuable 
insights into the dynamic behaviour of these diverse biological systems. 
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Appendices: 
Appendix A: The sequential order ODEs for the G1/S model  
0
1 4 5 2 0 3 0 3( )   
dx
k k x k x k x x
dt
                                                                                         (A-1) 
1
5 21 8 6 6 1 7 1 4( )   
dx
k x k x k x k x x
dt
                                                                                    (A-2) 
2
9 26 12 8 10 2 11 2 4( )   
dx
k x k x k x k x x
dt
                                                                                 (A-3) 
3
4 5 13 5 3 0 3( )  
dx
k x k x k x x
dt
                                                                                               (A-4) 
24
8 6 12 8 14 9 15 8 16 6 17 7 7 1 4 11 2 4( )       
dx
k x k x k x k x k x k x k x x k x x
dt
                                (A-5) 
5
3 0 3 19 15 21 11 4 5 13 5 18 5 14 20 5 10 44 5 18( )       
dx
k x x k x k x k x k x k x x k x x k x x
dt
                     (A-6) 
6
7 1 4 23 7 8 6 16 6 22 6 7( )    
dx
k x x k x k x k x k x x
dt
                                                                    (A-7) 
27
22 6 7 25 12 27 16 23 7 24 7 10 26 7 4 17 7( )      
dx
k x x k x k x k x k x x k x x k x
dt
                                 (A-8) 
8
11 2 4 29 9 12 8 15 8 28 8 9( )    
dx
k x x k x k x k x k x x
dt
                                                                         (A-9) 
9
28 8 9 31 13 33 17 14 9 29 9 30 9 10 32 9 14( )      
dx
k x x k x k x k x k x k x x k x x
dt
                                (A-10) 
10
34 21 11 25 12 31 13
20 5 10 24 7 10 30 9 10 35 7 10 36 9 10( )
   
    
dx
k k x k x k x
dt
k x x k x x k x x k x x k x x
                                            (A-11) 
11
20 5 10 21 11 
dx
k x x k x
dt
                                                                                                       (A-12) 
12
24 7 10 25 12 
dx
k x x k x
dt
                                                                                                      (A-13) 
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13
30 9 10 31 13
 
dx
k x x k x
dt
                                                                                                     (A-14) 
14
37 19 15 27 16 33 17 38 24
39 14 18 5 14 26 7 14 32 9 14( )
    
   
dx
k k x k x k x k x
dt
k x k x x k x x k x x
                                                                (A-15) 
15
18 5 14 19 15 
dx
k x x k x
dt
                                                                                                       (A-16) 
16
26 7 14 27 16 
dx
k x x k x
dt
                                                                                                      (A-17) 
17
32 9 14 33 17 
dx
k x x k x
dt
                                                                                                      (A-18) 
18 41
40 43 18 44 5 18
42 23
( )
1
   

dx k
k k x k x x
dt k x
                                                                        (A-19) 
19
45 21 23 46 5 19 47 11 19 48 15 19( )   
dx
k x x k x x k x x k x x
dt
                                                             (A-20) 
20
46 5 19 47 11 19 48 15 19 49 7 20 50 9 20( )    
dx
k x x k x x k x x k x x k x x
dt
                                             (A-21)  
21
52 51 21 49 7 20 50 9 20 53 21 45 21 23 54 9 21( )      
dx
k k x k x x k x x k x k x x k x x
dt
                            (A-22)  
22
49 7 20 50 9 20 55 22  
dx
k x x k x x k x
dt
                                                                                     (A-23) 
23 58
56 55 22 57 23 45 21 23
59 18
( )
1
    

dx k
k k x k x k x x
dt k x
                                                         (A-24) 
24
60 61 24 25 62 24( )   
dx
k k signal degradation x x k x
dt
                                                      (A-25) 
9
25 66 27
63 64 259 9
65 27
  

dx k x
k k x
dt k x
                                                                                             (A-26) 
26
68 21 69 26 
dx
k x k x
dt
                                                                                                         (A-27) 
27 70 24
67 27
71 24 251
 

dx k x signal
k x
dt k x x
                                                                                             (A-28) 
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Appendix B: The details of the behaviour of the key proteins in 
G1/S transition under different DNA-damage situations 
 
As mentioned in Section 4.1, proteins (E2F, CycE and CycA) are the important factors in 
G1/S transition while proteins (p53 and p21) are the significant indicators for the DNA-
damage signal and for blocking the cell cycle progression into the S phase. Therefore, we 
investigate the behaviour of these notable chemical species under normal and two different 
DNA-damage situations as shown in Figure B-1. For the normal cell, the concentration of p53 
and p21 are kept at low levels. We focus on the dynamical behaviour of E2F, CycE, CycA 
and p27 in Figure B-1 (a). Based on the biological theory and experimental findings, p27 
maintains the high concentration during the G0 phase and the early G1 phase [Sherr, 1994]. 
However, the level of p27 decreases in the G1 phase or later due to the degradation of p27 
caused by the activation of CycE/CDK2 [Vlach et al., 1997; Zerfass-Thome et al., 1997]. As a 
result, the concentration of E2F increases with the decrease in the concentration of p27. The 
reason is that the activation of E2F can promote the synthesis of CycE and CycA, and the 
increased level of CycE can promote the activation of CycE-CDK2 for p27 degradation. 
Although the activation of E2F promotes the synthesis of CycE and CycA, the expression of 
CycA is delayed compared to that of CycE [Ohtsubo et al., 1995]. It means that there is a 
discrepancy in peak time between CycE and CycA. All these results are shown in Figure B-1 
(a), which indicates that the dynamical behaviour of these chemical species revealed from the 
model in normal condition is in qualitative agreement with the biological theory and 
experimental findings.  
 
For the DNA-damage situations, the damaged signal can trigger the activation of p53. The 
activated p53 can promote the accumulation of p21 as one of the CDK inhibitors, resulting in 
the arrest of cell cycle progression [Dulic et al., 1994]. Therefore, the delays in these chemical 
species (E2F, CycE and CycA) cause discrepancies in their PTs compared to healthy cells. 
The comparison of the PT of proteins (E2F, CycE and CycA) between Figure B-1 (a) and 
Figure B-1 (b and c) is a good agreement with the experimental observations. More 
importantly, we also analyse the concentration of E2F, p21 and p53 under three difference 
intensities of DNA-damage signal as shown in Figure B-2.  According to Figure B-2, it can be 
seen that the level of p53 and p21 is very low in normal cells. More importantly, the 
concentration of p21 under the low-level DNA-damage is larger than that under the high-level 
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Figure B-1 Time course of the key chemical species in the G1/S transition under 
different DNA-damage situations: (a) Normal Cell, (b) Low DNA-damage and (c) High 
DNA-damage (Standard Protein Level = 
( )
( ( ))
C t
Max C t
, where ( )C t  denotes the 
concentration of the chemical specie and ( ( ))Max C t  is the maximum level in the time 
range). 
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Figure B-2 Time course of E2F, p21and p53 under different DNA-damage situations: (a) 
E2F, (b) p21 and (c) p53. 
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DNA-damage. This is reflected in the fact that both damage situations cause delays in E2F 
reaching the peak time but the low-level DNA-damage results in a slightly larger delay than 
the high-level DNA-damage. The larger delay for low DNA-damage allows a cell to arrest 
cell cycle and attempt repair; wheras, smaller delay for high DNA-damage reflects the 
alternative path of apoptosis/senescence taken by the cell requiring less time delay. As a result, 
the model results related to the dynamical behaviour of both p21 and E2F qualitatively 
support the experimental findings and the biological theory that the synthesis of p21 is mainly 
enhanced and induced after the low-level DNA-damage [Li and Ho, 1998]. 
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Appendix C: The details of the effectiveness of CKIs alone and 
simultaneous variation of CDK2/CKIs on lowering senescence bar 
under parameter range 50%  
 
 
 
Figure C-1 The probability β of a damaged cell passing the G1/S checkpoint in response 
to only changing CDK2 or CKIs (i.e. p21 degradation rate and p27 initial condition) for 
three different ranges of normal, 30% and 50% - specifically, CKD2 or p21 degradation 
rate reduced or p27 initial condition increased by 0%, 30% and 50%, respectively - 
using the behaviour of E2F for parameter range 50%  under different DNA-damage 
conditions: low level DNA-damage and high level DNA-damage. 
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Figure C-2 The probability β of a damaged cell passing G1/S in response to 
simultaneously changing CDK2 and CKIs (i.e. p21 degradation rate and p27 initial 
condition) for three different ranges of normal, 30% and 50% - specifically, CKD2 and 
p21 degradation rate both reduced by 0%, 30% and 50%, respectively, or CDK2 
reduced and p27 initial condition increased by 0%, 30% and 50%, respectively- using 
the behaviour of E2F for parameter range 50%  under two different DNA-damage 
conditions. 
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Figure C-3 The probability β of a damaged cell passing the G1/S the checkpoint for only 
changing CDK2 or CKIs (i.e. p21 degradation rate and p27 initial condition) for three 
different ranges of normal, 30% and 50% - specifically, CKD2 or p21 degradation rate 
reduced, or p27 initial condition increased by 0%, 30% and 50%, respectively - using 
the behaviour of CycE for parameter range 50%  under different DNA-damage 
conditions: low level DNA-damage and high level DNA-damage. 
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Figure C-4 The probability β of a damaged cell passing G1/S in response to 
simultaneously changing CDK2 and CKIs (i.e. p21 degradation rate and p27 initial 
condition) for three different ranges of normal, 30% and 50% - specifically, CKD2 and 
p21 degradation rate both reduced by 0%, 30% and 50%, respectively, or CDK2 
reduced and p27 initial condition increased by 0%, 30% and 50%, respectively - using 
the behaviour of CycE for parameter range 50%  under two different DNA-damage 
conditions. 
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Appendix D: The details of mathematical models for the p53-
Mdm2 oscillation system 
 
Table D-1 Description of variables and parameters in the four models for the p53-Mdm2 
oscillation system [Geva-Zatorsky et al., 2006]. 
 
Model variables and parameters Description 
x  nuclear p53 
0y  Mdm2 precursor 
y  nuclear Mdm2 
S  active signal 
0  Mdm2 maturation rate  
x  Mdm2-independent p53 degradation rate 
y  Mdm2 degradation rate 
xy  Mdm2-dependent p53 degradation rate 
s  Mdm2-dependent signal inactivation rate 
k  saturating p53 production rate inactivation rate 
x  p53 product rate  
y  p53-depdendent Mdm2 production rate 
S  
constant activation rate of signal (when damage is 
present) 
  delay in Mdm2 accumulation 
  linear p53 production rate  
k  P53 threshold for degradation by Mdm2  
n  cooperativity of signal 
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Table D-2 Parameter values and Initial conditions of the four models for the p53-Mdm2 
oscillation system [Geva-Zatorsky et al., 2006]. 
 
Common parameters III IV V VI 
0  - 0.8 20%  1.1 25%  - 
x  0 0 - - 
y  24 0.8 25%  0.9 30%  0.7 20%  
xy  120 - 3.7 50%  1.4 20%  
x  2.3 0.9 35%  - 0.9 60%  
y  24 1.1 55%  1.5 60%  1.0 10%  
  3.3 - - 0.9 25%  
Initial conditions     
x  0.02 0 0.02 0 
0y  - 0.1 0.2 - 
y  0.02 0.8 0.5 0.9 
S  - - - 0 
Particular parameters           0.0001k              2.0 25%           4n   
          2.7 30%s        0.9 25%S         1.7 20%k    
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Appendix E: The details of HoMP calculation  
In this research, HoMP is the ratio of the half-life and the mean period as a measure of the 
robustness the p53-Mdm2 oscillation system in respose to various levels of perturbations in 
the model parameters. The half-life of the correlation is the time corresponding to a 50% 
decrease in the intial correlation value indicated by the autocorrelation function. Now, we 
give a summary of how to generate the autocorrelation function and the mean period. 
 
In stastistics, autocorrelation can be considered as the correlation  of a time series with its own 
past and future values. The most important factor in autocorrelation is autocorrelation 
coefficients, which measure the correlation between  the given time series and a time-shifted 
version of itself. Furthermore, the autocorrelation function is a set of autocorrelation 
coefficients [Black, 2007]. Now, we take the calculation of the first-order autocorrelation as 
an example. The first-order autucorrealtion means that the lag is one time unit, and represents 
the correlation coefficient of the first N-1 observations and the next N-1 observations. The 
autocorrelation coefficent of tx  and 1tx   can be written by  
1
(1) 1 (2)
1
1 1 2 1 2
1
2 2
(1) (1)
1 2
( )( )
( ) ( )
N
t t
t
N N
t t
t t
x x x x
R
x x x x




 
 

   
    
   

 
                                                                              (E-1) 
where R is the autocorrelation coefficient, (1)x  represents the mean of the first N-1 
observations, 
(2)x  denotes the mean of the next N-1 observations and N is the length of the 
given time series. 
 
If N becomes very large, the difference between the following contents can be ignored: one is 
the difference between 
(1)x  and (2)x ; the other is difference between the summations over 
observations from 1 to N-1 and from 2 to N. Therefore, Eq. (E-1) can be simplified as  
1
1
1
1 1
2
1
( )( )
( )
N
t t
t
N
t
t
x x x x
R
x x





 




,                                                                                                      (E-2) 
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where  1
N
t
t
x
x
N


. 
 
According to Eq. (E-2), we can generalize the mathematical formula of the autocorrelation 
coefficient at lag j: 
1
1
2
1
( )( )
( ) , 1,2,3, 1
( )
N j
i i j
i
N
i
i
x x x x
R j j N
x x





 
  



.                                                                 (E-3) 
 
Once the autocorrelation function is generated, we can calcualte the half-life of the correlation, 
a time period for 50% decrease in the initial correlation value (See Figure E-1). Meanwhile, 
we also calculate the periods for the p53-Mdm2 system (time interval between a pair of 
successive peaks) as well as their mean value, called the “mean period”.  Therefore, HoMP 
can be computed based on the equation given below: 
Half-life
HoMP
Mean Period
 .                                                                                                         (E-4)  
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Figure E-1 Time evolution of the autocorrelation function, with indication of half-life, 
for the oscillation based on the behaviour of p53 for a time-length of 48 hours. The red line 
denotes the  50% decrease in the initial correlation value. 
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Appendix F: The behaviours of p53 and Mdm2 when HoMP 
equals 3 
 
 
Figure F-1 The behaviours of p53 and Mdm2 when HoMP equals 3 for 40% reduced 
parameter values for s  : (a) phase plane trajectories and (b) temporal performances of 
p53 and Mdm2. 
 
 
 
 
